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ABSTRACT 
Protein disulphide isomerase (PDI; EC 5.3.4.1) is a multifunctional enzyme 
which resides in the lumen of the endoplasmic reticulum (ER). It is 
approximated that over one-third of all human proteins fold in the ER. PDI is 
one of the main folding catalysts, specifically facilitating native disulphide 
bond formation. 
PDI has four domains, three of which have been solved and all possessing a 
thioredoxin-type fold consisting of the P-a-P-a-P-a-P-P-a structure. Due to 
the intransigent nature of the b' domain of PDI, it remains structurally un- 
elucidated. The bI domain is vitally important as it holds the principal binding 
site and is essential for PDI activity. 
The investigation of the two species which were produced during expression 
of most b' domain containing constructs led to the further biophysical 
analysis and identification of the monomer and dimer species. It was found 
that fractionation of the monomer and dimer species was vital in obtaining 
high resolution NIVIR data. 
An elaborate method using assignments from the b domain and Wx were 
used, and proved very effective in achieving the goal of full backbone 
assignment of the large 27.5 kDa bb'x protein molecule. The fruit of this 
labour is that it allowed further probing dynamic and more detailed molecular 
NIVIR analysis. 
NIVIR analysis identified evidence that the bb'x monomer species can exist in 
two forms, the closed form where the x-region binds to the W domain and 
open form where the x-region is unbound. Chemical shift analysis revealed 
several key residues involved in protein flexibility and chemical shift mapping 
revealed the interface between the b domain and Wx. Defining the interface 
described here offers a method to model the full length PDI domain structural 
organisation; which can be used to more clearly define PDI function and how 
the domains of PDI are coordinated in protein function. 
More detailed NMR analysis of relaxation dynamics (TI and T2) revealed 
significantly differing motions attributed to the b, W domains and x-region in 
the bb'x construct. The slower W domain motion is believed to be related to 
the substrate binding function, where the W domain appears to be gently 
flexing, in search for a substrate molecule. 
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Chapter 1. General Introduction 
1.1. Introduction 
This Chapter presents an overview of this study. It will summarise protein 
folding in the endoplasmic reticulurn (ER) and how protein disulphide isomerase 
(PDI), a multifunctional enzyme involved in thiol-disulphide exchange acts as a 
foldase and chaperone; facilitating protein folding. It will describe structural and 
functional information available for PDI and related proteins. Due to the 
intransigent nature of the W domain of PDI, structural determination by x-ray 
crystallography and nuclear magnetic resonance (NIVIR) has previously been 
unsuccessful. In addition, this Chapter will describe the aims of this project to 
overcome the difficulties in obtaining structural data on the b' domain by 
working on the bb'x and Wx domain constructs. Preliminary data, discussed 
later in detail, suggests that the b' domain is more stable in these constructs. 
Protein synthesis and the flow of cellular information follow a pathway with 
several critical stages starting with transcription in the nucleus of specific DNA 
segments by RNA polymerase to produce messenger RNA (mRNA). These 
mRNA molecules are then translated in the cytoplasm, with the aid of transfer 
RNA (tRNA) into proteins. These newly synthesised protein molecules are not 
immediately physiologically functional; they require folding into their native state. 
Proteins destined for secretion to the outer membrane and compartments in the 
secretory pathway such as the Golgi, must first enter the endoplasmic reticulum 
(ER) in an unfolded state and only exit once they have correctly folded and 
assembled. It is estimated that 33% of all human proteins fold in the ER (Chen 
et aL, 2005). The ER is highly regulated and has several defined functions such 
as steroid production (Miller, 2005), but the main function is protein folding and 
post-translational modification which takes place in a specialized compartment, 
the lumen of the ER. The ER therefore contains a wide variety of catalysts for 
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post-translational modifications such as N-glycosylation (Helenius and Aebi, 
2004) and protein folding such as disulphide bond formation (Sevier and Kaiser, 
2002). 
The formation of disulphide bonds requires an oxidising environment (Raines, 
1997), the ER provides this environment where the reduction potential (EO') is - 
0.18V, hence allowing the formation of native disulphide bonds. Disulphide 
bonds are covalent linkages between two cysteine residues in proteins and their 
main function is protein structure stability in the extracellular environment. 
Since any cysteine residue can, in principle, form a disulphide bond with any 
other inter or intra-molecular cysteine during the process of protein folding, the 
rate-limiting step is correct disulphide bond formation (Creighton et aL, 1995). 
Protein folding in the context of the formation of native disulphide bonds is 
carried out by the ubiquitously expressed protein disulphide isomerase (PDl) 
which can increase the rate of native disulphide bond formation by a factor of 
between 1000 to 6000 by catalysis of disulphide bond formation and 
interchange (Freedman et aL, 1994). 
In mammalian cells, proteins begin to fold co-translationally in the ER and 
folding is completed post-translationally. Proteins are synthesised by ER- 
associated ribosomes and are translocated through the ER membrane via a 
translocon believed to be the Sec6l protein complex as shown in Figure 1-1, 
part a. This combination of processes translation-translocation-sequentiaI 
folding immediately as proteins are synthesised, has been shown to enhance 
the folding efficiency of proteins, particularly with multi-domain proteins (Netzer 
and Harti, 1997). 
Newly synthesised proteins transported into the ER are retained in the ER due 
to their interactions with chaperones (ElIgaard and Helenius, 2001). Unfolded or 
partially folded proteins in ER have exposed hydrophobic regions and so are 
likely to be more prone to aggregation. Small and growing aggregates are 
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potentially cytotoxic and so a quality control method of preventing their build up 
is essential (Ellgaard and Helenius, 2003b). Chaperones are believed to be 
able to recognise proteins in this state, interact with them and prevent their 
aggregation (Fewell et aL, 2001). A two-chaperone system exists to prevent 
their build up and facilitate the folding of mis-assembled, aggregation-prone and 
newly-synthesised unfolded proteins. 
The first system involves lectin-like chaperones, calnexin (CNX) and calreticulin 
(CRT) as shown in Figure 1-1, part b. As newly synthesised glycoproteins enter 
the ER they are modified by Winked glycans consisting of two N- 
acetylglucosamines, nine mannose and three glucose molecules. Two of the 
glucose molecules are trimmed by glucosidase I and 11 (Kornfeld and Kornfeld, 
1985), the single glucose glycoprotein is then a substrate for CNX and CRT 
which bind. CNX and CRT facilitate folding by preventing aggregation and 
retaining the nascent protein in the ER, while the actual functional folding is 
carried out with the aid of accessory proteins such as UD P-g lucose: g lyco protein 
glucosyltransferase (UGGT) and ERp57, a member of the PDI family (Parodi, 
1991). The removal of the final glucose on the nascent protein leads to the 
removal of the CNX and CRT binding site and provided the nascent protein is 
fully folded, the nascent protein is then transported to the Golgi (Hebert et aL, 
1995) as shown in Figure 1-1, part c. 
The second system involves ER chaperone BiP which recognises hydrophobic 
regions of unfolded proteins (Flynn et aL, 1991). BiP belongs to the ER Hsp70 
family of proteins which all bind ATP and ADP, which regulate the binding and 
release of nascent protein molecules in a process called the ATPase cycle 
(Bukau and Horwich, 1998). The cycles of binding and release during the 
Hsp70 ATPase cycle promote the folding of the nascent protein to a more folded 
state, with the folding occurring during the release cycle and the binding 
preventing aggregation or inappropriate interactions (Hendershot et aL, 1996). 
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When proteins are released by CNX, CRT or BiP and if the secretory protein is 
correctly folded, then the secretory protein is transported out of the ER via 
transport vesicles and continues on the secretory pathway to the Golgi as 
shown in Figure 1-1, part c. If the protein is a glycoprotein then exit from the ER 
is facilitated by ER-Golgi intermediate compartment (ERGIC-53) (Schrag et aL, 
2003). Alternatively if the proteins released by the chaperones are mis- 
assembled then they are removed from the folding pathway and targeted to the 
ER-associated degradation (ERAD) pathway. The upstream signals targeting 
mis-assembled proteins to downstream degradation remain unclear. BiP is 
known to associate with the protein translocation channel (Sec6l -containing 
translocon structure) during import into the ER. (Wiertz et aL, 1996). BiP forms 
a seal on the luminal side of the ER channel during import (Hamman et aL, 
1998). This same translocation channel involved in protein import has been 
identified as the point of exit for mis-assembled proteins targeted for ER export. 
PDI has recently been shown to interact with BiP whilst bound to the 
translocation channel. Therefore a proposed method of protein export involves 
PDI delivering the mis-assembled protein to the translocon, where a PDI-BiP- 
mis-assembled protein complex forms on the luminal side of the ER which 
triggers an opening in the channel, then the mis-assembled protein can pass 
through and out into the cytosol (Gillece et aL, 1999), as shown in Figure 1-1, 
part d. During the process of exporting from the ER, mis-assembled proteins 
are polyubquitinated on the cytosolic surface of the ER membrane (Hershko and 
Ciechanover, 1998) and then degraded by the cytosolic 26S proteasome 
(Oberdorf et aL, 2001). 
During the process of ERAD, high levels of mis-assembled proteins in the ER 
also trigger the unfolded protein response (UPR), which is a coordinated 
response to reduce the levels of mis-assembled proteins as shown in Figure 1-1, 
part e. Three main ER-transmembrane sensors IRE1, PERK and AFT6 act in a 
synergic fashion (Kaufman, 2002), whereby AFT6 up-regulates the transcription 
of ER proteins and chaperones, Irel indirectly induces transcription factors that 
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facilitate ERAID, and PERK transiently attenuates translation, limiting protein 
load. This coordinated response is an efficient method of maintaining the 
balance of retaining and degrading harmful proteins and yet continuing the 
export of biologically active and essential proteins (Sitia and Braakman, 2003). 
If this response fails to clear the ER of the high concentration of harmful mis- 
assembled proteins, then apoptosis is induced (Otomo et al., 1999). 
A similar response occurs in the cytosol, whereby the accumulation of mis- 
assembled proteins in the cytosol triggers the heat-shock response which 
involves the transcriptional up-regulation of Hsp70 and other cytosol 
chaperones (Morimoto, 1998). 
Transport 
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P-R membrane 
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MRNA, 
Figure 1-1. Schematic diagram of protein folding and degradation in the endoplasmic 
reticulurn (taken from Ma and Hendershot, 2004). 
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1.2. Protein Disulphide Isomerase 
1.2.1. Activity 
PDI (E. C. 5.3.4.1) was the first identified catalyst of protein folding (Delorenzo et 
aL, 1966; Freedman, 1984), recognised by Anfinsen in 1964 to be a catalyst of 
disulphide bond formation. By studying the components involved in enhancing 
the rate of reactivation of reduced ribonuclease in rat liver lysates, this group 
found that PDI did not contribute to the net oxidation of reduced ribonuclease 
but did increase the formation rate of correct disulphides; measured by recovery 
of enzymatically active ribonuclease (Delorenzo et aL, 1966). 
1.2.2. Abundance 
PDI is present in the ER in high concentrations, possibly as high as millimolar 
concentrations, typically representing 0.4 to 0.8 % of total cellular proteins 
(Hillson et aL, 1984). The folding and assembly in the ER, of newly synthesised 
proteins is not 100% efficient and proteins can take from between 1 to 100 
minutes to achieve their fully native state (Freedman, 1995). The rate-limiting 
step is protein folding, but this occurs with the aid of many chaperones and 
catalysts of protein folding such as Erp57, Erp27, PDlp and PDL PDI in 
particular is very important as it can increase the oxidation, reduction and 
isomerisation of disulphide bonds by a factor of between 1000 to 6000 
(Freedman et aL, 1994). Without such catalysts, natural random formation of 
disulphide bonds at physiological pH would take far too long for life to be 
sustained. 
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1.2.3. PDI location 
PDI is found in a variety of species, tissues and organs; species include bovine 
(Delorenzo et aL, 1966), chicken, pigeon and pig (Venetianer and Straub, 1963). 
PDI is also found in a range of tissue such as the liver and pituitary gland, which 
have hosted the highest concentrations of PDI in mammalian species. PIDI 
cellular localisation also appears to be broad and not just localised to the ER. 
Interestingly, PDI has been linked to extracellular locations, such as the cell- 
adhesion protein retina cognin (Pariser et aL, 1998), which is reported to be 
involved in cell recognition and neuronal differentiation of embryonic retina cells. 
This protein has been speculated to be a truncated version of PDI from which 
the KDEL ER retention signal is removed (Phillips et al., 1997; Pariser et aL, 
1998). PDI is also found as a subunit of prolyl-4-hydroxylase (P4-H) and 
microsomal triglyceride transferase (MTP), discussed further later in sections 
1.2.9 and 1.2.10. 
1.2.4. Redox-Isomerase function 
Research on the refolding of denatured ribonuclease A, showed that disulphide 
bond formation could occur spontaneously (Anfinsen, 1973). It was observed 
that disulphide bond formation could occur much slower in air than in the cell, 
suggesting the involvement of enzymatic catalysis for oxidative protein folding. 
This led to the identification of the enzymatic catalyst of oxidative refolding 
(disulphide bond formation), PDI (Goldberger et aL, 1963). After exhaustive 
investigations the in vitro function of PDI has been shown to be the catalysis of 
the oxidation, reduction and isomerisation of disulphide bonds. Another 
possible method of direct oxidation by molecular oxygen is possible but without 
any catalysts the reaction would be too slow. 
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1.2.4.1. Erol 
Erol (ER oxidoreductin) is a 65 kDa flavoenzyme, associated with the luminal 
face of the ER membrane. Several Erol proteins from a number of species 
have been characterised including Human (Cabibbo et al., 2000) and 
Saccharomyces cerevisiae (Frand and Kaiser, 1998). Erol p is a yeast 
membrane associated ER protein homologue of human Erol. Erolp was 
shown to be involved in producing oxidising equivalents necessary for protein 
disulphide bond formation in the ER, since intra-molecular disulphides were not 
present in secretory proteins of Erol p knockout cells (Frand and Kaiser, 1998). 
Interestingly, mixed disulphide linked complexes between Erolp and PDIp 
(yeast PIDI homologue) were found, suggesting the PDIp is an important 
intermediate in the transfer of disulphide bonds between Erolp and secretory 
proteins (Frand and Kaiser, 1999). 
regulatory 
C7 
C150-C295 active-site 
17 C352-C355 
FAD 
jo 
C143-C166 shuffle 
C100-C105 
90 regulatory C90-C349 
C208 
Figure 1-2. Yeast Erol structure, taken from Sevier and Kaiser, 2000b. Green and yellow 
spheres highlight the cysteine side chains, orange sticks highlight the FAD cofactor. The 
polypeptide chain which contains the shuttle cysteines (residues 90-175) are highlighted 
red. 
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Erol has two pairs of catalytic cysteines, the shuttle cysteines (C100-105) and 
active site cysteines (C352-C355). There are also two pairs of regulatory 
cysteines (C90-C349, C150-C295) as highlighted in Figure 1-2 (Frand and 
Kaiser, 2000b). Erol activity and flexibility of the polypeptide chain around the 
shuttle cysteines is believed to be controlled by the regulatory cysteine pairs 
(Sevier et aL, 2007). 
Erol catalysis works by firstly direct oxidation of the PDI by the shuttle cysteine 
pair and then re-oxidation of the now reduced shuttle cysteine pair by internal 
dithiol disulphide exchange with the active site cysteine pair (Frand and Kaiser, 
2000b). Electrons are then transferred from active site cysteine pair to the flavin 
cofactor and molecular oxygen to produce hydrogen peroxide, resulting in the 
re-oxidation of the active site cysteine pair (Tu et aL, 2000). This process using 
the electron shuttling between two cysteines and direct oxidation of PDI, 
prevents Erol indiscriminately oxidising other ER proteins by controlling the 
access to the highly oxidising the FAD-active site cysteines (Sevier and Kaiser, 
2008). 
Hence Erol is involved in protein oxidation by coupling the oxidising power of 
molecular oxygen and uses its flavin cofactor to generate disulphide bonds. 
The disulphide bonds are transferred to PDI, which can then transfer these 
disulphide bonds on to the folding substrate protein molecule (Frand and Kaiser, 
1999). Therefore in the reverse direction, electrons are transferred from 
substrate proteins to PDI, from PDI to Eroll as a set of direct thiol-disulphide 
exchange reactions as shown in Figure 1-3, to achieve disulphide bonded 
substrate in their native state. Also PDI is required to reduce incorrect 
disulphides which is carried out by reduced PDI in vivo, however PDlp was 
observed in vivo to exists in the oxidised form (Frand and Kaiser, 1999). PDI 
could be reduced by GSH, so facilitate reduction and lead to isomerisation of 
disulphide bonds in substrate proteins, as shown in Figure 1-3. Hence there 
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appears to be some functional cross-talk between PDI, Erol and glutathione 
pathways (Frand et aL, 2000a). This model only considers direct 
oxidoreductase and does not address the formation of incorrect disulphides and 
their subsequent isomerisation to achieve the correct final fully folded native 
state, which has been shown to be the rate-determining step in vitro and in the 
cell (Land et al., 2003). Importantly PDI family members are the only enzymes 
which catalyse these complex rate limiting isomerisation reactions (Weissman 
and Kim, 1993). 
Disulfide bonds 
S-S ! I&ISH -S-S AN 
H20 Native/Noq 
Sub 
02 
HS SH S-S HS SH 
S-S 
m 
HS SH 
GSSG 
Native/Non 
Sub 2 GSH 
S-S 
HS SH ISOMERISATION 
Electrons 
Figure 1-3. A Graphical representation of the proposed electron flow, disulphide bond 
formation pathway for the oxidation and isomerisation of protein substrates. 
1.2.4.2. Oxidised glutathione 
Native disulphide bond formation requires an oxidising environment and in 
eukaryotes this is provided by the ER. Glutathione is a major small molecule 
redox buffer in the ER. The redox potential relies on the ratio of 1/1 or 3/1 GSH 
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(reduced) (Bass et aL, 2004) and GSSG (oxidised) (Hwang et aL, 1992) forms in 
the ER with a total concentration >1mM. The cytosolic GSH/GSSG ratio is 30/1 
to 100/1 and a total concentration of approximately 10mM; hence the ER is 20 
to 100 times more oxidative than the cytosolic environment. It is not known how 
exactly the higher oxidative state of the ER is maintained especially since, it is 
suggested that there is a preferential transport of GSH into the ER from the 
cytosol (Banhegyi et aL, 1999). 
It was shown in mutant cells unable to produce glutathione (GSH) that 
disulphide bonded proteins were still produced, indicating that although GSSG 
is the main oxidising equivalent in the ER, other chemicals could replace GSSG 
(Frand and Kaiser, 1998). Glutathione was shown to rely on oxidising 
equivalents from Erolp, as GSSG production was coupled in vivo to Erolp 
activity, hence it is likely glutathione may not be directly involved in oxidative 
protein folding pathway (Frand and Kaiser, 1998; Frand et aL, 2000a). The 
exact role of glutathione in vivo is still not known, it is suggested that glutathione 
may protect against hyper-oxidising conditions in the ER (Cuozzo and Kaiser, 
1999). 
1.2.4.3. Flavin-dependent sulfhydryl oxiclase 
It has been suggested that flavin containing monooxygenases (FMOs) which 
are known to oxidise thiols may be involved in the maintenance of cellular redox 
balance (Ziegler and Poulsen, 1977). It was recently shown with the yeast 
homolog of FIVIO, yFMO, that in yFMO inactive cells the ER were unable to 
maintain the optimal oxidising environment for the folding of disulphide bonded 
proteins (Suh et al., 1999). These experiments also showed that yFMO is 
localised to the cytoplasmic surface of the ER membrane. It is known that GSH 
reductase catalyses the NADPH dependent reduction of GSSG to GSH (Hwang 
et aL, 1992) and this is essentially the main system of controlling the redox 
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potential in the cytosol. So it appears that both GSH reductase and yFMO 
control the GSHIGSSG ratio in the cytosol and then by an unknown process 
GSH is transported into the ER. 
Members of the Quiescin-sulfhydryl oxidase (QSOX) family have a thioredoxin 
domain and a small FAD-binding domain homologous to the yeast ERVIp 
protein, which are used to oxidize sulfhydryl groups to disulphides with the 
reduction of oxygen to hydrogen peroxide. Isolated from human lung fibroblasts, 
hQSOX1a (Coppock et aL, 1993) and other enzymes from the QSOX family 
have the ability to produce disulphide bonded proteins in vitro (Hoober et aL, 
1999). QSOX enzymes have been shown to possess the ability to introduce 
disulphide bonds directly into substrate protein molecules without the 
requirement of any interaction with PDI or Eroll in vitro, but this ability causes 
the rapid and indiscriminate oxidation of substrate proteins (Hoober et aL, 1999). 
The QSOX enzyme has been shown to be localised to Golgi apparatus and so 
is believed to be involved in the later stages of the secretory pathway, either to 
maintain disulphide bonds or oxidise specific substrates (Chakravarthi et aL, 
2007). QSOX family of proteins have also been found to be distributed in a 
range of species and highly active secretory tissue (Thorpe et aL, 2002). As a 
result of the wide distribution of QSOX proteins it has been hypothesized that 
there may be new pathways of disulphide bond formation outside the eukaryotic 
ER (Chakravarthi et aL, 2007). 
1.2.5. Thioredoxin fold 
PDI is a member of the thioredoxin protein superfamily. Members of this 
superfamily have an a/P fold with an overall domain structure consisting of P- a- 
P-a-P-a-P-P-a folds (Martin, 1995), whereby the central core consists of a five 
stranded P-sheet (four are parallel except 04) which is surrounded by 4 a- 
helices as shown in Figure 1-4. The x-ray crystal structure of oxidised form of 
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thioredoxin was determined in 1990 (Katti et al., 1990) and shortly after the 
reduced structure was determined by NMR (Forman-Kay et aL, 1991). 
Figure 1-4. Structural diagram of Human thioredoxin (reduced form) PDB ID 1ERT. 
Thioredoxin is found in all species and is a small 12 kDa protein, localised to the 
cytosol, nucleus and mitochondria. This enzyme is primarily a protein reductant 
but has been linked to stimulating cell growth, inhibition of apoptosis and is 
believed to play a role in a variety of human diseases including cancer, where 
an increased level of thioredoxin was found in many human tumour cells (Powis 
and Montfort, 2001). A number of protein families such as glutaredoxin, DsbA 
and PDI, share this archetypal thioredoxin fold and have been associated with 
sulfur-based redox reactions. Most of these enzymes have a conserved active 
site motif of Cys-X-X-Cys. Thioredoxin has these two vicinal cysteines in a Cys- 
X-X-Cys tetra-peptide active site motif which is exposed between P2 and a2. 
The C-terminal Cys35 is buried behind the N-terminal end Cys residue (Cys32), 
which is highly reactive since it is surface exposed, at the N-terminal end of the 
a2 helix, with a pKa of 7.1 (Dyson et al., 1997); lower than a free cysteine which 
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would have a pKa of 8.7. It has been suggested that the buried partial charge 
on Asp26 influences Cys32 and Asp26 acts as a general acid/base for 
thioredoxin catalysed redox reactions (Chivers and Raines, 1997). The general 
method of cytoplasmic thioredoxin-catalysed cysteine thiol-disulphide exchange 
activity, involves the Cys32 in making a nucleophilic attack on a substrate 
disulphide bond producing mixed disulphides that are then further disrupted by 
the Cys35 (Figure 1-8 reactions 5,7). This causes the release of the disulphide- 
bonded Cys32-Cys35 form of thioredoxin, which itself is recycled back to its 
reduced form by thioredoxin reductase and NADPH. 
1.2.6. PDI structure 
The PDI cIDNA was first sequenced in 1985 (Edman et a/., 1985) from rat liver, 
which encoded 508 amino acids, included a N-terminal ER signal sequence and 
a C-terminal ER retrieval sequence. Using sequence homologies within the 
protein a multi-domain architecture was predicted. The current domain 
architecture, including the x-linker region has been proposed using a 
combination of experimental data (in terms of proteolysis of native PDI and the 
characterisation of recombinant fragments) and bioinformatics data. The 
current model therefore describes 4 structural domain a, b, b' and a', a C- 
terminal acidic extension and a short 19 residue x-linker region between domain 
b, and a'; as shown in Figure 1-5 (Kemmink et aL, 1997; Freedman et aL, 1998). 
The catalytic a and a' domains are separated by two non-catalytic b and b' 
domains; also the x-region. It is likely that PIDI evolved from internal gene 
duplication, which over time lost sequence similarity but retained the overall 
domain fold. Studies on the molecular evolution of PDI using phylogenetic 
analysis have suggested PIDI evolved from an ancestral thioredoxin-like double 
domain protein (Kanai et aL, 1998; McArthur et aL, 2001). 
14 
Chapter 1 General Introduction 
4 G? 
N 
. 351 463 491 
Figure 1-5. PDI domain architecture. Domain boundaries are based on NMR-derived 
structural information, homology modelling of b' domain and data from limited 
proteolysis of native PDL Residue numbers are for mature human PDL 
1.2.6.1. a and a'domains 
The a domain was the first domain structurally determined by NMR shown in 
Figure 1-6, in 1996 (Kemmink et al., 1996) and as yet unpublished NMR 
assignments and low resolution structure of the al domain has been submitted 
to the Protein data bank, PDB file 1X5C (Tochio et al., to be published). Both a 
and a' domains show a significant sequence similarity to thioredoxin, 41% and 
32% respectively. The homologous a and a' domains have a 49% sequence 
similarity and both have the Cys-X-X-Cys tetra-peptide active site motif (Cys- 
Gly-His-Cys in human PDI). This motif lies at the N-terminus of the a-helix2 and 
just prior to the P-strand 3, there is also a conserved cis-proline which is 
spatially juxtaposed and associated with substrate interactions in other protein 
family members (Kemmink et al., 1996); similar features are displayed in 
thioredoxin. 
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Figure 1-6. Structural diagram of the human PDI a domain (PDB code - 1MEK). 0-helices 
shown in red, P-sheets shown in yellow and active site residues shown in blue sticks. 
Furthermore the a domain has a buried acidic residue, GIu3O, which is in an 
analogous position to the Asp26 residue in thioredoxin, which is believed to 
affect redox properties of the protein (Martin, 1995). In addition to sharing these 
features with the thioredoxin domain, the a domain also has the same overall 
fold. Although there is no high resolution a' domain structure, - there do appear 
to be similarities with the a domain distinguishable using the low resolution 
structure. A difference between the a domain and thioredoxin is that the N- 
terminal cysteine residue in the a domain active site has a pKa of 4.5, which is 
stabilised by the active site histidine imidazole group and positive charged 
amino acid side chains which occur after the active site motif and before the N- 
terminus of the a-helix2. This results in the less stable disulphide form of the a 
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domain in comparison to thioredoxin and so results in the oxidative nature of the 
a domain in comparison to thioredoxin's reductive nature. 
Functionally, the isolated a and a' domains have redox activity; using a redox 
assay with short peptide substrates the a and a' domain were shown to have 
intermediate properties lying between a strong reductant (thioredoxin) and 
strong oxidant (DsbA), hence depending on the substrate and redox 
environment the a and a' domains can act as a reductant or oxidant. The 
activity of full length PDI on larger substrates which require complex 
isomerisation was not possible with individual a and a' domains (Darby and 
Creighton, 1995). Therefore other domains of PDI are involved and required for 
more complex reactions which involve thiol chemistry and conformational 
changes. 
1.2.6.2. C-terminal extension 
The C-terminal extension consists of 29 residues, many of which are either 
glutamate or aspartate (Pihlajaniemi et aL, 1987). This extension has been 
reported to have a putative low-affinity, high capacity calcium ion binding site 
(Macer and Koch, 1988). The functional importance of this acidic extension is 
not known, but this extension does contain the -KDEL, ER retention sequence 
which is essential to retain PDI in the ER lumen. 
1.2.6.3. b and b' domain 
The b domain has little sequence similarity to thioredoxin (only 27%) but from 
the NIVIR determined structure and like the a and a' domain, the b domain has a 
thioredoxin fold as shown in Figure 1-7 (Kemmink et aL, 1999). But unlike the a 
and a' domain, the b and b' domains do not have the conserved thioredoxin- 
like active site residues or other redox associated residues which have been 
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replaced and therefore the b and b' domains do not have dithiol-disulphide 
oxidoreductase activity. The b' domain does have a high sequence similarity to 
the b domain, which is also expected to have a thioredoxin fold. 
Figure 1-7. Diagram of the human PDI b domain (PDB ID 1BJX). a-helices shown in red 
and P-sheets shown in yellow. 
As previously mentioned, the a and a' domains alone are not sufficient for 
complex isomerisation (Darby and Creighton, 1995). Work carried out on 
various linear combinations of PDI domains using various assays to define 
transitions between oxidation, reduction and isomerisation showed that only 
simple thiol-disulphide reactions could be carried out by the a and a' domains 
(Darby and Creighton, 1995; Darby et aL, 1998). For simple isomerisation 
reactions the a and a' domain constructs required the addition of the b' domain 
and complex isomerisation reactions required all four PDI domains but did not 
require the C-terminal extension. This indicates that the C-terminal extension 
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appears to play no part in PDI function and the non-catalytic b and b, domains 
are functionally important. It was later also shown using bovine pancreatic 
trypsin inhibitor (BPTI), as a model substrate for PDI to investigate the 
redox/isomerase activity that the b' domain is very important for isomerisation 
activity (Darby et aL, 1998). It was also found that the b'a'c construct was the 
minimum PDI domain combination that allowed isomerisation of disulphide bond 
in BPTI intermediates and the addition of the b, domain to this construct 
increased the activity further. 
A specific binding site has been localised to the bI domain (Klappa et aL, 1998) 
using cross-linking assay with short radio-labelled peptides and larger 28 
residue peptides derived from BPTL This investigation revealed that the bI was 
essential for binding small peptides but requires other domains to bind larger 
peptides such as BPTI and scrambled RNase. Again as referred to earlier 
(Darby et aL, 1998) the b'a'c construct was the minimum fragment to allow 
peptide binding; followed by the abb' fragment. The bI was also shown, with 
aid from the b domain, to bind to the partially unfolded substrate protein while 
the catalytic a and a' domains can carry out their thiol-disulphide exchange 
reactions. This indicates a synergic relationship between the PDI domains to 
allow complex dithiol-disulphide oxidoreductase activity (Freedman et aL, 2002). 
These results clearly suggest that the b' domain is vitally important, holds the 
principal binding site and is essential for PDI isomerase activity. 
1.2.6.4. x-region 
The 19 residue x-linker/region between domains b' and a' was first reported ten 
years ago (Freedman et aL, 1998). The x-linker is believed to allow flexibility 
between domains and contains a single tryptophan residue. 
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1.2.7. PDI function 
Mutation studies on the C-terminal cysteine of the C-X-X-C active site, revealed 
the inability of the mutated PDI to catalyse the refolding of reduced RNase. 
PDI-Erolp-mixed disulphides were identified, suggesting that PDI is reoxidised 
after acting as a protein dithiol-disulphide oxidant (Tu et al., 2000). Similarly 
mutations in yeast PDlp also indicated PDI was essential for protein disulphide 
bond formation in the ER. 
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Figure 1-8. Reaction scheme for disulphide oxidation, reduction and isomerisation by PDI 
and other thioredoxin family members taken from (Hatahet and Ruddock, 2007). 
When PDI is in the oxidised state, a mixed disulphide is produced by 
nucleophilic attack by the substrate thiol on the N-terminal active site cysteine 
(see reaction 1, Figure 1-8). From this mixed disulphide species there are three 
possible options: 
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a) Nucleophilic attack by the substrate thiol on the mixed disulphide 
species, producing reduced PDI and a net oxidation of the substrate (see 
reaction 2, Figure 1-8) this reaction prevents PDI getting kinetically trapped as a 
mixed disulphide species. 
b) Nucleophilic attack by the C-terminal cysteine on the mixed disulphide 
molecule, producing the original products of oxidised PDI and the unchanged 
substrate (see reaction 3, Figure 1-8). 
C) Nucleophilic attack by the substrate thiol on the substrate disulphide 
bond producing an isomerised PIDI-substrate mixed disulphide molecule (see 
reaction 4, Figure 1-8) this molecule can then undergo the same reaction as 
stated in a) whereby the final product is a reduced PDI and a net oxidation of 
the substrate. 
If the PIDI is in a reduced state, again a mixed disulphide is produced, by 
nucleophilic attack by N-terminal active site cysteine (see reaction 5, Figure 1-8). 
Again from this mixed disulphide species there are three possible reaction 
options: 
d) Nucleophilic attack by the substrate thiol on the mixed disulphide, 
resulting in the return to the original state of substrate and PDI (see reaction 5, 
Figure 1-8) 
e) Nucleophilic attack of a different substrate thiol group on the mixed 
disulphide species resulting in a net isomerisation of the substrate species (see 
reaction 6, Figure 1-8) 
0 Nucleophilic attack by C-terminal active site cysteine on the mixed 
disulphide resulting in a net reduction of the substrate species (see reaction 7, 
Figure 
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PDI kinetics and activity on various model substrates have been well studied to 
provide information of the in vitro mechanisms but fall short of fully explaining in 
vivo reactions (Lyles and Gilbert, 1991; Darby et aL, 1994). Mutant forms and 
various domain combinations have also provided information of the in vitro 
mechanisms, such as substrate reduction or isomerisation (Lyles and Gilbert, 
1994; Walker et al., 1996). Mutations of CXXC active site containing domains 
have been useful as they increase the proportion of on the mixed disulphide 
species. But there are inherent limitations in these types of analyses, of mixed 
disulphide complexes undergoing isomerisation or oxidative folding, which 
would not be trapped with using active site cysteine mutations. However it is 
possible to obtain data on non-productive kinetically trapped mixed disulphides 
(Hatahet and Ruddock, 2007). Due to the multiple reaction schemes that take 
place it is very difficult interpret data obtained in these types of experiments. 
The in vitro experiments do not fully explain in vivo catalysis because the in vitro 
assays are so dependent on conditions. The only in vivo analysis for substrate 
specificity has been to knockout ERp57, which was lethal in embryonic mice 
(Garbi et aL, 2006). However, in ERp57 knock out cells, very few proteins were 
affected by the loss (Solda et aL, 2006), this indicates that ERp57 is involved in 
the folding of a few proteins or other PDI family proteins are able to compensate 
for the loss of ERp57. 
1.2.8. Molecular chaperone function 
PDI has previously been functionally described as a protein folding catalyst, as it 
increases speed of the rate limiting steps in the protein folding pathway by 
means of disulphide bond oxidation, reduction and isomerisation. But PDI can 
also exhibit molecular chaperone activity defined as the ability to prevent the 
aggregation of substrate molecules and so preventing substrates following a 
non-productive folding pathway (Wang and Tsou, 1993). PDI was shown to 
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promote reactivation and prevent aggregation of rhodanese (guanidine- 
hydrochloride denaturation or thermal inactivation), independent of 
redox/isomerase function (since rhodanese has no disulphide bonds), in vitro 
and at near stoichiometric concentrations (Song and Wang, 1995). The redox 
activity was found to be independent from the chaperone activity, since mutated 
active site residues did not affect the chaperone activity (Winter et aL, 2002). 
Furthermore it was shown that mutations in the principal binding site in b' of PDI 
(KIappa et aL, 1998) could reduce the binding and refolding of substrate, but not 
completely abolish it. This indicates the substrate binding extends through all 
the PDI domains and further analysis showed that the other domains also 
contribute to chaperone activity of PDI (Winter et aL, 2002). The substrate 
binding was earlier reported to be weak (Kd>lOOpM) and was dependent on the 
length of the substrate backbone binding to PDI, unless cysteine residues are 
involved, whereby the binding would be much stronger as a result of mixed 
disulphides forming (Morjana and Gilbert, 1991). 
PDI has also been shown to possess chaperone function using a number of 
other substrate proteins including D-glyceraldehyde-3phosphate dehydrogenase 
(GAPDH, EC 1.21.12) (Li et al., 2001). GAPDH contains no disulphide bonds 
and so is used as a target protein to examine the intrinsic chaperone activity 
devoid of disulphide-linked activity. Recently, the shorter domain combinations 
of ab and b'a'c of PDI were shown to lack chaperone function and this was 
speculated to result from the lack of protein substrate binding requiring more 
than the peptide-binding site in the b' domain (Sun et aL, 2000). 
1.2.9. PDI as a subunit of collagen prolyl 4-hydroxylase 
Collagen prolyl 4-hydroxylase, P4-H (EC 1.14.11.2) is an enzyme which like PDI 
resides in the lumen of the ER and belongs to a 2-oxoglutarate and non-heme- 
Fe (I I)-depen dent oxygenase family of enzymes. P4-H catalyses the formation 
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of 4-hyd roxypro line by hydroxylation of prolines, which requires Fe 2', 2- 
oxoglutarate, 02, ascorbate and involves the oxidative decarboxylation of 2- 
oxoglutarate (Kivirikko et aL, 1989). This catalysis is essential in the formation 
of procollagen polypeptide chains into triple helical molecules. P4-Hs are 
regarded as suitable drug targets for antifibrotic therapy to combat fibrotic 
disease which involves an excess build up of connective tissue, primarily 
collagen. 
The collagen P4-H enzyme from vertebrates consists of a C1202 tetramer with an 
approximate molecular weights of 240 kDa total (Tuderman et aL, 1975), with 
the a-subunit of 63 kDa (Pankalainen et aL, 1970) and the P-subunit of 55 kDa. 
The P-subunit was found to be PDI (Koivu et aL, 1987). It was also later found 
that two isoforms of the a-subunit existed, a(l) and a(II), which can associate to 
produce type 1 a(1)2P2 and type 2 a(11)2P2 (Annunen et aL, 1997). It was also 
shown that mixed a(I)a(II)P2 did not form in insect coexpression experiments 
(Annunen et aL, 1997). The a(l) subunit consists of 517 residues including a 17 
residue signal peptide, the a(II) subunit consists of 514 residues including a 21 
residue signal peptide and the two subunits have a 64% sequence identity 
(Annunen et aL, 1997). Recently a third a-subunit was identified, which 
consisted of 525 residues including a 19 residue signal peptide and has a 36% 
sequence identity to the a(l) subunit (Van Den Diepstraten et aL, 2003). All a- 
subunits contained five conserved cysteine residues, four of which in the a(l) 
subunit, form intrachain disulphide bonds, required to maintain the structure and 
so enable tetramer assembly (Kivirikko and Myllyharju, 1998). The a-subunits 
were also shown to have an asparagine linked oligosaccharide site, but this was 
found not to influence catalytic activity or assembly (Lamberg et aL, 1995). The 
catalytic site of P4-H is believed to be within the a-subunit and located in a 
range of separate sites to allow the binding of all the co-substrates (Kivirikko 
and Myllyharju, 1998). Using site-directed mutagenesis the Fe 2+ was located in 
the a-subunit and the residues His412, Asp414, His483 (Lamberg et al., 1995) 
24 
Chapter 1 General Introduction 
and Lys493 were seen to be involved in 2-oxoglutarate binding (Myllyharju and 
Kivirikko, 1997). 
The P-subunit of P4-H were first identified as PDI in 1987 and it was shown that 
the PIDI in the native human P4-H tetramer has half the isomerase activity of 
wild type PIDI (Koivu et aL, 1987). Later it was shown by mutating active site 
residues in PIDI, that PIDI activity was not essential for tetramer assembly or P4- 
H enzyme activity (Vuori et al., 1992a). Also, a-subunits expressed in 
baculovirus system in insect cells without the P-subunit (PIDI) formed highly 
insoluble and catalytically inactive aggregates (Vuori et aL, 1992b). It was 
demonstrated that P4-H can be assembled in a cell-free system and the 
solubility of the a-subunit is dependent upon its association with PIDI (John et al., 
1993). Hence it appears that the P-subunit (PIDI) is required to maintain the 
catalytic activity and ensure the a-subunits of P4-H are in a non-aggregated 
conformation (Vuori et aL, 1992b). The importance of PIDI in terms of 
maintaining the catalytic activity of P4-H was made clear in experiments which 
showed that co-expression of the a-subunit and BiP, a molecular chaperone, 
produced soluble but non-active P4-H enzyme. Since expression of a-subunit 
only resulted in insoluble protein, hence PIDI function as a molecular chaperone 
is required to keep the a-subunit soluble and so ensure 134-H maintains it 
catalytic activity (Veijola et aL, 1996). The P-subunit (PDl) contains the -KDEL 
ER retention signal, known to interact with receptors. Proteins with this 
sequence are retrieved from the traffic of secretory proteins and so retained in 
the lumen of the ER (Munro and Pelham, 1987). Since the a-subunit does not 
have the ER retention signal, it is believed that the P-subunit is also important to 
retain P4-H in the ER (Vuori et al., 1992b). 
Since there is no full length PDI structure or full P4-H structure, determination of 
subunit organisation is difficult. Also since the detailed mechanism of PDI 
substrate binding and function is not known, understanding PDI's role in P4-H is 
also demanding. 
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1.2.10. PDI and MTP 
Microsomal trig lyceride-transfer protein (MTP) was originally isolated from 
bovine liver microsomes (Wetterau and Zilversmit, 1984) and then later from rat 
liver and intestines (Wetterau and Zilversmit, 1986). MTP was shown to be 
composed of two subunits, a 97 kDa a-subunit and the 58 kDa P-subunit 
(Wetterau and Zilversmit, 1986); the total MTP purified molecular weight was 
found to be 150 kDa by sedimentation equilibrium experiments (Wetterau et al., 
1991), indicating the protein forms a heterodimer of the two protein subunits. 
The P-subunit was found to be identical to PDI using sequence analysis and 
immunological characterisation (Wetterau et aL, 1990). While no homologous 
protein was found for a subunit, regions of low sequence homology were found 
to lipovitellin, which is a protein found in lipoprotein complexes in egg-laying 
animals (Shoulders et aL, 1994). 
MTP was initially shown in vitro to transfer triglycerides, cholesteryl esters and 
phospholipids between membranes in the ER (Wetterau and Zilversmit, 1985) 
and later shown by kinetic analysis that transport occurs by a shuttle 
mechanism (ping-pong, Bi-Bi kinetics) (Atzel and Wetterau, 1993). It was later 
shown that MTP plays a vital role in the assembly of lipoproteins, since a rare 
genetic disease, a beta lipop roteine m ia, which results in decreased plasma levels 
of apolipoprotein b (apoB) and triglycerides, was caused by a mutation in the 
MTP gene (Wetterau et aL, 1992). 
MTP was assumed to be localised to the ER (Wetterau et aL, 1997), this was 
based on the fact that MTP was isolated from the microsomal fraction which 
consists primarily of the ER membrane. Also, since MTP includes a PDI subunit, 
which has the -KDEL signal, it was assumed that MTP would be retained in the 
ER and could not move out into the Golgi. MTP is associated with lipoprotein 
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assembly, but plasma very low density lipoproteins (VLDL) are believed to be 
assembled by sequential addition of lipids to already existing nascent molecules 
in the ER and Golgi (Higgins and Hutson, 1984). Hence contrary to the MTP 
ER localisation hypotheses, it was speculated that MTP was not restricted to the 
ER. Later it was found using immunohistochernical studies and confocal 
microscopy, that MTP was indeed co-localised to the ER and to within the Golgi 
apparatus (Swift et al., 2003). 
MTP was shown to possess two classes of lipid binding sites; the first class, 
rapidly transports neutral lipids and phospholipids between MTP and 
membranes. The second class, slowly transports lipid molecules between MTP 
and membranes and appears to be selective for phospholipids (Atzel and 
Wetterau, 1994). The lipid binding pocket was speculated to be hydrophobic 
and flexible, since it can bind neutral and polar lipid molecules; the influence on 
substrate binding from the P-subunit (PDI) binding site is not known. 
The carboxy-terminal 30 amino acids of MTP a-subunit was found to be vital in 
interactions between the a and P subunits, since truncated a-subunit was 
unable to form a soluble complex with the P-subunit (PDI) (Ricci et aL, 1995). 
The PDI P-subunit is known to be vital to ensuring the a-subunit maintains a 
catalytically active state and soluble complex, since dissociated a-subunits 
formed inactive insoluble protein aggregates (Wetterau et aL, 1991 b); this was 
further proven, since individually expressed a-subunit also formed inactive, 
insoluble aggregates (Lamberg et aL, 1996). Also shown was that the redox 
activity of PDI was not essential to ensure assembly and maintain functional 
activity of MTP. Both active sites in PDI were mutated and yet the comparable 
MTP activity and solubility was recorded from both mutant and wild-type co- 
expression experiments with PDI (Lamberg et aL, 1996). 
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1.3. PDI Family 
PDI is the archetypal representative of the family, proteins in the family 
comprise of at least one thioredoxin-like domain. This section aims to 
summarise the domain organisation and highlight the structural/functional 
information available for human PDI family member domains and for PDI-like 
proteins from other species as shown in Table 1. 
1.3.1. Human PDI family members and structurally determined 
related proteins 
Although the name protein disulphide isomerase implies isomerase ability; this 
is not true or has not been experimentally proven for all family members, such 
as PIDILT (van Lith et al., 2007). In the case of ERp27 and ERp28, it is likely 
that since they lack any catalytic domains, they show no isomerase activity. 
Hence, all family members do not share a common function, they are related 
and grouped on the basis of their common structure (in terms of the thioredoxin 
fold which can be catalytic or non-catalytic), sequence similarities and ER 
localisation. The three related PDI proteins from Saccharomyces cerevisiae, 
oryctolagus cuniculus and Humicola insolens, are included here since they are 
the only related proteins which share an appreciable sequence similarity 
coinciding with available three-dimensional structural data. 
All family members share in common at least one domain either a or b. 
ERp28/29 (named either in literature) is an exceptional member in that it has a 
non-thioredoxin like, helical D-domain at the C-terminus (Liepinsh et aL, 2001). 
A second exception is ERdj5 (Cunnea et aL, 2003) which has a N-terminal J- 
domain, which associates with BiP (Hsp70 chaperone family member) in an 
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ATP-dependant manner which enhances ATPase activity (Hosoda et aL, 2003). 
Also, most PDI family members are ER localised, with the aid of C-terminal - 
KDEL or a -KDEL variant ER retention signal. The exceptions to this are Hag2 
(KTEL), Hag3 (QSEL), ERpI8 (EDEL), which may not be localised to the ER but 
this is not proven since there is no H. sapiens expression analysis to date 
(Persson et al., 2005). ERp44 was initially identified as a ER-located binding 
partner for Erol, involved in thiol-mediated retention of client proteins (Anelli et 
al., 2002). ERp44 has a -RDEL motif but was found to be not retained in the 
ER, but co-localised to the ER and ER-Golgi intermediate compartment and cis- 
Golgi (Gilchrist et aL, 2006). 
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Table 1: 
Species Source Amino Protein Domain PDB code 
Acids architecture 
Homo sapiens 508 
Homo sapiens 505 
Homo sapiens 645 
PDI 
ERp57 
ERp72 
a-b-b'-x-a'-c 
a-b-b'-x-a'-c 
a-a-b-b'-x-a'-x 
a: 1MEK 
b: 1BJX 
a': lX5C 
a: 2ALB 
bb': 2H8L 
a': 2DMM 
a 2DA 
a 2DJ2 
a' 2DJ3 
a ASEN 
b-D: 10VN 
a: 2DML 
a': lX5D 
Homo sapiens 172 ERp18 a 
Homo sapiens 261 ERp28/ERp29 b-D 
Homo sapiens 440 P5 a-a'-b 
Homo sapiens 432 ERp46/endoPDI a-a-a' a': 2DIZ 
Homo sapiens 525 PDlp a-b-b'-x-a'-c 
Homo sapiens 519 PDlr b-a-a-a-c 
Homo sapiens 793 ERdj5 J-a-b-a-a-a' 
Homo sapiens 273 ERp27 b-b' 
Homo sapiens 584 PDILT a-b-b'-x-a'-c 
Homo sapiens 406 ERp44 a-b-b' 
Homo sapiens 165 HAG3 a 
Homo sapiens 175 HAG2 a 
Saccharomyces 522 PD11p a-b-b'-x-a'-c 2B5E 
cerevisiae 
Oryctolagus 367 Calsequestrin lA8Y 
cuniculus 
Humicola 133 PDI U 2DJK 
insolens 
Table 1. Summary of protein information for 15 human ER resident-PDI-family members 
and three PDI-like proteins from other species. Highlighted in red are domains which 
have solved three-dimensional structures. J- dnaJ domain, D- helical domain. 
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1.3.2. Structural/functional data available for PDI family and 
related protein 
The most complete structural information for a human PIDI family member is that 
for ERp57, whereby the individual a and a, domains have been structurally 
determined by NIVIR (Silvennoinen et aL, 2001; Silvennoinen et aL, 2005) and 
the bbl domain combination by x-ray crystallography (Kozlov et aL, 2006). No 
structural information for a full length human PIDI family member, incorporating 
all four a, b, b' and a' domain is available and apart from the bb' domain 
combination of ERp57, no other human b' domain structural information is 
available. Until 2006 the closest protein with sequence similarity and three- 
dimensional structural data was calsequestrin which was determined in 1998 by 
X-ray crystallography (Wang et aL, 1998). It was not until 2006, that the bbl 
domain combination was structurally determined by x-ray crystallography 
(Kozlov et aL, 2006), shortly after the NIVIR assignments of the thermophilic 
fungal Humicola insolens W domain were published (Nakano et aL, 2006). Also 
that same year and most importantly, the first full length PIDI structure from 
Sacchar-omyces cerevisiae (Yeast) was reported, solved by x-ray 
crystallography (Tian et aL, 2006). 
No three-dimensional structure of the full length human PDI molecule has been 
solved to date or of any other human catalytically active PDI family member. 
The only experimental data available on full length human PDI comes, again 
very recently, from low resolution small angle x-ray scattering (SAXS) (Li et al., 
2006). As shown in Figure 1-9, the SAXS data revealed an elliptical cylinder 
structure which when modelled with two a domains (replacing a' with a, since no 
high resolution a' structure is available) and two b domains (replacing bl with b, 
since no bl domain structure is available) appear to show PDI having an annular 
arrangement. Interestingly, this is similar to the twisted "U" structure of the full 
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length Saccharomyces cerevi . siae PDI (Tian et al., 2006), discussed in more 
detail in section 1.3.5. Although as a result of the low resolution of the SAXS 
data, no definitive comparisons can be made. 
Figure 1-9. Model of human PDI structure using SAXS data, superimposed with two b 
domains, IBJX (pink and green domains) and two a domains, IMEK (blue and yellow), 
showing an annular arrangement of a-b-b'-a' in the counter-clockwise direction taken 
from Li et al, 2006. 
1.3.3. ERp57 
Other than PDI, ERp57 is the most characterised of all the PDI family members. 
ERp57 has 505 residues including a 24 amino-acid N-terminal signal sequence 
(Bourdi et aL, 1995) and a -QDEL ER retrieval sequence. ERp57 has also 
been shown to have the same domain architecture as PDI, in that it has two 
thioredoxin-like catalytic active a and a, domains with similar and similarly 
positioned active site residues (Ferrari and Soling, 1999). The sequence 
identity between PDI and ERP57 has been reported to be 29% and 56% 
similarity, but ERp57 has been shown to be unable to substitute for PDI as the 
P-subunit in P-4H (Koivunen eta/., 1996). 
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ERp57 is multifunctional, like PDI and has been shown, in vitro, to act as a 
oxidoreductase (Frickel et aL, 2004). ERp57 has also been shown to be 
involved with calnexin, calreticulin to fold glycoproteins (Ellgaard and Frickel, 
2003a). This pathway termed the calnexin cycle, involves firstly synthesis of a 
protein molecule, which is then N-glycosylated, has two glucose residues 
trimmed to produce a GlclMan9GIcNAc2 glycoprotein which binds to ERp57 
and calnexin or calreticulin (lectin-like chaperones) (Zapun et aL, 1997; Zapun 
et aL, 1998). The complex of ERp57 and calnexin or calreticulin can then allow 
correct formation of disulphide bonds via the interaction of ERp57 and the 
substrate (Helenius et aL, 1997). 
As highlighted in Table 1, the a and a' domains have been structurally 
determined and the bb' domain combination. The a and a' domains have 
approximately 50% sequence identity and the b and b' domains have 
approximately 20% sequence identity. The closest structural homolog to the 
ERp57 bb' domain combination was Saccharomyces cerevisiae (Yeast) PDI, 
which when superimposed gave a rmsd (root mean squared deviation) of 3.5 
Angstroms over 199 residues, indicating a similar orientation of both domains in 
both proteins (Kozlov et aL, 2006). This b' domain from ERp57 is the only PDI 
human family member b' domain structure available, highlighting the difficulty in 
crystallisation and obtaining NIVIR spectral data on this domain. 
The bb' ERp57 construct (PDB code 21-181) includes the x-region; when the bI 
sequence of the bb' construct is aligned with human PDI b'x, a 22% sequence 
identity and a 39% sequence similarity is observed. Whereas if human bI 
domain alone is aligned with the b' region of bbI ERp57 domain then 18% 
sequence identity and a 32% sequence similarity is observed. The human b' 
domain consists of 123 residues, human Wx has 147 residues, the ERp57 bI 
sequence has 139; too long to be a lone domain and since the sequence 
similarity and identity increase when aligned with the human b'x construct, it 
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appears that the ERp57 bb' di-domain construct indeed includes the x-region. 
Interestingly, as shown in Figure 1-10, the C-terminal section or x-region of 
construct appears free and not bound to or in close proximity to the rest of the b' 
domain, this observation is discussed in greater detail in the discussion. 
Figure 1-10. Secondary structure diagram of b, b' domains and x-region at the C- 
terminus of ERp57 taken from Koszlov et al, 2006. 
1.3.4. Calsequestrin 
Calsequestrin is a 40 kDa protein, located in the luminal spaces of the terminal 
cisternae of the sarcoplasmic reticulum in muscle cells and is involved in the 
regulation of the Ca 2+ ion channel (Kawasaki and Kasai, 1994). Until as recently 
as 2006, the closest protein with sequence similarity and three-dimensional 
structural data to PDI was calsequestrin, which was solved in 1998. 
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Calsequestrin is made up of three domains (DI, DII, Dill) all thioredoxin-like but 
showing low sequence similarity to thioredoxin (Wang et aL, 1998). The highest 
similarity between individual calsequestrin domains and individual PDI domains 
were 39% similarity for DI and PDI a domain and 46% for DII and PDI b domain, 
but the Dill gave very low similarity to all PDI domains, 6.7% with PDI bI domain. 
Hence it is possible to use calsequestrin to infer structural information with 
regards to the PDI a and b domains, but since low sequence similarities are 
measured with the b' domain, similar suppositions can not be made. 
Figure 1-11. Secondary structure diagram of the Calsequestrin taken from Wang et al, 
1998. 
1.3.5. Yeast - PD11 p 
PD11p from Saccharomyces cerevisiae (Yeast) was the first full length PDI 
structure solved by x-ray crystallography in 2006 at 2.4 Angstrom resolution 
(Tian et al., 2006). The sequence similarity between PDI and PD11 p is high and 
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by superimposing the a and b domains of PD11p and PDI, there were rmsd's of 
1.4 Angstroms for 106 Ca atoms and 1.8 Angstroms for 75 Ca atoms, 
respectively. There is an insertion in PD11p, in the middle of the b' domain, the 
implication of which is as yet unknown. There is also reported to be an 
approximately 700 AngstroM2 buried surface area between the b and b' 
domains, this interface poses as a hydrophobic patch and is surrounded by the 
active sites from the a and a' domain, producing a continuous hydrophobic 
surface. This hydrophobic cleft is speculated to be large enough to 
accommodate a folded protein of approximately 100 residues. This is 
speculated to be crucial for the interaction of PDI and substrate proteins. Since 
exposed hydrophobic residues in unfolded or partially folded substrates could 
be suppressed by sequestering them in the PDI 1p hydrophobic cleft (Tian et aL, 
2006). As shown in Figure 1-12 PID11p is a U-shaped molecule with a 28 
Angstrom space between the C61 and C406 active site residues which face 
each other, which is in agreement with structural data using SAXS collected on 
human PDI (Li et al., 2006). 
There are some distinct differences between PD11p and human PDI, one is that 
the human PDI C-terminal extension is believed not to hold any functional 
activity (Darby et aL, 1998), yet the it has been shown to be involved in PDI Ip 
activity (Tian et aL, 2006). Also the redox potentials of the a and a' domains are 
more similar in PDI to each other than in PDI I p. 
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Figure 1-12. Ribbon diagram of PD11p domains. The active site cysteines in the a and a' 
domain shown in space fill representation and sulphur atoms in yellow, taken from Tian 
eta/2006. 
1.3.6. Thermophilic fungus b' (2djk) 
No functional data has been reported for the PDI protein isolated from the 
thermophilic fungus, Humicola insolens, but a low resolution NMR structure has 
been deposited, PDB code 2djk (Nakano et al., to be published). The reported 
W domain isolated from Humicola insolens consists of 133 residues, longer than 
the human b' domain and a greater sequence similarity is recorded when 
compared to b'x than the b' domain. Hence it is likely that the Humicola 
insolens W domain (2djk) is actually the b'x domain combination. The human 
bIx and 2djk has a 26% sequence identity and has sequence similarity of 43%. 
The secondary structure of 2dik does appear to have the consensus a-P-a-p-a- 
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P-P-a thioredoxin fold motif and since the sequence similarity and identity is 
reasonably high, it is likely that the human W will also have thioredoxin fold. 
Figure 1-13. Ribbon diagram of Thermophilic fungus Humicola insolens b' (PDB ID - 
2djk). 
The same group who submitted the backbone assignments of Humicola 
insolens W domain, also submitted those for the Humicola insolens a' domain 
(Nakano et al., 2006). But as yet no full structure has been deposited in the 
PDB data bank. 
1.3.7. Human bb'chemical shifts 
The most important and relatable structural information to date was the bb' 
domain NIVIR chemical shifts assignments, published two years into this study in 
2006 (Denisov et al., 2006). The chemical assignments are from human PDI 
residues 135-357, this construct has an extra 5 residues on the N-terminus 
which are not found in the human PDI sequence. But more importantly, the 
construct has only the first 7 residues of the widely accepted x-region 
(Freedman et al., 1998) and lacks the final 12 residues of the x-region. The 
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implications of this trimmed version of essentially the bb'x domain are 
discussed later in the Discussion section. 
1.4. Protein NMR Spectroscopy 
This section does not aim to give a complete and detailed description of nuclear 
magnetic resonance spectroscopy, but in order to understand the NIVIR 
experiments carried out in this research, a basic understanding of NIVIR theory, 
terms and nomenclature is required. This section aims to give a brief 
introduction to the various NMR experiments used in this research. 
X-ray crystallography and nuclear magnetic resonance spectroscopy are the 
only two bio-physical methods which can provide high resolution structures of 
biological molecules at atomic resolution. The advantages of NIVIR over 
crystallography is that NIVIR uses molecules in solution and so crystallisation is 
not required; hence NIVIR is not limited to those proteins that crystallise well. 
Without the need for crystallisation NIVIR samples are not prone to crystallisation 
packing affects, so NIVIR will provide information on a protein structure which is 
closer to its native-like structure in the cell. Furthermore, crystallisation is often 
a bottleneck in structural determination in x-ray crystallography, whereas NIVIR 
is more reliable and the major limiting factor is the time taken to analyse data. 
NMR also allows the study of molecular properties in addition to structural data, 
such as protein flexibility and ligand binding. This is not possible with 
crystallography as it would require a new ligand bound crystal. NMR can 
provide information about conformation or chemical exchange, internal mobility 
and dynamics at timescales ranging from picoseconds to seconds. Hence, 
flexible loops regions can easily be seen by NMR but in crystallography these 
are not visible due to spatial averaging of the electron density. The greatest 
advantage of NMR over crystallography is the analysis of interactions with other 
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molecules such as protein-protein and protein-ligand. For example a protein 
ligand can be titrated into a protein sample, which induces chemical shift 
changes in the spectrum for residues which lie near the binding site. Therefore 
chemical shift mapping can locate the binding site and determine the 
dissociation constants (KD). 
The only drawback is an upper weight limit of proteins for NIVIR structural 
determination, which is approximately 50kDa, but with recent advances in 
magnetic field strengths, the use of segmental labelling (Otomo et aL, 1999) and 
cryoprobes NMR spectra can be collected for molecules over 1OOkDa. But, x- 
ray crystallography provides the only method of high-resolution structural 
determination over these NIVIR limits. 
In the case of PDI and PDI family members, protein flexibility is likely to be the 
main reason why crystallisation of the W domain have failed, this is an inherent 
problem in crystallisation of proteins, it is widely known that compact, stable 
proteins produce the best diffracting crystals for study. Until very recently 
structural data on PDI family members was derived from NIVIR studies only, as 
discussed in the previous section. Therefore, NIVIR offers the most optimistic 
method to obtain structural data on the b' domain. 
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1.4.1. Basic principles of NIVIR 
Jo 
Figure 1-14. Diagram representing the motion of a nucleus in an external magnetic field, 
adapted from (Evans, 1995). B, - magnetic field, p- magnetic moment and J- nuclear 
angular momentum. 
Nuclear magnetic resonance relies on atoms which have a magnetic moment or 
spin 1>0. Nuclei with an even mass number and even charge number have no 
3 
nuclear spin (I = 0). Nuclei with an odd mass have a half integral spin (1=1/2 , 
/2 
etc. ). Nuclei with an even mass and odd charge number have an integral spin (I 
= 1,2 etc. ). The most common biological nuclei 12C, 14 N, 16 0 have an I =0 and 
so do not give NIVIR spectra. Fortunately 1H has a nuclear spin Of 1/2. Carbon 
and Nitrogen nuclei can only be observed when isotopically labelled with 13C 
and 15 N which have an I= 1/2, to enable the collection of NIVIR spectra. The 
nuclear magnetic moment (p) is given by p= yl. The gyromagnetic ratio, y, is a 
constant which determines the resonant frequency of the nucleus in a given field. 
A nucleus with a nuclear spin Of 1/2 can be viewed as a small bar magnet (as 
shown in Figure 1-14), where a nucleus in an applied magnetic field B0, the 
magnetic moment p experiences a torque which is the vector product of the 
nuclear angular momentum, J. The nucleus, when placed in a static external 
field, has an energy which varies depending on the orientation to the field. The 
41 
Chapter 1 General Introduction 
two possible energies are quantised as a or P corresponding to parallel or 
antiparallel orientations of the nucleus to the external field. Hence, when a 
NIVIR sample is placed in a static magnetic field B. the spins of molecules are 
either in an a or 0 state as shown in Figure 1-15. 
P anti-parallel 
E 
a Parallel 
Bo 
Figure 1-15. Diagram showing the energy levels for a nucleus. B, - Magnetic field, E- 
Energy, AE - Change in energy. 
The population between a and 0 energy states will be unequal, since a parallel 
orientation on the z axis, which is the same direction as the magnetic field has a 
lower energy than the antiparallel one. Hence there is a net magnetisation in 
the z axis (called M. ) and so ensembles of spins are aligned to the z axis as 
shown in Figure 1-16. 
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z 
Bo 
y 
Figure 1-16. Diagram showing the z axis magnetisation (M, ) in the same direction as the 
magnetic field (B, ) 
So in order to induce nuclear magnetic resonance, an oscillatory magnetic field 
is applied at a frequency which matches the difference between the two spin 
energies (AE). These resonance frequencies correspond to radiofrequency 
wavelengths at the low frequency end of the electromagnetic spectrum. The 
frequencies required to induce resonance of all the nuclei in a protein will vary 
slightly as a result of chemical environment, so a range of frequencies is 
required. The range of frequencies can be encoded into a short radiofrequency 
pulse which is then applied, allowing an induction for the complete frequency 
spectrum in one experiment called a Fourier transform NMR. The output of this 
experiment is a super-position of the frequencies for every spin in protein 
molecule as a function of time F(t), this is mathematically transformed into F(w) 
an intensity as a function of frequency. 
1.4.2. Chemical shift 
The resonant frequencies also called chemical shifts, measured in parts per 
million (ppm) and vary in different nuclei as a result of shielding of magnetic field 
by electrons in the local environment of the nucleus. Chemical shift (6) is used 
to describe the position of a frequency, V, of a NIVIR signal in relation to the 
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signal from a standard of known frequency, as defined by 6= Pref - Vobs)N, f)x 
106 where V, f is the resonance frequency of a standard substance, Vobs is the 
resonance frequency observed (Hammes, 2005). Chemical shifts are 
dimensionless and are independent of magnetic field strength. 
So it is possible to distinguish between various nuclei spins, for example the 
shielding from a backbone amide proton HN will give a different chemical shift to 
the Ha in the same protein because each hydrogen nucleus has a different 
chemical environment. In this way, NIVIR can be used to assign individual NIVIR 
signals to specific atoms in a molecule. 
1.4.3. HSQC 
Heteronuclear Single Quantum Correlation (HSQC) is a 2D experiment which 
detects correlations between the 1H atoms and the directly bonded NIVIR active 
heteroatoms 15 N or 13C (Maudsley and Ernst, 1977). NIVIR samples prepared 
for HSQC analysis are 15 N-labelled and so provide information for the amide 
backbone and side chain NI-12 groups (seen as a pair of peaks in the 1H 
dimension, as shown in Figure 1-17). 
Glycine 
CL 
Aliphatic 
.C hydroxyl (1) residues 
M 
Aliphatic 
residues 
except 
z Glycine 
Aromatic 
Basic an IH Chemical Shift (ppm) acidic 
d 
residues residues 
Figure 1-17.15NPH HSQC spectrum of '5N-bb'x domain at 400C used to highlight the 
average chemical shifts for residues groups. 
" 
-U- 
"\ cc 
'. 
. _! .... 
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The chemical shifts highlighted in Figure 1-17 are average chemical shifts for 
different protein side chains groups and glycine; actual recorded chemical shifts 
may vary since they are dependent on the local chemical environment. 
1.4.4. Through-bond experiments for sequential assignment 
In order to order to obtain structural data on macromolecules, multidimensional 
NIVIR is required. Multidimensional NIVIR relies on the principle of linking two 
resonances, either through space or through a small number of chemical bonds. 
The resulting cross-peaks give information on spatial relationships. The method 
of choice for sequential assignment is triple resonances experiments such as 
HNCACB (Grzesiek and Bax, 1992b) and CBCA(CO)NH (Grzesiek and Bax, 
1992a) which uses, as the name suggests, three different nuclei (1H, 13C, 15 N) 
that are correlated. The experiments are performed on double labelled (13C, 15 N) 
protein samples. 
1.4.4.1. HNCACB 
The HNCACB experiment is a 3D experiment which correlates the amide 11-1, 
15 N resonances with both the intraresidue Ca and CO resonances, and with the 
13Ca 
and 
13Cp 
of the preceding residue as shown in Figure 1-18. 
HH HH 
--N C -C 
HH0H 
1-1 residue i residue 
preceding residue 
Figure 1-18. A dipeptide segment of a protein backbone showing correlations obtained in 
HNCACB experiments. 
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1.4.4.2. CBCA(CO)NH 
The CBCA(CO)NH experiment is a 3D experiment which correlates the 1H and 
15 N amide resonances of one residue with both 13 Ca and 13C P resonances of its 
preceding residue via the intervening 13CO spin as shown in Figure 1-19. These 
experiments complement the HNCACB experiments and the two are used 
together for sequential assignment. 
Cp- H 
Ca- C 
H0 H0 
i-1 residue i residue 
preceding residue 
Figure 1-19. A dipeptide segment of a protein backbone showing correlations obtained in 
CBCA(CO)NH experiments. 
1.4.4.3. TROSY 
The increased size in protein molecular weight is accompanied with faster 
decay of the NMR signal due to relaxation. The NMR spectral line widths are 
inversely proportional to the relaxation rate; hence the signal-to-noise ratio is 
much higher for larger proteins. Transverse relaxation-optimised spectroscopy 
(TROSY) (Pervushin et al., 1997) has been shown to improve the sensitivity of 
triple resonance experiments by suppressing the transverse nuclear spin 
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relaxation; the event that causes the deterioration of NIVIR spectra for larger 
molecular structures. The sensitivity can be increased with deuterated 13C, 15 N 
labelled proteins (Salzmann et al., 1998). 
1.4.4.4. HNCA 
The HNCA (Salzmann et aL, 1998) is also a 3D experiment, which in this 
research was carried out on a uniformly deuterated 13C, 15 N labelled protein to 
maximise sensitivity and resolution. The HNCA experiment correlates 15N 
amide resonances of one residue with the Ca intraresidue shift as shown in 
Figure 1-20. 
Cp- -- HH Cp 
Ncc 
H0 HH0 
i-1 residue 1 residue 
preceding residue 
Figure 1-20. A dipeptide segment of a protein backbone showing correlations obtained in 
HNCA experiments. 
1.4.4.5. TROSY - HN(CO)CA 
The 3D HN(CO)CA (Salzmann et al., 1998) is the complementing experiment 
for the HNCA experiment, used together for sequential assignment. This 
experiment correlates the 15 N amide resonances of one residue with the 
intraresidue Ca via the intervening 13CO spin, shown in Figure 1-21. 
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H Cp HH 
--N Ca- C 
0 HH0H 
i-I residue i residue 
preceding residue 
Figure 1-21. A dipeptide segment of a protein backbone showing correlations obtained in 
HN(CO)CA experiments. 
1.4.5. Through-space experiments 
The HetNOE and Tj/T2 relaxation were the two types of through-space 
experiments carried out in this research. As the name suggests measurements 
recorded are those through-space interactions between magnetic dipoles of two 
nuclear spins. The use of relaxation studies to obtain dynamic properties of 
biological proteins was recognised in the early 1970's (Allerhand et al., 1971). 
Early dynamic experiments in the 1980's involved observations made using 1D 
NMR techniques, due to lack of resolution of 1D experiments, dynamic also 
suffered from low resolution and sensitivity (Fuson and Prestegard, 1983; Smith 
et aL, 1987). More recently, now well established NMR relaxation experiments 
using 2D pulse schemes have been developed to provide higher resolution data 
pertaining to the internal dynamics of proteins (Kay et al., 1989; Clore et al., 
1990). Data on the internal motional properties are important as they aid the 
understanding of protein functionality (Brunger et al., 1987; Buchberger et a/., 
2000). 
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Modern TI/T2 experiments have been analysed using the model-free formalism 
for isotropic proteins where motions are described byrm global correlation time, 
a generalised order parameter S2 (degree of spatial restriction of motion) and 
effective internal correlation time, r. (Lipari and Szabo, 1981; Lipari and Szabo, 
1982). The main dynamic parameter for Tj/T2 is the global (overall) correlation 
time (, rm or rc) which is defined as the time taken for a molecule to rotate I 
radian (57.3'). Therm is related to diffusion coefficient of a molecule in solution 
hence is dependant on protein size, temperature and solution viscosity. The Tm 
is in the order of several nanoseconds (10-9) and the magnitude of 'rm increases 
with molecular size and so rm can give information on the overall shape of a 
molecule. Nuclear motion faster than rm are found in loop regions and in the 
order of nano to picoseconds (10-9 to 10-12). Side chain motions and movement 
of secondary structure elements are of slower order, milliseconds to 
nanoseconds (10-3 to 10-9). These types of motions for single residues and 
globally for the whole molecule including size/overall shape can be analysed 
using the Tj and T2 relaxation measurements. 
1.4.5.1. T, relaxation 
Relaxation is the summation of the process which involves magnetisation decay 
over time. Heteronuclear longitudinal relaxations (Ti) also known as spin lattice 
relaxation involves redistributing the populations of the nuclear spin states in 
order to reach the thermal equilibrium distribution, the nuclear spin energy is lost 
to the surroundings or lattice. A Tr/2 pulse is applied which results in a 
magnetisation in the xy plane, the relaxation involves the return of the 
magnetisation with a time constant T, (see Figure 1-16). The rates of T, 
relaxation are strongly dependent on the NIVIR frequency and vary considerably 
with magnetic field strength, BO. The T, rate is dependant on specific tumbling 
and internal protein properties, giving information on the size and shape of the 
protein; in terms of global Tm on a nanosecond motion scale. 
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1.4.5.2. T2 relaxation 
Heteronuclear transverse relaxation time (T2) also known as spin-spin relaxation, 
whereby nuclear spin coherence or energy is lost to a neighbouring spin system 
and is the decay constant for the component of M, perpendicular (y axis) to M, ' 
as shown in Figure 1-22. T2 gives information on the nanosecond time scale, 
hence global motions but are affected by slower internal motions in the protein 
(Te). So the T2 data give information on both the nanosecond time scale and 
slower internal motion on the micro-nanosecond time scale (10-6 to 10-9). 
The T2 decay follows an exponential decay; T2 is defined as the time required 
for the transverse magnetisation vector to return to 37% of the starting 
magnitude after the 90' excitation pulse. The two relaxation rates individually 
can be used to measure the backbone dynamics and together to analyse the 
anisotropy of molecular tumbling of the protein in solution. 
z 
Bo 
Li x 
Figure 1-22. Diagram showing transverse magnetisation (T2)- z axis magentisation (M, ) 
in the same direction as the magnetic field (B, ), the transverse magentisation (M, ) is 900 
on the y axis. 
51 Pulse 
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1.4.5.3. HetNOE 
Heteronuclear Nuclear Overhauser Effect (HetNOE) is used to measure internal 
motions of proteins, providing information about the motion of individual N-H 
bond vectors. NOE's are observed between the amide proton and nitrogen 
NOE, and is the change in the intensity of an NIVIR resonance associated to 
cross-relaxation or transfer of magnetisation through space between atoms in 
close proximity and is more negative as fast picosecond motions increase. A 
decreased NOE intensity relative to the average observed for the majority of the 
residues indicates motion faster than the overall tumbling of the molecules. A 
standard HSQC is collected and then again with 1H saturation to record 1H - 15N 
NOEs (Kay et al., 1989). 
1.4.6. Deuteration 
In large proteins assignments have been impeded by the fast transverse 
relaxation of spins which increase with the protein molecular size (Wagner, 
1993). Uniform deuteration reduces the transverse relaxation rates for IHN, 15N 
and 13C spins, this enables better resolution and improved data quality, which 
when accompanied with the use of TROSY experiments enabled backbone 
assignment of large proteins (Salzmann et aL, 2000). The deuteron has a much 
smaller gyromagnetic ratio (1/6.5 that of a proton) so reduces the 11-1_13 C dipolar 
relaxation of the 13 C nuclei. The transverse relaxation of the Ca is reduced 
fivefold in cleuterated proteins (Matthews, 2004). 
1.4.7. Secondary structure prediction 
The Torsion Angle Likelihood Obtained from Shift and sequence similarity 
(TALOS) is a database system for empirical prediction of the phi and psi 
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backbone torsion angles (Comilescu et aL, 1999). Torsion angles are important, 
since they are used in the Ramachandran plot which defines the helix and 
strand secondary structure and form the output of this program (Ramachandran 
et aL, 1963). The TALOS program uses a combination of five types of chemical 
shift (Ca, Cp, 13C9,1 HN and Ha) for any number of residues in a given sequence. 
The program uses sequential groups of three amino acids of the input sequence 
which is interrogated against the database. This means for a central residue in 
a triplet, TALOS uses potentially 15 chemical shifts and three residue types. 
Hence if a triplet of residues in a structurally determined protein has similar 
chemical shifts to the target sequence, then the psi and phi angles of the 
structurally determined protein would be a very useful for predictions. The 
TALOS database holds 186 proteins with over 24000 triplets and when a target 
sequence is searched against this database the 10 best matches to the 
chemical shifts for every residue is outputted. Hence TALOS uses chemical 
shift data and sequence information to make quantitative predictions for protein 
backbone angles and to provide a measure of the uncertainties in these 
predictions. 
1.4.8. Chemical shift mapping 
Chemical shift mapping is a simple method of measuring changes in chemical 
shifts. These types of measurements are carried out using HSQC based 
experiments. Whereby a fully assigned HSQC is compared to another assigned 
HSQC and any perturbations recorded. The perturbations can then be mapped 
on to a structure or to a sequence. The perturbations resulting from chemical 
shifts are generally caused by changes in the residue local-environment or more 
specifically by temperature, ligand interactions or as in this research, interaction 
with adjacent domains. The inherit problem associated with chemical shift 
mapping is that any observed perturbations do not only result from direct 
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interaction but can also be observed in a site further away as a result of protein 
structural changes (Spitzfaden et aL, 1992). 
1.4.9. Hyd rogen/de uteri um exchange 
Hydrogen/deuterium (H/D) exchange experiments involves a process oi 
dissolving a protein sample in D20, the backbone amide protons will, over time, 
exchange with deuterons. The intrinsic kinetics of the exchange process is 
dependant on pH, temperature and the neighbouring side chains (Woodward et 
aL, 1982; Englander and Kallenbach, 1983). The classical model for 
interpreting protein H/D exchange data was described by Linderstrom-Lang 
(Linderstrom-Lang, 1955). The model describes how the slow exchange 
hydrogens with the solvent occur as a result of structural fluctuations (local and 
global) around an average native conformation. This model therefore infers that 
hydrogen bonds are broken and reformed during these structural fluctuations 
and during these events proton transfer can take place. It was later 
experimentally proven that highly protected hydrogens had low exchange rates 
and are linked to thermal stability; only exchanging as result of global unfolding 
(Wuthrich et al., 1980). Whilst intermediate exchanging hydrogen rates resulted 
from more localised structural fluctuations (Englander and Kallenbach, 1983). 
Hence H/D exchange experiments provide detailed information at an amino-acid 
specific level on protein structure, structure change and dynamics. 
1.5. Alms of this Study 
Since the discovery of PDI in 1964, it had taken 32 years before the first domain, 
the a domain, was structurally determined by NMR in 1996 (Kemmink et aL, 
1996). The b and a' domains of human PDI were subsequently solved by NIVIR 
spectroscopy; x-ray crystallography attempts were made but had not been 
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fruitful. Protein flexibility or conformational exchange is widely accepted to 
cause difficulties when attempting to crystallise proteins. This is likely to be the 
cause of difficulties associated with PDI domains and x-ray crystallography 
attempts. Hence PDI domain structure determinations have been achieved 
using NMR where protein flexibility is not as great a hindrance to data collection. 
Therefore, a NMR based approach was deemed to be the best technique to use 
to derive structural data on the W domain of human PDL 
It was not until two years into this research in 2006, that the ERp57 bb' domain 
combination was structurally determined by x-ray crystallography (Kozlov et aL, 
2006), shortly after the NIVIR assignments of the thermophilic fungal Humicola 
insolens b' domain were published (Nakano et aL, 2006). Also that same year, 
and most importantly the first full length PIDI structure from Saccharomyces 
cerevisiae (Yeast) was reported to have been solved by x-ray crystallography 
(Tian et aL, 2006), which was the first full length PIDI related structure with 
functional activity. The only experimental data available on full length human 
PDI is derived from low resolution small angle x-ray scattering (SAXS) (Li et al., 
2006) also obtained in 2006. 
So at the start of this research, the only data available was the structural data 
on the a, b and a' domains of human PDI, determined approximately ten years 
previous. The closest related protein to human PDI with a structure available 
was calsequestrin, but as highlighted earlier the W domain shared very little 
sequence similarity to calsequestrin domains. Hence no related b' domain data 
was available and since the principal peptide binding site had been localised to 
the bI domain and therefore this domain was crucial for substrate binding; 
understanding this mechanism could be aided with structural determination of 
the final and only domain undetermined in human PDL Furthermore, no 
structural data had, at this time, been reported on any PDI domain: substrate 
complexes which would provide valuable information on binding mechanisms. 
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The initial aim was structural determination of the b' domain, but during the 
course of the research it became apparent that there was clearly insufficient 
spectral resolution to achieve this goal, so only backbone assignment could be 
achieved. Prior NMR data suggested the inclusion of the x-region; this 
stabilises the b' domain and allowed the collection of better resolved spectra. 
The key outcome of obtaining full assignments of a domain construct including 
the b' domain would be to allow the study of dynamics and ligand binding 
properties. The ambitious aim of full structure determination was reduced to 
achieving the following aims: 
Assess and optimise the resolution of spectra collected on b' containing 
domain constructs. 
Obtain backbone assignments by collecting triple resonance multi- 
dimensional NIVIR experimental data, using isotopically labelled domain 
constructs which include the x-region. 
0 Obtain backbone dynamics data. 
Heteronuclear relaxation T, and T2 data. 
Heteronuclear NOE data. 
Hydrogen/Deuterium exchange. 
Use domain combinations to define domain interfaces. 
55 
Chapter 2 General Materials and Methods 
Chapter 2. General Materials and Methods 
2.1. Materials 
All chemical reagents used were of analytical grade, and were obtained from the 
following sources unless otherwise stated, Fisher Scientific (UK), Sigma (USA). 
Deuterium oxide and isotopically labelled reagents were purchased from 
Cambridge Isotope Labs Inc. Celtone 2H >97% and Spectra 92 H/13C/15 N >97% 
were purchased from Spectra Stable Isotopes (USA). 
2.2. Protein Expression and Analytical methods 
In this section the materials and methods used during the process of expressing 
and purifying various domain constructs of recombinant PDI proteins is 
discussed. 
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2.2.1. Expression constructs 
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Figure 2-1. Vector map of pET-23b. This vector map was reproduced from the vector map 
for pET-23b from Novagen. 
Expression vectors were derived from a pET-23b vector (see Figure 2-1). The 
expression vector encoding the various protein constructs, carrying a T7 RNA 
polymerase promoter and a multiple cloning site were kindly provided by the Dr. 
L. Ruddock group. Expression vectors were made by cloning into the Ndel site, 
resulting in a protein with a non-cleavable hexa-histidine tag (MHHHHHHM). 
The non-cleavable N-terminal hexa-histidine tag was cloned into the Ndel site, 
where the final HM forms the Ndel site. The expression vectors which carry 
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ampicillin resistance were used for the expression of proteins with a hexa-his 
tag. 
The pET-23b derivative used in this research included synthetic oligos replacing 
the coding between the Xbal and Ndel sites, resulting in a modified ribosome 
binding site (as highlighted in Figure 2-2). Also a stop codon was inserted 
before the C-terminal hexa-histidine tag to prevent the addition of a C-terminal 
histidine tag on the expressed protein. This construct was found to have a 2-10 
fold higher expression compared to the original pET-23 vector (personal 
correspondence with Dr. L. Ruddock). DNA constructs were confirmed by 
sequencing on arrival or after transformation by myself or Dr. K. Wallis (see 
section 2.2.5, for procedure) and plasmids were transformed (see section 2.2.3, 
for procedure) into E. coli BL21 (DE3) pLysS (chloroamphenicol resistance) 
strain cells obtained. 
Synthetic 
Oligonucleotides 
cloned in here 
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T7 p nater Xba I 
AGATCTCGATCCCGCGAAATTAATACCACICACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGA 
T7480 pE T -23o 
"M " Eag 
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bts-LI BarM I ECOR I Sw I Sall ý*WIII Not "IS-11bg 
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M*tAloSorM*tThrG[yGlyCinClMM*tGlyArgGlyS*rGIwPhoGluLouArgArgGlmAlaCysClyArgTheArgAloProProProProPrOL. ý 
pE T -23b GGTCGGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGACCACCACCACCACCACCAC GA 
pET-23d GlyArgAepProAsmSorS*rS*rValAspLyaLoukinAloAloL*uCluWt*Hi*Hi*HismisHinEmd Ato I 
TACCATGGCTAGC pET-23c, d GGTCGGAT CCGAAI T CGAGCTCCCTCGAC AAGCTTGCGGCCGC ACTCGAGCACCACC ACCACCACCAC TGA 
MetA! oS&r GlyArgll*ArglioArgAlOProSerThrS*rLouArgPr6HlsSarSorThrThrThrThrThrThrGl,, 
1WI021 T7 toffnInator 
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Figure 2-2. pET23b derivative cloning and expression region with highlighted regions 
where insertions were cloned in. Reproduced from the vector map for pET-23b from 
Novagen. 
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2.2.2. Preparation of E. coli competent cells for DNA 
transformation 
LB agar plates with appropriate antibiotics added were streaked with the 
required E. coli strain (DH5a and BL21 (DE3) pLysS) from a glycerol stock 
(stored at -80'C) and incubated at 37 OC overnight. A single colony was used to 
inoculate a 10 mL sterile Luria-Bertani (LB) broth (with appropriate antibiotics 
added) and left shaking at 180 rpm overnight. 100 mL sterile LB broth was 
inoculated with 1.0 mL of overnight culture and incubated at 37 OC with shaking 
at 180 rpm until the optical density at 600nm reached 0.5. The culture was then 
centrifuged at 4000 xg for 10 minutes to pellet cells, and resuspended in TF131 
buffer (30 mM potassium acetate, 50 mM manganese chloride, 100 mM 
rubidium chloride, 10 mM calcium chloride, 15% (v/v) glycerol, pH 5.8), 
centrifuged and resuspended in TF132 buffer (10 mM MOPS, 75 mM calcium 
chloride, 10 mM rubidium chloride, 15% (v/v) glycerol, pH 6.8), following the 
protocol adapted from Hanahan (Hanahan, 1985). Competent cells were frozen 
in 200 pL aliquots, in liquid nitrogen and stored at -80 OC. 
2.2.3. DNA transformation of E. coli cells 
Chemically competent cells (prepared as described in section 2.2.2) were 
thawed on ice and 100 pL of cells incubated with approximately 50-200 ng of 
plasmid DNA for 30 minutes on ice. Cells were heat-shocked at 42 OC for 90 
seconds and returned to ice for 2 minutes. 100 pL of sterile LB broth was added 
and cells were incubated at 37 OC with shaking for 60 minutes. The 
transformation mixture was then plated using aseptic technique onto LB agar 
plates containing the appropriate antibiotic selection for the transformed plasmid. 
Plates were incubated at 37 'C overnight. 
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2.2.4. Preparation of plasmid DNA 
Plasmid DNA was extracted from E. cofi cells grown overnight in LB containing 
the appropriate antibiotic, using a Qiagen miniprep kit, according to the 
manufacturer's instructions. These kits employ the alkaline lysis method, where 
DNA is purified by adsorption to a silica matrix under high salt conditions. 
2.2.5. DNA sequencing of plasmid constructs 
To ensure that the cloned gene had inserted correctly into the plasmid vector 
and no mutations were incorporated by PCR errors, constructs were sequenced 
using approximately 500 ng of plasmid DNA (prepared as described in 2.2.4) 
and 5 pmol of primer per sequencing reaction. Specific primers for the T7 
promoter at the 5' end of the cloned gene (5' TAATACGACTCACTATAGG 31, 
Novagen) were used. Reactions were carried out using an ABI-Prism DNA 
sequencer, by the molecular biology service (Department of Biological Sciences, 
University of Warwick). The resulting sequences were translated into the protein 
sequence using the program ClustalW (Chenna et aL, 2003) to check for point 
mutations introduced by PCR. Sequences were also manually checked to 
identify the presence of start and stop codons and ensure the genes had 
inserted in the correct orientation. All PDI domain constructs were made with 
the domain boundaries as shown in Figure 1-5. 
2.2.6. Preparation of E. coli glycerol stocks 
5 mL sterile LB broth was inoculated with a single E. coli colony from a fresh 
transformation (described previously in section 2.2.3) and grown overnight in the 
presence of the appropriate antibiotic for plasmid selection with shaking at 37 "C. 
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600 pL of culture was aseptically mixed with 400 pL analytical reagent grade 
50% (v/v) glycerol in a Corning cryovial and frozen at -80 OC. 
2.2.7. Expression of recombinant protein in E. coli 
Recombinant proteins were expressed in Ecoli BL21 (DE3) pLysS strains. 
Cells which contain the expression plasmid were plated with the appropriate 
selective antibiotics (Chloroamphenicol and Ampicillin). A single colony was 
picked for a small scale 2x 20 mL overnight culture at 37 OC shaking at 180 rpm. 
The small overnight culture was used to inoculate a larger culture, typically two 
400 mL cultures, starting at O. D. 6oo 0.1; the volume of inoculant required was 
calculated as follows: 
Volume of inoculant to start at expression at O. D. 600 0.1 (ml-) = 
Volume of expression culture (mL) / (O. D. 600 Overnight Culture / start O. D. ) 
Cultures were then grown at 37 'C shaking at 180 rpm until O. D-6oo reached 0.5, 
unless otherwise stated. Cultures were then induced with 1mM isopropyl P-D- 
thiogalactopyranoside (IPTG) and grown for 4 hours (varied depending upon 
optimum expression time) at 37 OC shaking at 180 rpm, unless otherwise stated. 
Cells were harvested by centrifugation at 15900 xg using a Beckman JA-8.1100 
rotor for 10 min at 4 OC. The cell pellet was then re-suspended in buffer A 
(20mM phosphate buffer, pH 7.3), in a tenth of the starting culture volume with 
final concentration of 10 mg/I DNase added and the sample was frozen. Once 
frozen, the sample was freeze thawed twice to lyse the cells. The cells where 
then centrifuged at 17418 xg for 20 min at 4 OC using a Beckman JA 25.50 rotor. 
The supernatant was then applied to an Immobilized Metal-Affinity Column 
(IMAC) column. Once purified, protein samples were stored frozen. 
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2.2.8. Determination of protein concentration 
Protein concentration was determined using a colorimetric assay at 595 nm 
(BioRad). A 10 pL protein solution was added to 790 pL water and 200 pL 
BioRad reagent in a cuvette, mixed and the absorbance measured at 595 nm 
using an Amersharn Biosciences Ultrospec 2000 UV-visible spectrophotometer. 
Samples were diluted and remeasured if the samples gave a reading outside 
the linear range of the assay (>0.6 at 595 nm). Protein concentration (mg/ml) 
was then calculated using the Beer-Lambert law. Alternatively protein 
concentration was measured by a direct measurement of UV absorbance, at 280 
nrn using a Cary 100 spectrophotometer (Varian). Whereby the extinction 
coefficient (C280)was calculated by submitting the protein sequence to a web- 
based server called Protparam (available at 
http: //www. expasy. ch/tools/protpa ram. html). The protein concentration was 
then calculated in mg/ml using the Beer-Lamberts law. 
2.2.9. LB broth and agar 
LB Broth per litre contained 10g tryptone, 5g yeast extract, I Og NaCl made up 
to volume with deionised water and autoclaved. When cool, appropriate 
antibiotics were added. LB agar was prepared as LB broth with the addition of 
15g per litre agarose, autoclaved and when cool appropriate antibiotic added 
before pouring in to Petri dishes 
2.2.10. Minimal growth medium 
Minimal media was used to allow the introduction of selective nitrogen, carbon 
and deuterium isotopes into expressed proteins. The minimal media was 
prepared as described in Table 2. 
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Nutrient Amount (mg) 
(NH4)2SO4 (a) 1000 
Glucose (b) 4000 
Na2HP04 6800 
KH2HP04 3000 
NaCI 500 
Na2S04 42 
EDTA 50 
MnC12 16 
FeC13 5 
ZnC12 0.5 
CUC12 0.1 
COC12 0.1 
H3BO3 0.1 
MgS04 0.25 
CaC12 44 
d-Biotin 1 
Thiamine I 
Table 2. Minimal medium nutrient amounts for aI litre of culture. 
(a) For 15N labelled samples the (NH4)2SO4 was replaced with (15NH4)2SO4 (15N 99% 
Cambrioge Isotope Labs Inc. ). 
(b) For 15NI13C labelled samples the glucose was replaced with D-Glucose U- 13 C6 13 C 99% 
Cambridge Isotope Labs Inc. ) and (NH4)2SO4 was replaced with (, 5NH4)2SO4 SN 99% 
Cambridge Isotope Labs Inc. ). 
In the instance when deuteration was required, H20 was replaced with an D20 
(Cambridge Isotopes Labs Inc. ) diluted with sterile H20 to give the appropriate 
percentage of deuterated atoms. For high deuterium percentages, some of the 
minimal medium nutrients were required to be prepared in D20 as opposed to 
sterile H20- 
2.2.11. SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
prepared using the Tris-Glycine buffer system (Laemmli, 1970) to identify 
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polypeptides under denaturing conditions. The discontinuous gel system 
consisted of a resolving gel at pH 8.8 and a stacking gel at pH 6.8. SDS-PAGE 
gels were produced with 12 or 16 % resolving gels depending upon the 
molecular weight of the protein to be resolved, overlaid with 5% (w/v) stacking 
gel. Gels were cast using a Mini Protean 11 gel kit from Bio-Rad. The 
composition of the resolving and stacking gel is given below in Table 3. 
Gel type Reagent 12 % Gel 16 % Gel 
Separation Gel Water 15.9 13.2 
premix Acrylamide (40%) 13.3 16.0 
1.5M Tris pH 8.8 10 10 
10% SDS 0.4 0.4 
APS (pl-) 60 60 
Terned (pl-) 6 6 
Stacking Gel Water 19.0 
premix Acrylamide (40%) 3.7 
1.5M Tris pH 6.8 3.75 
10% SIDS 0.3 
APS (pQ 24 
Temed (pQ 24 
Table 3. Composition of 12 and 16 % separation gel and stacking gel. All volumes in mL 
unless stated. 
8 mL of the separation premix was used to make two gels and polymerised by 
adding 60 pL APS and 6 pL Temed. 4 mL of the stacking gel premix was used 
for two gels and polymerised using 24 pL of APS and 24 pL of Temed. 20 pL 
protein samples were prepared for analysis by mixing with 5 PL of 4x reducing 
sample buffer (1M Tris-HCI pH 6.8,40% glycerol, 0.8% SIDS, 0.1% (w/v) 
bromophenol blue, 10 % P-mercaptoethanol) and heat denatured at 95 OC in a 
heating block for 5 minutes. 1OuL of the samples (unless otherwise stated) 
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were then loaded into the stacking gel wells and electrophoresed using running 
buffer (25 mM Tris, 0.192 M glycine, 0.1% SIDS pH 8.3). A low molecularweight 
marker (purchased from Amersharn Biosciences) was also loaded in one lane, 
which contained Phosphorylase b (97.0 kDa), Albumin (66.0 kDa), Ovalbumin 
(45.0 kDa), Carbonic anhydrase (30.0 kDa), Trypsin inhibitor (20.1 kDa) and a- 
lactalburnin (14.4 kDa). Gels were run at 200 Volts for 40 minutes or until the 
gel front reached the base of the gel. Proteins resolved by SIDS PAGE were 
stained for 1 hour in 50% methanol, 10% acetic acid, 40% water containing 10 
mg L-1 Coomassie R-250 dye. Gels were then de-stained overnight at room 
temperature in the same solution in the absence of the Coomassie R-250. Gels 
were photographed and dried between two sheets of cellulose stretched over a 
frame. 
2.2.12. PAGE under native conditions 
PAGE run under native conditions involved the same method as SDS-PAGE 
under denaturing and reducing conditions (2.2.11), but omitting SIDS and p- 
mercaptoethanol from the stacking and resolving gel; also from the loading and 
running buffer. 
2.2.13. Reduction and carboxymethylation 
Protein samples (typically of a 20pl- volume) were firstly reduced with the 
addition of 5 pL of loading buffer containing 10% SIDS, P-mercaptoethanol with a 
final concentration of 5% and then heated at 950C for 5mins. 
Carboxymethylation was carried out by the addition of 7.5pL 1M iodoacetamide 
and incubated at room temperature in the dark for 20 minutes. Samples were 
then run on SDS-PAGE as described earlier. 
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Figure 2-3. S-Carboxymethylation of cysteine residues scheme. 
2.3. Chromatography Methods 
2.3.1. Affinity chromatography 
The first step of the purification of proteins was carried out using Immobilized 
Metal-Affinity Column (IMAC), where nickel chelated to chelating sepharose 
(Amersham Biosciences) resin was used to bind to the hexahistidine tags. 
Bench-top columns were produced by, packing glass wool into the bottom of an 
empty plastic 20mL syringe. Chelating sepharose was pipetted into the syringe 
to produce a column volume of 5mL. The resin was then washed with 10 
column volumes of water and then 2mL of 0.2M nickel chloride added. The 
column was then washed with 5 column volumes of water and then 5 column 
volumes of 20 mM Sodium Acetate, 0.5M NaCl pH 3.0 to chelate the nickel to 
the sepharose resin. Excess nickel was then washed off and column re- 
equilibrated with 5 column volumes of 20mM Sodium Phosphate pH 7.3. The 
re-suspended clarified cell lysate was loaded onto the column and the flow- 
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through collected. The column was then washed with 5 column volumes of 25 
mM Imidazole, 0.5 NaCl, 20mM Sodium Phosphate pH 7.3 buffer to remove 
loose bound impurities; this fraction was collected. The column was then 
washed with 5 column volumes of 20mM Sodium Phosphate pH 7.3 buffer as a 
low salt wash step; also collected. The hexahistidine-tagged protein was then 
eluted and collected with 5 column volumes of 50mM EDTA, 20mM Sodium 
Phosphate pH 7.3 buffer. After use the column was cleaned with 5 column 
volumes of water and was then stored at 40C in 20% ethanol for reuse with the 
same hexahistidine-tagged protein at a later date. 
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2.3.2. Anion-exchange chromatography 
Anion-exchange was carried out using a Source 30Q column (10 mL column 
with 30 pm beads) attached to the AKTApurifier 100 system (Amersham 
Biosciences). These resins have an attached quaternary amine group, which 
gives the resin a strong positive charge over the broad pH range of 2.0 to 12.0. 
Generally proteins are applied in a low salt buffer preferably above the protein 
isoelectric point, hence causing an overall negative charge on the protein and 
so maximise the binding to the positively charged resin. The protein can then 
be eluted with a salt gradient whereby weakly bound proteins are eluted in low 
salt and tightly bound proteins eluting at a high salt concentration. 
Samples loaded onto the column, generally came from the affinity 
chromatography elution. The elute from the affinity chromatography was diluted 
from 25 mL to 100 mL in Buffer A (20 mM Sodium Phosphate pH 7.3), to reduce 
the salt concentration, before loading onto the anion-exchange column. 
Columns were equilibrated and washed in 5 column volumes of Buffer A and 
then 5 column volumes of 20 mM Sodium Phosphate, 0.5 M NaCl pH 7.3 (Buffer 
B) and finally back into 20 mM Sodium Phosphate pH 7.3 for a further 5 column 
volumes to ensure no excess salt was present. Samples were loaded via an 
injection loop and the column eluted by washing with a Buffer B gradient from 
zero to 100 % (0.5 M NaCI) over 10 column volumes, unless stated otherwise. 
Fractions of 2 mL were collected throughout the gradient and the presence of 
the eluted protein measured by an increase in absorbance at 280 nm. 
2.3.3. Size exclusion chromatography 
The Superdex 75 (Amersharn Pharmacia Biotech, UK) gel filtration column 
matrix was poured as thick slurry into a 318 mL column (2.6 cm x 60 cm). The 
column was equilibrated in 2 column volumes of 20 mM sodium phosphate, 150 
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mM NaCl pH 7.3. Samples loaded on to the Gel filtration column were usually 
pooled fractions from the anion-exchange column and so pooled fractions were 
typically concentrated using Centricon filter columns (5000 Da molecular weight 
cut off) to give a final volume of 2 mL which could then be applied to a gel 
filtration column. The sample of interest was loaded via a2 mL injection loop 
and the column was washed with the identical buffer with which the column was 
equilibrated at a flow rate of 2.0 mL per minute. The elution of excluded protein 
was monitored following the A280 on an AKTApurifier 100 system (Amersharn 
Biosciences) and 3 mL fractions were collected between 0 mL - 300 mL. 
2.4. Hydrodynamic methods 
2.4.1. Analytical ultra-centrifugation - sedimentation velocity 
experiments 
Sedimentation velocity experiments were performed using an XL-I analytical 
ultracentrifuge (Beckman Coulter) equipped with a four-cell An-60 Tj rotor at 
20"C. A protein sample of 400 pL at a concentration of 79 pM in a 50mM Tris, 
150mM NaCl buffer (pH 7.5) was used as the protein buffer and reference 
solution. The experiments were performed at a speed of 60,000 rpm for 3 hours. 
The sedimentation coefficients and molecular weight were calculated using 
SEDFIT (Schuck, 2000). These experiments were preformed by Lei Wang, in 
the lab of Prof. C. C. Wang (Chinese Academy of Sciences, Institute of 
Biophysics, Beijing). 
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2.5. Spectroscopic Methods 
2.5.1. Electrospray mass spectrometry 
For electrospray mass spectrometry undertaken by the Mass Spectrometry and 
Proteomics service (Department of Biological Sciences, University of Warwick), 
PDI protein samples were prepared to a concentration of between 10 - 200 pM 
in 50 pl IOmM ammonium bicarbonate. Samples were analysed by positive ion 
electrospray ionisation tandem mass spectrometry (ESI-MS/MS), to confirm the 
mass and relative isotope incorporation. 
2.5.2. Circular dichroism spectroscopy 
Circular dichroism spectra were recorded on a Jasco J600 spectropolarimeter, 
thermostatically controlled at 250C. The protein samples were diluted to 
between concentrations 2.5 and 10 pM in 20mM phosphate pH 7.3 buffer and 
the final concentrations determined by spectrophotometric analyses at 280nm, 
using appropriate extinction coefficients and molecular weights. Far-UV spectra 
were recorded over a range of 190nm to 260nm in 0.5nm increments with a cell 
pathlength O-1cm- Spectral data was averaged over 8 scans, corrected for 
baseline and the mean ellipicity per residue calculated. Spectra were 
corrected for buffer signal and converted to molar CID per residue before 
analysis using SELCON 3 algorithm (Sreerama et al., 1999) on the 
DICHROWEB website (Lobley et al., 2002) to estimate the secondary structure. 
Typical secondary structure signals are shown below in Figure 2-4. 
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Figure 2-4. Typical secondary structure signals obtained by circular dichroism. Solid 
curve - a-helix, long dashes - anti-parallel P-sheet, dots - type I P-turn, dots and short 
dashes - irregular structure, taken from (Kelly and Price, 1997). 
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2.5.3. Nuclear Magnetic Resonance Spectroscopy 
2.5.3.1. Preparation of protein samples for NMR 
Protein samples for NIVIR and Mass Spectrometry were concentrated using 
Centricon filter columns (5000 Da molecular weight cut off). All NIVIR 
experiments were carried out on 330pl-, 1.0-1.5 mM samples (as determined by 
A280 measurements) in 25 mM Sodium Phosphate, 150mM NaCl buffer at pH 
6.5 with 10% (v/v) D20. The samples were placed in a5 mm Shigemi matched 
with D20 (Shigemi Inc. ) and stored a 4"C for a short amount of time until 
required. 
2.5.3.2. Data acquisition and processing 
All NMR data was collected by Dr. M. Howard (University of Kent), typically at 
250C unless otherwise stated, using a four-channel Varian Unitylnova NMR 
spectrometer operating at 14.1 Tesla (600 MHz 1H resonance frequency) and 
equipped with a5 mm HCN z-pulse field gradient probe. The 1H chemical shift 
was referenced based on the position of the water resonance which has an 
exact value based on the relationship of 'H20 resonances with temperature 
(Wishart and Sykes, 1994). The 13 C and 15 N were referenced using a 
spectrometer based macro which is the gyromagnetic ratios relationship 
(Wishart and Sykes, 1994). All experiments, unless stated, were solvent 
suppressed to reduce the water signal using WATERGATE (Piotto et aL, 1992) 
using a gradient field strength of 40-50 G cm". 
Data was processed using Varian and Bruker software, zero filled to increase 
the number of data points for the F1, F2 and when required in the F3 dimensions. 
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In the triple resonance experiments a'rr/2.5 sine squared weighting function was 
applied in all dimensions prior to Fourier transformation. All NMR experiments 
and data processing were carried out by Dr. M. Howard (University of 
Canterbury, Kent). All data was analysed using the CcpNMR Analysis package 
(Vranken et al., 2005), carried out by myself and with assistance from Dr. L. 
Byrne (University of Canterbury, Kent). 
2.5.3.3.15N/'H HSQC 
The 15 NPH heteronuclear single quantum correlation (HSQC) experiments were 
collected with acquisition times were 45 ms in the F1 (15 N) and 114 ms in the F2 
(11-1) dimensions. The total acquisition time was approximately 30 minutes. 
Data was typically acquired with 2048 points (9000 Hz) in the direct F2 
dimension (11-1) and 4096 points (1850 Hz) in the F1 (15 N) dimension. The 15 N 
dimension was centred on 118ppm. If a 13C/1 5N sample was used then a 
modified 15 NPH HSQC was used which incorporates 13 C decoupling during both 
T, and T2 acquisition periods. 
2.5.3.4. Triple resonance experiments 
Sequence specific backbone resonance assignments (N, NH, Ca and CP) were 
obtained for bb'x and b'x, by identifying the intra and inter residue 
connectivities in the HNCACB and CBCA(CO)NH spectra using methods 
described by Bax and Grzesiek (Grzesiek and Bax, 1992a; Grzesiek and Bax, 
1992b). A 13C/1 5N sample of bb'x and Wx were used to collect the data. 
The bbIx HNCACB and CBCA(CO)NH datasets were acquired with 1024 points 
(900OHz) in the direct F3 dimension (1H) and 60 points (1000OHz) in the direct 
F2 dimension (13C) and 28 points (1850Hz) in the indirect F1 dimension (15N). 
The number of transient and relaxation delays were set to give 63 hours, 7 
73 
Chapter 2 General Materials and Methods 
minutes experimental time for CBCA(CO)NH and 61 hours and 48 minutes for 
the HNCACB. Carrier frequencies for these triple resonances experiments were 
set to 4.568 ppm, 45.743 pprn and 118.246 ppm for the 11-1,13 C and 15N 
respectively. 
The Wx HNCACB and CBCA(CO)NH datasets were acquired with 768 points 
(900OHz) in the direct F3 dimension (11-1) and 60 points (1000OHz) in the direct 
F2 dimension (13C) and 32 points (180OHz) in the indirect F1 dimension (15 N). 
The number of transient and relaxation delays were set to give 70 hours, 3 
minutes experimental time for CBCA(CO)NH and 69 hours and 40 minutes for 
the HNCACB. Carrier frequencies for these triple resonances experiments were 
set to 4.568 ppm, 45.743 ppm and 118.246 ppm for the 11-1,13 C and 15 N 
respectively. 
Using the deuterated sample HNCA and HNCOCA experimental data was 
obtained where data was acquired with 2040 points (1200OHz) in the direct F3 
dimension (11-1) and 48 points (270OHz) in the direct F2 dimension (13 C) and 56 
points (2818Hz) in the indirect F1 dimension (15 N). The numbers of transient 
and relaxation delays were set to give approximately 48 hours experimental 
time for HNCOCA and 48 hours for the HNCA. Carrier frequencies for these 
triple resonances experiments were set to 4.760 ppm, 117.558 pprn and 
176.131 ppm for the 11-1,13 C and 15 N respectively. 
2.5.3.5. Sequential backbone assignment 
Sequential assignment of the NMR backbone were achieved using HNCACB 
and CBCA(CO)NH experiments using a 13C /15N sample and HNCA and 
HNCOCA experiments using a deuterated sample. The approach is based on 
the unique Ca and CP chemical shifts of Glycine, Alanine, Serine and Threonine 
which differ from all other amino acid chemical shifts. This difference is 
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highlighted in Figure 2-5, which are the average chemical shift standards 
obtained for all amino acids (Wishart et al., 1995a). 
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Figure 2-5. Chemical shift patterns for "Ca and 13C P resonances for all amino acids in 
random coil conformation, adapted from (Wishart et al., 1995a). 
The method of sequential alignment involved matching the patterns of the Ca 
and CP of the i-1 amino acid in the CBCA(CO)NH data with the Ca and CP of 
the i amino acid in the HNCACB data. The Analysis software allowed each data 
pair, Ca and CP of a single amino acid to be interrogated against all other Ca 
and CP shifts, producing a list of matches in rank order of closest fit, which the 
analyst can use to link residues to produce a sequential assignment. Using the 
unique nature of certain residues mentioned previously, it is possible to 
unambiguously assign the 1 3CC(, 13Cp, 15 N and 1H resonances. In a similar 
fashion the HNCA and HNCOCA data was used to also sequentially assign 
residues, so when ambiguity or NIVIR overlap occurred, these assignments were 
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used to confirm/fill-in assignments. Also, other data sets were used to cross- 
correlated the assignment for Wx and the b domain. 
2.5.3.6. Secondary structure prediction using TALOS 
The chemical shift data for bb'x was used to obtain secondary structure 
predictions. The Analysis software has a facility to output the collated NIVIR 
chemical shift data in the appropriate format to be inputted into the TALOS 
program. TALOS is a UNIX based program which uses a tabulated Ca, CP , 
13C,, 
1HNand Ha chemical shift input file to predict secondary structure. The TALOS 
output gives a Ramachandran graphical interface where individual residue 
predictions can be analysed. The output highlights the secondary structure 
predictions in terms of helix, turn and coil. The prediction algorithm determines 
secondary structure by predicting the phi and psi angles of residues using the 
chemical shift data provided for that residue (Comilescu et aL, 1999). 
2.6.3.7. Chemical shift mapping 
The chemical shift difference was calculated as shown below: 
-- -T- / 'NT Shift difference N 'T M' H. A 
1/6 R 
The A'HN is the chemical shift change in the 'HN dimension (ppm) and A15N is 
the chemical shift change in the 1,5N dimension (ppm). The chemical shift 
changes are squared to ensure the difference is a positive number and 15 N 
difference is scaled down by 1/6 due to the chemical shift range Of 15 N being 
approximately 30 ppm and the 1HN chemical shift range of approximately 5 ppm. 
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2.5.3.8. T, and T2 relaxation experiments 
All spectra was collected by Dr. M. Howard using a 1.5 mM 15 N-bb'x sample, in 
25 mM Sodium Phosphate, 150mM NaCl buffer at pH 6.5 with 10% (v/v) D20 at 
250C, using the four-channel Varian Unitylnova NMR spectrometer operating at 
14.1 Tesla (600 MHz 1H resonance frequency) at the University of Kent NMR 
facility. To obtain T, relaxation rates delays of 128,256,385,512,641,769 and 
897 milliseconds were employed. To obtain T2 relaxation rates delays of 20,40, 
60,80,100,120,140,160 milliseconds were employed. 
T, and T2 values were extracted by measuring the peak volumes in the 2D- 
HSQCs as a function of a relaxation delay. Experimental T, values for each 
residue were fitted to the three parameter nonlinear fit to the following equation 
I(T)=l. -[ I. -lo] exp(-, rfTl), and T2 values were likewise obtained from the three- 
parameters fits to the equation 1(, r)=I- +[ 1. +I. ] exp(-, r/T2) as described by 
Mackay and colleagues (MacKay et aL, 1996). In these equations, 10 and 1. are 
the cross-peak volumes at zero- and infinite-time, respectively. The non-linear 
curve fitting was carried out using the GraphPad Prism4 program (GraphPad 
Software, San Diego, CA). 
2.5.3.9. Heteronuclear NOE experiments 
Spectra was collected by Dr. M. Howard using a 1.5 mM 15 N-bb'x sample, in 25 
mM Sodium Phosphate, 150mM NaCl buffer at pH 6.5 with 10% (v/v) D20 at 
400C, 600 MHz Varian Unity1nova NMR spectrometer at the University of Kent 
NIVIR facility. A pulse sequence was used which recorded the correlation 
spectra for measuring 'H-15H NOEs as described by Kay and colleagues (Kay et 
aL, 1989; Stone et aL, 1992). HSQC spectra were recorded in the presence 
and absence of the 1H saturation. Experimental data was obtained where data 
was acquired with 2048 points (900OHz) in the direct F2 dimension (11-1) and 192 
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points (370OHz) in the direct F1 dimension (15N). Carrier frequencies for these 
triple resonances experiments were set to 4.580 ppm and 117.257 ppm IH and 
15 N respectively. The peak heights were recorded fro both spectra and NOE 
values obtained by comparing peak heights for (1-1o)/Io, where I is the peak 
height with 1H saturation off and 1, ) 
1H saturation on. 
2.5.3.10. Hydrogen/deuterium exchange experiments 
Spectra were collected by Dr. M. Howard using a 1.5 mM 15 N-bb'x and a 15 N-b 
domain sample in 25 mM Sodium Phosphate, 150mM NaCl buffer at pH 6.5, 
which were freeze-dried and dissolved in 100% D20. The first time point of 5 
minutes was the time taken to dissolve the sample and collect the first HSQC at 
250C using the 600 MHz Varian Unitylnova NMR spectrometer at the University 
of Kent NMR facility. H/D exchange values were extracted by measuring the 
peak volumes in the 2D-HSQCs as a function of time. The values were fitted to 
a single exponential decay curve and the decay rate calculated using the 
program GraphPad Prism4 (GraphPad Software, San Diego, CA). 
2.6. Structure Modelling 
2.6.1. Molecular modelling 
Geno3D (http: //geno3d-pbil. ibcp. f ), an automatic web server for protein 
molecular modelling was used to model the structure of the Wx domain. The 
protein sequence is supplied to the server which performs the homology 
modelling, firstly the program identifies homologous proteins with known 3D 
structures by using PSI-BLAST; in the case of Wx the structure from ERp57 bb' 
domain was used (PDB code 2H81). The program then performs an alignment 
of both query and subject sequences, extracts geometrical restraints (dihedral 
angles and distances) for corresponding atoms between the query and the 
template. Then finally performs the 3D construction of the protein by using a 
distance geometry approach which was sent via e-mail to the user (Combet et 
al., 2002). 
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Chapter 3. Preparation and Preliminary 
Characterisation of PDI Proteins 
3.1. Introduction 
Preliminary data generated by previous work in the group had indicated that the 
bb'x construct gave useful NIVIR spectroscopic data. The main objective of this 
thesis was therefore to undertake a detailed structural characterisation of the 
bbIx domain combination using NIVIR techniques; the preparation, optimisation 
and characterisation of labelled and unlabelled samples are described in this 
Chapter. As an input to this analysis, it was necessary to generate and analyse 
labelled samples of the b domain which previously had been characterised 
(Kemmink et aL, 1999). During the process of structural characterisation it was 
identified that Wx assignments could assist the bb'x assignments, this Chapter 
describes the preparation and characterisation of labelled Wx samples for NIVIR 
analysis. 
In order to understand the the properties of the bblx domains of PDI, it was 
necessary to compare these properties with those of full-length PDI and those of 
isolated b and bb' domains. In this Chapter, the preparation and preliminary 
characterisation of all these domains and domain combinations are reported. 
All domains and domain combinations were expressed in Ecoli BL21 (DE3) 
pLysS cells prepared as described in the Material and Methods Chapter. 
Expression was carried out as described in section 2.2.7, unless otherwise 
stated. 
Purification generally involved three steps, affinity chromatography, anion- 
exchange chromatography and finally gel-filtration; any deviations from this 
protocol are stated. Two species were identified during purification, it is 
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important to note that fractionation by anion-exchange chromatography led to 
two pools (Pool 1 and Pool 2). The early or first peak from anion-exchange 
chromatography was designated Pool 1 and the late or second peak was 
designated Pool 2. When these pools are further purified by gel-filtration, 
fractions are now referred to as dimer (early peak) and monomer (late peak). 
3.2. b domain 
The b domain had previously been characterised (Kemmink et al., 1999). Early 
in to this study it was identified that the assignment of bb'x, expected to be 
demanding, could be aided with a preassigned spectrum of the b domain. 
Hence producing a 1,5N-labelled b domain was essential to assess the quality of 
NIVIR data achievable and lead onto the backbone assignment of the b domain. 
3.2.1. Expression and characterisation of the b domain 
The b domain construct was grown as described in section 2.2.7. Two 400mL 
unlabelled minimal cultures were grown in two 2 Litre flasks (preparation 
described in section 2.2.10). The sample was then applied to an Immobilized 
Metal-Affinity Column as described in section 2.3.1. 
80 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
66 
45 
30 
20 
-- am-oft 
14 
1 
0"0 
0" 
1234567 
Figure 3-1.12% SDS-PAGE of the b domain purification using IMAC. Lane 1, low 
molecular weight marker. Lane 2, Total expressed protein. Lane 3, Soluble protein 
fraction. Lane 4, IMAC Flow through. Lane 5, IMAC Wash fraction. Lane 6, Low salt 
wash fraction. Lane 7, hexa-histidine tagged b domain elute fraction. 
it is clear that IMAC purification step in Figure 3-1 was very effective at 
removing virtually all of the non-tagged protein impurities, except one band of a 
slightly larger molecular weight, just above the main protein band in Lane 7. To 
ensure all impurities were removed, the elute was then prepared and further 
purified on an anion-exchange column as described in section 2.3.2 
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Figure 3-2 L; nromatogram OT b domain using a Source 30Q column. Black line is the 
absorbance at 280 nm, red line is the Buffer B0% to 100 %. The x axis shows the 
accumulative volume. 
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The chromatogram in Figure 3-2 appears to be a single peak apart from a small 
shoulder at the end of the peak decline. To further analyse and determine the 
homogeneity of the peak, 20 pL samples from each of the 2 mL fractions across 
the peak were treated as described in section 2.2.11 and run on an SDS-PAGE. 
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Figure 3-3.12% SDS-PAGE of anion-exchange fractions of b domain. Lane 1, low 
molecular weight marker. Lane 2, fraction from 50-52 mL. Lane 3, fraction from 52-54 mL. 
Lane 4, fraction from 54-56 mL. Lane 5, fraction from 56-58 mL. Lane 6, fraction from 58- 
60 mL. Lane 7, fraction from 60-62 mL. Lane 8, fraction from 62-64 mL. Lanes 9, fraction 
from 64-66 mL. Lane 10, fraction from 66-68 mL. Lane 11, fraction from 68-70 mL. 
The material in Lanes 4 to 9 in Figure 3-3 appear to be homogenous and so 
were pooled, concentrated down using a Centricon filter columns (5 kDa 
molecular weight cut off) and buffer exchanged into Buffer A (20mM Sodium 
Phosphate, pH 7.3). While Lanes 10 and 11 appear to contain a higher 
molecular weight impurity or a second species, so these two fractions were 
discarded. The concentration by measurement of absorbance at 280 nm as 
described in section 2.2.8 and was calculated to be 24.8 mg, 1.53 mM in a 1.25 
mL solution. 
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Figure 3-4. Positive ion mass spectrum of the b domain. 
The deconvoluted electrospray mass spectrum gave a mass of 13146.5 Da 
shown in Figure 3-4, which was in agreement with the predicted mass using the 
sequence of 13147 Daltons. The species at 13169.3 Da, with an extra mass of 
23 Da results from a sodium adduct. The other ion present was a species with 
an extra mass of 178 Daltons with a total mass of 13324.7 Da. This species 
results from a spontaneous a-N-6-Phosphogluconoylation of the histidine tag 
which is reported to produce a species with an extra mass of 258 or 178 Daltons. 
It has been show in Ecoli that an extra mass of 258 Daltons results from a 
modification of the poly-histidine tag sequence involving the addition of a 6- 
phosphogluconoyl group and if this group is dephosphorylated, this results in an 
extra mass of 178 Daltons. A possible mechanism is the acylation by 6- 
phosphoglucono-1,5-lactone, produced from glucose-6-phosphate 
dehydrogenase (Geoghegan et al., 1999). It was therefore possible that the 
slight double banding appearing in Lanes 4-9, in Figure 3-3 results from this 
histidine tag modified species. 
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Figure 3-5. A Far UV CD spectrum for the b domain, using a sample of 10liM, 0.14 mg/ml. 
From the CID spectrum shown in Figure 3-5 it was clear that the recombinantly 
expressed b domain was folded, since there was a large positive peak at 
approximately 190nm and two negative peaks at approximately 209 and 222 nm-, 
typical of proteins with well-ordered structures. Analysis of the spectrum using 
the DICHROWEB website (Lobley et al., 2002), indicated 30% helical and 18% 
beta content, which is in close agreement to the 34% helical and 18% beta 
content as quoted in the b domain (1 BJX) PDB file. 
3.2.2. Optimisation of b domain expression 
The aim of this optimisation experiment was to identify the optimum induction 
time and attempt to reduce the amount of glucose used and yet still produce 
sufficient amounts of recombinant protein. A future aim is to produce I 3C_ 
labelled protein for NIVIR experiments. Isotopically labelled 13C_g lucose was an 
expensive reagent and so here we aim to produce sufficient quantities of protein 
on the least amount of glucose supplied to the bacterial expression culture. 
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Four 5 mL overnight starter cultures were used to inoculate four 50 mL minimal 
medium cultures (minimal medium was prepared as described in section 2.2.10). 
The four overnight-50 mL cultures differed only in the concentration of glucose 
which was 4g/l, 3g/l, 2g/l and Ilg/l. The 50 mL cultures were inoculated at A600 
0.1 and grown to A600 0.5, then induced with 1 mM IPTG. 1 mL samples were 
taken from each of the four 50 mL cultures after 4 hours, 6 hours and overnight 
(approximately 24 hours) of induction with IPTG. All the 1 ml samples were 
treated in the same way as stated in Figure 3-6. The 20ulL samples were then 
prepared for SDS-PAGE as described in section 2.2.11. 
Spin 5000 rpm Resuspend l m L 1 ML Fre eze and - pellet in 100ul 
[S 
a m ple 5 minutes buffer A+ 1 ul 
ý 
f rost defrost 
DNase 
Spin 13000 rpm 
10 minutes 
Take 20uL of Take 20ul- 
supernatant Total Protein 
which is the sample to run 
Soluble Protein on SIDS-PAGE 
sample to run 
on SDS-PAGE 
Figure 3-6. Flow diagram of 1 mL sample treatment for SDS-PAGE analysis. (I JiL of 10 
mg/l DNase stock was added, samples were centrifuged using a small benchtop 
centrifuge) 
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Figure 3-7.12% SDS-PAGE of 1 mL b domain test induction samples. T= Total protein 
sample, S= Soluble protein sample, t= time of sample taken after induction (Hours), m 
low molecular weight marker (kDa). 
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Figure 3-8.12 % SDS-PAGE of 1 mL b domain test induction samples. T= Total protein 
sample, S= Soluble protein sample, t= time of sample taken after induction (Hours), m 
low molecular weight marker (kDa). 
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The b domain protein has a molecular weight of 13147 Daltons and so was 
believed to be the band that runs approximately in line with the 14 kDa marker. 
There are two bands that appear at the 14 kDa markers and at this stage 
(without further analysis) it was uncertain whether this was a soluble protein 
impurity or the histidine tag modification discussed in section 3.2.1. 
Firstly, by comparing the relative size of the bands in relation to induction time 
(either overnight, 4 or 6 hours); it is clear that the expression of b domain is at 
its highest during the 4 hour samples. Secondly, by then comparing the relative 
intensities of the b domain soluble fractions during the 4 hour expression time 
and with the different glucose concentrations, it is clear the 3 and 2 g/L glucose 
gave the highest yields of protein. It is although unclear whether 2 or 3 g/L gave 
the highest yields. So in the interest of reducing cost of the expensive I 3C_ 
glucose reagent, it would be best to use 2g/L when producing 13C-labelled 
protein samples, half the normal levels of unlabelled glucose used in normal 
minimal medium expressions. At this stage it has not been investigated whether 
the reduction in 13C_glucose would reduce the overall soluble protein expression 
yield. This was expected to be the case but it was hoped that the reduction in 
yield will not be so detrimental that the sample concentration would be too low 
for NIVIR analysis. But what is clear here is that 4 hours is the optimum time for 
expression as there is clear reduction in soluble protein expression beyond this 
expression time. 
3.2.3. Expression and purification Of ISN-labelled b domain 
In order to confirm and directly relate our data with that of the published 
structure of the b domain by Dr. J. Kemmink (Kemmink et at, 1999), it was 
essential to reproduce and assign the b domain independently. The conditions 
at which we aim to collect our NIVIR data differ from those used in the published 
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b domain and so we need to identify any differences in the spectra that may 
arise. It was not possible to use the spectra and assignments deposited by Dr. 
Kemmink as slight difference in preparation or buffers could affect the residue 
shifts seen on a HSQC spectrum. In order to first assess any difference in 
preparation and assess the quality of the data, it was required to produce a 15 N- 
labelled b domain protein sample, from which we can collect a 2D-HSQC 
spectrum. 
The b domain was expressed as described in section 2.2.7 in minimal medium 
with 15N-labelled ammonium sulphate, the preparation of which is described in 
section 2.2.10. The purification procedure was the same as all expression 
purifications, starting with IMAC as described in section 2.3.1 and the SDS- 
PAGE analysis of which is shown in Figure 3-9. The IMAC elute was then 
further purified using anion-exchange chromatography as described in section 
2.3.2.20 pL samples from each of the 2 mL peak fractions were treated as 
described in section 2.2.11 and run on an SDS-PAGE gel shown in Figure 3-9 
and Figure 3-10. 
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Figure 3-9.16% SDS-PAGE of 15N b domain applied to IMAC and Anion-exchange 
fractions. Lane 1, low molecular weight marker. Lane 2, total protein. Lane 3, soluble 
protein. (Lanes 4-7; analysis of IMAC purification) Lane 4, flow through. Lane 5, 
imidazole wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged protein elute. Lane 
8-10 fractions from anion-exchange Source 30Q column. 
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It is clear that IMAC purification step was very effective at removing almost all of 
non-tagged protein impurities, except one band of a slightly larger molecular 
weight. To ensure all impurities were removed, the elute was then prepared 
and further purified on an anion-exchange column as described in section 2.3.2. 
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Figure 3-10.16% SDS-PAGE of anion-exchange fractions of 15N-labelled b domain. Lane 
1, low molecular weight marker. Lane 2-8 fractions from across the peak in the anion- 
exchancie Source 30Q column. 
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Figure 3-11. Chrornatogram of "'N b domain using a Source 30Q column, eluted with a 
25% Buffer B gradient over 100mL. 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
From the anion-exchange chromatogram in Figure 3-11, the eluted b domain 
appears to be homogenous, eluting in one peak, with a slight shoulder at end. 
To analyse the homogeneity of the protein, samples were taken from each of 
the 2mL fractions and run on SIDS PAGE see Figure 3-9 and Figure 3-10. 
Fractions in lanes 5 to 8 in Figure 3-10 appear to be heterogeneous, with what 
appears to be a larger molecular weight impurity. This was possibly as a result 
of the a-N-6-Phosphogluconoylation of the histidine tag, identified in section 
3.2.1. At this stage it was unclear if this species will affect the NIVIR spectrum 
and so these fractions were discarded. Fractions Lanes 9,10 in Figure 3-9 and 
Lanes 2 to 4 in Figure 3-10 appear homogenous and so were pooled. These 
samples were then concentrated down using a Centricon filter columns (5 kDa 
molecular weight cut off) and buffer exchanged into the NIVIR Buffer (20mM 
Sodium Phosphate, 150 mM NaCl pH 6.5). The concentration by measurement 
of absorbance at 280 nm as described in section 2.2.8 was calculated to be 
28.2 mg, 2.12 mM in a 0.5 mL solution. 
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Figure 3-12. Positive ion mass spectrum of the '5Nb domain. 
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The expected molecular weight if all 153 nitrogen atoms were labelled with the 
15 N isotope would be 13300 Da. The actual molecular weight of the major 
species recorded by electrospray mass spectrometry was 13298 Da, which 
indicates 2 of the 153 nitrogen's were not labelled and so the labelling efficiency 
was 98.7%. 
The mass spectrum in Figure 3-12 also reveals a sodium ion adduct at 13320.2 
Da and the dephosphorylated a-N-6-Phosphogluconoylation of the histidine-tag 
modification at 13476 Da (+178 Da). There was also an unknown adduct with 
an extra mass of 98 Da, with a total mass of 13395.7 Da, this could be as a 
result of a phosphorylation (H203PO-) of the protein at an unknown site 
This initial work established the optimum expression conditions for the b domain. 
The 15N-labelled b domain sample described here gave good spectra to allow 
assignment and indeed as expected there were subtle differences in chemical 
shifts resulting from differing sample conditions to the published b domain data, 
this analysis is shown and described further in Figure 5-8 and section 5.3.3. 
The task of obtaining b domain assignments was taken over by Dr. K. Wallis 
(University of Warwick), who proceeded successfully to produce a 13C, 15 N- 
labelled b domain NMR sample, using 2 g/L 13C_g lucose, enabling the full 
assignment of the b domain. These assignments are used in this research to 
assist in the assignment of the bbx domain. 
3.3. bb'x domain 
Since the b' domain was the main target of interest and since prior NIVIR data 
shows that the W alone gives poor NIVIR spectra, bbIx was a better target since 
bb'x was shown to give a better resolved NIVIR spectra as described in Chapter 
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4. So production of high yields and homogenous isotopically labelled bbIx 
samples for NMR analysis are crucial to enable the collection of good NIVIR data. 
3.3.1. Expression and characterisation of the bb'x domain 
The bblx domain construct was grown as described in section 2.2.7. Two 40C 
mL minimal medium cultures were grown in two 2 Litre flasks. The sample was 
then applied to an Immobilized Metal-Affinity Column as described in section 
2.3.1. 
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Figure 3-13.16% SDS-PAGE of bb'x applied to IMAC. Lane 1, low molecular weight 
marker. Lane 2, total protein. Lane 3, soluble protein. Lane 4, flow through. Lane 5, 
imidazole wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged bb'x protein elute. 
The IMAC purification, as shown in Figure 3-13, was not as efficient as seen 
previously, this may result of the high level of bb'x protein expression; hence 
overloading of the column. The IMAC elute was therefore further purified using 
anion-exchange chromatography as described in section 2.3.2. 
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The chromatogram in Figure 3-14 shows a broad peak which results from a 
poor resolution of what appears to be two species. But when samples taken 
from across the peak were run on a SDS-PAGE the protein appears to consist 
of a single species, as shown in Figure 3-15. 
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Figure 3-15.16% SDS-PAGE of fractions taken across the peak in chromatogram peak 
shown in Figure 3-14. 
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Figure 3-14. Anion-exchange chromatogram of bb'x using a Source 30Q column. 
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The fractions of the peak in Figure 3-14 were then pooled and re-run with a 
shallower gradient in an attempt to achieve a better resolution. As shown in 
Figure 3-14, the gradient was set to 100% Buffer B over 100 mL. Since the 
peak is eluted below 50 % Buffer B, to improve the resolution the gradient was 
set to 50 % Buffer B over 100 mL as shown in Figure 3-16. 
Figure 3-16. Chromatogram of bb'x using a Source 30Q with a 50% Buffer B gradient 
over IOOmL 
There is still some overlap of the two species, but the overall ratio was much 
smaller. 20 plL samples from each of the 2 ML peak fractions were treated and 
run on a native-PAGE gel as described in section 2.2.12; in an attempt to 
identify the species producing the two peaks observed in Figure 3-16. 
94 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
13456789 10 
Figure 3-17.16 % Native-PAGE of bb'x from fractions of the peak in 
Figure 3-16. Lane 1, Elute of IMAC before loading onto Source 30Q column. Lane 2, 
fraction 35. Lane 3, fraction 36. Lane 4, fraction 37. Lane 5, fraction 38. Lane 6, fraction 
39. Lane 7, fraction 40. Lane 8, fraction 41. Lane 9, fraction 42. Lane 10, fraction 43. 
The early fractions, as shown in Lanes 2 to 4 (Figure 3-17) contain a single 
species presumed to be a monomer while the late fractions in Lanes 5 to 10 
containing a mixture presumed to be a monomer and dimer. To confirm this, 
the first peak (not all fractions run on the gel in Figure 3-17) up to fraction 38 
(lane 5, Figure 3-17) were pooled, called Pool 1. The second or late peak in 
Figure 3-16 from fractions 39 (lane 6, Figure 3-17) to fraction 49 (or 68 to 90 ml-) 
(not all fractions run on gel in Figure 3-17) were pooled separately, called Pool 2. 
Each pool was then applied to a Superdex 75 Gel filtration column as described 
in section 2.3.3. 
Figure 3-18. Superdex 75 gel filtration chromatogram of pool 1. The void volume 
highlighted with Vo was 106 mL. 
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Pool 1 now appears to be completely homogeneous, since only a single peak 
was visible from the gel filtration chromatograrn shown in Figure 3-18,3 mL 
peak fractions were taken from which 20 pL samples where treated with native- 
loading buffer and 20 pL run on a native-PAGE as described in section 2.2.12. 
1 
Figure 3-19.16 % native-PAGE of fractions taken across peak in chromatogram in Figure 
3-18. 
The fractions across the peak in Figure 3-18 are in fact homogenous as shown 
in Figure 3-19, whereby no higher molecular weight protein bands are visible. 
All fractions from the peak in Figure 3-18 were pooled and called monomer. 
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Figure 3-20. Superclex 75 gel filtration chromatogram of Pool 2. The void volume 
highlighted with VO is 115mL 
Note that previously in Figure 3-18, the void volume was 105 mL and the first 
peak elutes approximately 55 mL after the void volume at approximately 160 mL 
(accumulated volume). The Pool 2 gel filtration column in Figure 3-20 was 
started 10 mL late (void volume was therefore 115 mL), so the same species 
which eluted at 160 mL (in Figure 3-18) now elutes at approximately 170 mL 
(later peak). The larger molecular weight species, which was first identified in 
the anion-exchange column run in Figure 3-17 and seen on native gel in Figure 
3-17, is therefore the first or early peak eluted in the gel filtration column 25 mL 
after the void volume of 115mL at approximately 140 mL. From the 
chromatogram in Figure 3-20, it appears that Pool 2 was a mixture of the two 
species, as expected since the Pool 2 fractions appeared to have both low and 
high molecular weight species in the native-PAGE analysis in Figure 3-17. 
Therefore, 20 pL samples from the 3 mL peak fractions in Figure 3-20 were 
taken treated with loading buffer and 20 pL run on a native-PAGE gel as 
described in section 2.2.12. 
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Figure 3-21.16% native-PAGE of fractions taken across peak in Figure 3-20 
chromatogram. 
From Figure 3-21, the native gel analysis of the chromatogram in Figure 3-20, 
reveals two species, the larger molecular weight peak (dimer) predominately 
residing in the first peak from the gel filtration chromatogram in Figure 3-20 and 
the smaller molecular weight species (monomer) residing in the later peak of the 
gel filtration chromatogram. From the gel therefore, fractions in lanes 1 to 4 
were pooled together into dimer pool, while fractions in Lanes 5 and 7 were 
added to the previously described monomer pool in Figure 3-19. 
As mentioned earlier and now somewhat clearer, pooled fractions from anion- 
exchange were titled Pool 1, early peak and Pool 2 for the later peak. These 
samples further purified and analysed by native-PAGE revealed Pool 1 samples 
constituted largely of a monomer species and the Pool 2 samples were 
somewhat heterogeneous but could be further fractionated to mainly consist of 
the dimer species. This is summarised in Figure 3-22. 
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Figure 3-22. Diagram showing the fractionation and pool designation. Note that 
fractionation of the early peak after anion-exchange generally is sufficient to isolate the 
monomer species, the dimer is rarely seen in Pool I treatment by gel-filtration. 
It was at this stage still an assumption that the low and high molecular weight 
species are monomer and dimer, respectively. But from the SDS-PAGE 
analysis, as shown in Figure 3-15 it appears that the protein is a single 
homogenous species. The evidence of the presence of the higher molecular 
weight species in Pool 2 samples comes from the fact that two species are seen 
on native-PAGE analysis and can be separated by gel filtration. Confirmation 
that this species is a dimer was carried out and is discussed later in Chapter 3.8. 
The monomer pool was concentrated down using Centricon filter columns (5 
kDa molecular weight cut off) and the concentration was measured using the 
Biorad assay as described in section 2.2.8. The concentration was calculated to 
be 98.9 mg, 3.6 mM in a 200 pL solution. The dimer pool was concentrated and 
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concentration calculated by the same method to be 9.89 mg, 0.36 mM in a 250 
plL solution. 
The mass spectrum of the bb'x monomer in Figure 3-23 reveals the major 
species has mass of 27477 Da which matches the predicted mass from the 
sequence. It also shows the dephosphorylated (+178 Da) a-N-6- 
Phosphogluconoylation of the histidine-tag at 27655 Da. There was also an 
unknown adduct, with an extra mass of 98 Da, with a total mass of 27575 Da, 
this could be as a result of a phosphorylation (H203PO-) of the protein at an 
unknown site. There also appears to be a very minor species possibly a 
degradation product with a -1454 Da with a total mass of 26023 Da. 
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Figure 3-23. Positive ion mass spectrum of the bb'x monomer. 
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The mass spectrum of the bb'x dimer in Figure 3-24 also reveals the 27477 Da 
species which matches the predicted mass using the sequence. The other 
species are very minor, at approximately 10% intensity of the major species 
observed and are the same as those observed previously. 
There appears to be no difference in mass spectrometry data between the 
monomer and dimer species, importantly no dimer mass was recorded-, it was 
likely that the treatment during the mass spectrometry preparation and analysis 
disrupts the dimer and as a result no dimer species was detected. 
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Figure 3-24. Positive ion mass spectrum of the bb'x dimer. 
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From the CID spectrum shown in Figure 3-25, it is clear that both recombinantly 
expressed bb'x domain monomer and dimer are folded and there was no major 
structural difference between the two species samples. Analysis of the 
spectrum indicated 39% and 15% helical and beta content, respectively, for the 
bb'x monomer sample. Also, 44% and 15% helical and beta content, 
respectively, were recorded for bb'x dimer sample. 
3.3.2. Optimisation of bb'x expression 
The aim of these experiments was to identify the optimum conditions in terms 
the cell density before induction with IPTG and protein expression time once 
induced with IPTG. Also, in light of producing 13C-labelled protein for NIVIR 
experiments, the aim was to also identify the optimum induction time in relation 
to reduced amount of glucose used. Isotopically labelled 13C_g lucose was an 
expensive reagent and so reducing the quantities used was financially beneficial. 
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Figure 3-25. A Far UV CD spectrum for the two pools of bb'x domain. Using a sample, of 
2.5uM, 0.07 mg/mI. 
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Three 50 mL minimal medium cultures were grown and induced with 1 mM 
IPTG at O. D. of 0.3,0.5 and 0.7.1 mL samples were taken from each culture at 
4,6 and 24 hours post induction. The 1 mL samples were treated as described 
in Figure 3-6 and run on a 16% SDS-PAGE. 
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Figure 3-26.16 % SDS-PAGE of bb'x test expression. T= Total protein sample, S= 
Soluble protein sample, t= time of sample taken after induction (Hours), O. D. = optical 
density measured at 600nm at which cells were induced, m= low molecular weight 
marker (kDa). 
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Figure 3-27.16% SDS-PAGE of bb'x test expression. T= Total protein sample, S= 
Soluble protein sample, t= time of sample taken after induction (Hours), O. D. = optical 
density measured at 600nm at which cells were induced, m= low molecular weight 
marker (kDa). 
From Figure 3-26 and Figure 3-27 it was clear that induction at 0.3 causes a 
huge reduction in protein expression when compared to lanes with induction at 
optical densities of 0.5 and 0.7. When comparing induction at optical densities 
of 0.5 and 0.7, the expression was perhaps slightly higher at O. D. 0.5. When 
comparing expression time at O. D. 0.5, it is very clear that the level of 
expressed protein is at its highest concentration at 4 hours and there is a 
marked decrease in protein after 6 hours of expression and almost no protein 
after 24 hours of expression. 
To measure the effect of glucose concentration on yield, four 50 mL minimal 
medium cultures were grown on differing concentrations of glucose of 4,3,2 
and 1 g/L and induced with 1 mM IPTG at O. D. of 0.5, highlighted by Figure 
3-26 and Figure 3-27 as being the optimum O. D. for induction for maximum 
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protein yield; determined previously. 1 mL samples were taken for each culture 
at 4,6 and 24 hours post induction. The 1 mL samples were treated as 
described in Figure 3-6 and run on a 16% SDS-PAGE. 
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Figure 3-28.16% SDS-PAGE of bb'x glucose test expression. T= Total protein sample, S 
= Soluble protein sample, Glucose concentration in g/L (grams per Litre), t= time of 
sample taken after induction (Hours), rn = low molecular weight marker (kDa). 
From Figure 3-28 it is clear that 24 hour induction results in a much lower yield 
of protein expressed. The samples taken at 2g/L at 24 hours appear anomalous 
in that the level of protein expression appears much higher than another sample 
taken over a 24 hour induction period. When comparing 4 hour and 6 hour 
inductions it is also clear that the expressed bb'x protein is at its highest 
concentration in the 4 hour samples. Comparing the soluble protein samples 
during the 4 hours inductions, it is clear that 1 g/L expresses the least amount of 
protein. Surprisingly, 4 g/L appears to expresses less protein than 3 and 2g/L, 
where there is less glucose present (this could be an anomalous result, resulting 
from poor handling handling of this sample). It was difficult to distinguish any 
great difference between the size of the bands in soluble protein samples of 3 
and 2g/L, but the sample at 3 g/L appears slightly larger. In the interest of cost 
effectiveness, the slight drop in expression in using 2 g/L was acceptable, since 
the difference in the expression level appeared slight. 
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3.3.3. Expression and purification of 15 N bb'x 
To first assess the quality of NIVIR data, a 2D HSQC experiment was necessary 
and this experiment requires at minimum a1 mM (1.5mM is preferred), 300ul- 
sample. The bb'x domain was expressed as described in section 2.2.7, in 
minimal medium with 15N-labelled ammonium sulfate as described in section 
2.2.10, to produce a 15 N-labelled NMR sample. The purification procedure was 
the same as all expression purifications, starting with IMAC as described in 
section 2.3.1. 
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Figure 3-29.16 % SDS-PAGE of 15N bb'x applied to IMAC. Lane 1, un-induced sample. 
Lane 2, total protein. Lane 3, soluble protein. Lane 4, flow through. Lane 5, imidazole 
wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged bb'x protein elute. Lane 8, 
low molecular weight marker. 
The IMAC purification step was very effective at removing the majority of protein 
impurities. But the elute still has several protein impurities remaining. The 
IMAC elute was then further purified using anion-exchange chromatography as 
described in section 2.3.2. 
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Figure 3-30. Chromatogram of bb'x using a Source 30Q. 
The chromatogram of the 15N-bb'x purification using anion-exchange in Figure 
3-30 reveals two peaks even though run at a lower gradient to improve 
resolution. But as seen in Figure 3-15 when run on SDS-PAGE there appears 
to be no difference between the two peaks. Although as seen previously, the 
two peaks represent two differing molecular species. Since this sample was to 
be used analysed by NMR, a homogenous species was essential and so to 
determine this, 10 pL samples across the peaks were run on native-PAGE. 
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Figure 3-31.16 % native-PAGE of bb'x from fractions of the peak in Figure 3-30, from 38 
mL to 48 mL eluted volume. 
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On the basis of the anion-exchange chromatogram (Figure 3-30) and native gel 
(Figure 3-31), the fractions were separated into two pools on the basis of the 
early and late peak in the chromatogram. Pool 1 consisted of lanes 1 to 3, 
which relates to volumes 38 to 44 mL in the chromatogram and Pool 2 relates to 
4 and 5, volumes 44 to 52 mL in the chromatogram. To further purify each pool, 
the pooled samples were concentrated using Centricon filter columns (5000 Da 
molecular weight cut off) to a final volume of 2 mL then applied to a gel filtration 
column. 
Figure 3-32. Superclex 75 gel filtration chromatogram of Pool 1. The void volume 
highlighted with V. is 105mL 
From Figure 3-32 it is clear that the initial anion-exchange Pool 1 separation 
was not very effective at separating the two species into a single homogenous 
sample. The separation by gel filtration appears to be more effective at 
separating the monomer and dimer. To confirm the homogeneity of the two 
peaks, 20 pL samples were taken from each peak and analysed by native- 
PAGE. 
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Figure 3-33.16 % native-PAGE of bb'x from fractions of the peaks in Figure 3-32. Lane 1, 
fraction containing first peak. Lane 2 to 4 fractions across second peak. 
The homogeneity of the second peak (monomer) was revealed by the native gel. 
So the second peak (lower molecular weight species) from the chromatogram in 
Figure 3-32 was pooled in what is defined as Pool 1, the first peak sample (the 
higher molecular weight species) does not to appear to be completely 
homogenous and so was discarded. 
Pool 2 from the anion-exchange column was then applied to gel filtration column, 
again to improve the separation of the initial anion-exchange pooling. 
Figure 3-34. Superclex 75 gel filtration chromatogram of Pool 2. The void volume 
highlighted with V, is at 105mL. 
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To check the identity of each peak, again samples from each peak were taken 
and run on a native gel. 
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Figure 3-35.16 % native-PAGE of bb'x from fractions of the peaks in Figure 3-34. Lane 1, 
fraction containing first peak. Lane 2, empty. Lane 3 and 4, fractions across second 
peak. 
As shown in the native gel, the first peak contains mainly the larger molecular 
weight species (dimer), with a slight contamination of the lower molecular weight 
species (monomer). These fractions from approximately 200 to 225 mL were 
pooled as the dimer pool. The fractions of the second peak in lanes 3 and 4 on 
the native gel, show that the later peak consists mainly of the lower molecular 
weight species (monomer) with a very small amount of dimer present. These 
fractions from approximately 230 to 250 mL were pooled into the monomer pool. 
Fractions in between; 225 to 230 mL were discarded as they would consist of 
higher mixture of the two species. 
The concentration by measurement of absorbance at 280 nrn as described in 
section 2.2.8 was calculated to be 63.9 mg, 2.3 mM in a 350 pL solution for the 
monomer pool and 56.9 mg, 2.05 mM in a 500 pL solution for dimer pool. 
Samples of each were then prepared and analysed by mass spectrometry. 
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The expected molecular weight if all 316 Nitrogen atoms were labelled with the 
15 N isotope would be 27793 Da since the unlabelled bb'x domains is 27477 Da. 
The actual molecular weight recorded electrospray mass spectrometry was 
27784.0 Da, which indicates 307 labelled Nitrogen of the 316-1 therefore the 
labelling efficiency was 97% in the monomer sample. The mass spectrum in 
Figure 3-36 also shows some minor species as discussed previously. 
ill 
Figure 3-36. Positive ion mass spectrum of '5N bb'x monomer pool. 
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Figure 3-37. Positive ion mass spectrum of '5N bb'x dimer pool. 
100% labelling of all the 316 Nitrogen atoms would reveal a species at 27793 
Da since the unlabelled bb'x domains is 27477 Daltons. The actual molecular 
weight recorded by electrospray mass spectrometry was 27783 Da, which 
indicates 306 labelled Nitrogen of the 316; therefore the labelling efficiency was 
96.8% in the dimer pool sample. 
The mass spectrum in Figure 3-37 also reveals the dephosphorylated (+178 Da) 
and phosphorylated (+258 Da) a-N-6-Phosphogluconoylation of the histidine-tag 
modification at 27961 Da and 28041 Da respectively. There was also some of 
the other minor species as discussed previously. The phosphorylated (+258 
Daltons) a-N-6-Phosphogluconoylation of the histidine tag has so far only 
appeared in the dimer samples, seen here in Figure 3-37 and seen in the 
unlabelled bb'x domain sample in Figure 3-24, the importance or relevance of 
this observation was unclear and could just be a coincidental. 
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3.3.4. Expression and purification of 15N/ 13 C bb'x 
In order to collect NIVIR data to assign the backbone of bb'x, a 15 N/13C 
isotopically labelled sample was required. The bb'x domain construct was 
grown as described in section 2.2.7. Two 400 mL minimal medium cultures with 
appropriate isotopically labelled reagents were grown in two 2 Litre flasks. From 
the test expression of in section 3.3.2, the optimised conditions of 2g/L of 13C 
glucose and induced for 4 hours would be applied. The sample was then 
applied to an Immobilized Metal-Affinity Column as described in section 2.3.1. 
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Figure 3-38.16% SDS-PAGE of the IMAC purification of 15N/13C bb'x- Lane 1, low 
molecular weight marker. Lane 2, total protein. Lane 3, soluble protein. Lane 4, flow 
through. Lane 5, imidazole wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged 
15N/ 13 C bb'x protein elute 
From Figure 3-38, it is clear that purification step was very effective at removing 
the majority of non-tagged protein impurities. But the elute still has several 
minor protein impurities remaining. This 13C/1 5N bbx sample was further 
purified by anion-exchange chromatography, this 13C/1 5N bbIx gave 
comparative data to the 15 N bb'x sample as described in section 3.3.3. 
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The 13C/1 5N bb'x sample was then separated into two pools on the basis of the 
gel filtration peaks and native-PAGE analysis, similar to as was done in section 
3.3.3. The two pools were then concentrated down and buffer exchange into 
the NMR buffer. The concentration by measurement of absorbance at 280nm 
and was calculated to be 179.1 mg, 6.17 mM in a 200 pL sample for monomer 
pool. For the dimer pool the concentration was calculated, using the same 
method, 29.0 mg, 1.0 mM in a 200 pL sample. A small sample of monomer and 
dimer was buffer exchanged into 10 mM ammonium bicarbonate and analysed 
by mass spectrometry. 
Figure 3-39. Positive ion mass spectrum of 
13C/I 5N bb'x monomer pool. 
The expected molecular weight if all the 316 Nitrogen and all the 1242 Carbon 
atoms were labelled with the 15N and 13C isotopes would be 29035 Da since the 
unlabelled bb'x domains is 27477 Da. The actual molecular weight recorded 
electrospray mass spectrometry was 28970, Da which indicates 1493 labelled 
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atoms of the 1558 total possible atoms available for labelling and so a 95.8 % 
labelling efficiency for the monomer pool. Several other minor species as 
described previously are also recorded. 
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Figure 3-40. Positive ion mass spectrum of 13C/1 5N bb'x dimer pool. 
The expected molecular weight if all 316 Nitrogen and all 1242 Carbon atoms 
were labelled with the 15 N and 13C isotopes would be 29035 Da since the 
unlabelled bb'x domains is 27477 Da. The actual molecular weight recorded 
electrospray mass spectrometry was 28970 Da, which indicates 1493 labelled 
atoms of the 1558 total possible atoms available for labelling and so a 95.8 % 
labelling efficiency for the dimer pool. 
There are also several other species which appear in the mass spectrometry 
analysis, the peak at 29065 Da results from a possible phosphorylated adduct 
with an extra mass of 95 Da. The species at 29235 Da, with an extra mass of 
265 Da could result from the a-N-6-Phosphogluconoylation of the histidine tag 
modification (258 Da), the extra 7 Dalton mass difference could result from six 
13C or 15N atoms. 
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Most interestingly and small amount of a species with a mass of 57945 was 
observed. This could result from the high molecular weight species or dimer 
seen in native gel. This weight suggests the species is a dimer, since half the 
weight of this species is 28973 Da, close to the major species seen in the mass 
spectrometry analysis. This was the only evidence of a dimer species observed 
by mass spectrometry for any domain combination. 
3.4. Wx domain 
Due to the size and properties of bb'x (discussed in later Chapters) assigning 
the backbone would be demanding. To aid accurate assignment, the b domain 
was initially assigned by Dr. K. Wallis. This would leave ambiguity and 
difficulties when attempting to assign the b'x domain section in the bb'x 
construct especially since the b' domain appears to be in conformation 
exchange; possibly resulting from functional requirements. Therefore, it would 
be beneficial to also initially assign Wx before tackling bb'x. 
3.4.1. Expression and purificati I on of 15 N blx 
The optimisation and test expression was carried out in the group by Dr. K. 
Wallis and was found to be the same as those described in section 2.2.7. Also 
carried out was mass spectrometry analysis, which confirmed the 17282 Da 
mass of the Wx domain construct identical to the predicted mass from the 
sequence. 
In order to isotopically label b1x the ammonium sulphate in the minimal medium 
was substituted with "N-labelled ammonium sulphate as described in section 
2.2.10. Two 400ml- cultures were grown in two 2 Litre flasks. The clarified cell 
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extract was then applied to an Immobilized Metal-Affinity Column as described 
in section 2.3.1. 
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Figure 3-41.16% SDS-PAGE of the IMAC purification of '5N b'x. Lane 1, low molecular 
weight marker. Lane 2, total protein. Lane 3, soluble protein. Lane 4, flow through. Lane 
5, imidazole wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged "N Wx protein 
eI ute. 
From Figure 3-41, it was clear that purification step was very effective at 
removing the majority of non-tagged protein impurities. But the elute still has 
several minor protein impurities remaining. The elute sample was then further 
purified using anion-exchange chromatography as described in section 2.3.2. 
Figure 3-42. Chromatogram of '-N Wx using a Source 30Q with a 100% Buffer B gradient 
over I OOmL. 
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The chromatogram of the anion-exchange reveals two major peaks; also this 
chromatogram was somewhat different from all other PDI domain purification 
chromatograms. To further analyse the eluted protein, samples were taken 
across both peaks and analysed by native-PAGE. 
dho 
3456 
Figure 3-43.16% native-PAGE of fractions across peaks in Figure 3-42. Lanes 1- 3 taken 
from across the early peak, Lane 4 taken from a fraction between the two peaks and 
Lanes 5,6 from fraction of the late peak. 
Since this protein was an expensive labelled preparation, only small number 
and volume of selected samples were used for native-PAGE analysis. 
Highlighted in Figure 3-43 the two peaks from the anion exchange 
chromatogram are distinguishable on the basis of the high and lower molecular 
weight species as observed in other domain construct purifications. But the 
peaks in the anion exchange chromatogram are overlapped and in order to 
separate the two species better and obtain the maximum amount of 
homogenous samples, all fractions were pooled, concentrated down to 
appropriate volumes so that the sample could be applied to a Superdex 75 Gel 
filtration column (as described in section 2.3.3. ) which in previous analyses gave 
better separation resolution. 
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Figure 3-44. Superclex 75 gel filtration chromatogram 15 N b'x. The void volume 
highlighted with V, at 105mL. 
From the gel filtration chromatogram it appears the two forms have been 
separated into two homogenous samples. To ensure this was the case samples 
from each of the two peaks were analysed by Native-PAGE. 
1234 
Figure 3-45.16% native-PAGE of fractions across each peak in Figure 3-44. Lanes 1-2 
from the early gel-filtration peak and Lanes 3-4 from the late peak. 
From the native-PAGE analysis taken from samples from each peak separated 
by gel-filtration it was clear that monomer and dimer species are well separated 
and result in homogenous fractions. Hence all fractions from the gel-filtration 
119 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
early peak (dimer) were pooled separately from the late peak fractions 
(monomer). Each of the two pools were concentrated down using the Centricon 
filter columns (5000 Da molecular weight cut off) and exchanged into NIVIR 
buffer, to be used to collect NIVIR HSQC spectra. 
The concentration by measurement of absorbance at 280nm was calculated to 
be 35.0 mg, 2.0 mM in a 400 pL sample for the monomer pool. For the dimer 
pool the concentration was calculated, using the same method was 17.6 mg, 1.0 
mM in a 300 pL sample. A small sample of monomer and dimer was buffer 
exchanged into 10 mM ammonium bicarbonate and analysed by mass 
spectrometry. 
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Figure 3-46. Positive ion mass spectrum of '5N Wx monomer. 
The expected molecular weight if all 205 Nitrogen were labelled with the 15 N- 
isotopes would be 17487 Da since the unlabelled Wx domains is 17282 Da. 
The molecular weight of the main species recorded by electrospray mass 
spectrometry was 17480 Da, which indicates 198 labelled atoms of the 205 total 
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possible atoms available for labelling and so a 97% labelling efficiency for the 
monomer pool. The 17658 Da and 17738 Da species have an extra mass of 
178 and 256 Da respectively, resulting from the His-tag modification. The 
species with a mass of 17504 Da has an extra mass of 24 Da and so was likely 
to result from a sodium ion adduct. The species with an extra mass of 98 Da at 
17578 Da, was likely to result from a phosphorylation. 
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Figure 3-47. Positive ion mass spectrum of '5N Wx dimer. 
The molecular weight of the main species recorded by electrospray mass 
spectrometry was 17481 Da, which indicates 199 labelled atoms of the 205 total 
possible atoms available for labelling and so a 97% labelling efficiency for the 
dimer pool. The 17659 Da and 17738 Da species have an extra mass of 178 
Da and 257 Da respectively, resulting from the His-tag modification. The 
species with a mass of 17504 Da has an extra mass of 24 Da, likely to result 
from a single sodium ion adduct and the mass at 17522 Da (extra 41 Da) likely 
to result from two sodium ions. The species with an extra mass of 98 Da at 
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17579 Da, was likely to result from a phosphorylation as seen in previous mass 
spectrometry analysis. 
3.4.2. Expression and purification of 13C/15N Wx 
In order to collect NMR data to assign the backbone of b1x, a 15 N/13C 
isotopically labelled sample was required. The Wx domain construct was grown 
as described in section 2.2.7. Two 400ml- minimal medium cultures were grown 
in two 2 Litre flasks. 2g/L of 13C glucose was used, supplemented with 15N- 
ammonium sulfate and induced for 4 hours. The sample was then applied to an 
Immobilized Metal-Affinity Column as described in section 2.3.1. The 
purification procedure was the same as that carried out for the 15N labelled b1x 
sample described in the previous section. The protein behaved similarly and 
gave similar chromatograms and PAGE results. The 15 N/ 13C sample was also 
fractionated into two pools, monomer and dimer. 
The concentration by measurement of absorbance at 280nm was calculated to 
be 27.0 mg, 1.5 mM in a 300 pL sample for the monomer pool. For the dimer 
pool the concentration was calculated, using the same method, 15.6 mg, 0.8 
mM in a 300 pL sample. A small sample of monomer and dimer was buffer 
exchanged into 10 mM ammonium bicarbonate and analysed by mass 
spectrometry. 
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Figure 3-48. Positive ion mass spectrum of 
13C/15 N Wx monomer. 
The expected molecular weight if all 205 Nitrogen and all 784 Carbon atoms 
were labelled with the 15 N and 13C isotopes would be 18272 Da since the 
unlabelled Wx domains is 17282 Da. The actual molecular weight recorded 
electrospray mass spectrometry was 18213 Da, which indicates 931 labelled 
atoms of the 989 total possible atoms available for labelling and so a 94% 
labelling efficiency for monomer pool. The 18469 Da species has an extra mass 
of 256 Da resulting from the His-tag modification. The species with a mass of 
18259 Da has an extra mass of 46 Da and so was likely to result from two 
sodium ions adduct. The minus 64 Da species, at 18149 Da was likely to be 
product of degradation. 
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Figure 3-49. Positive ion mass spectrum of 
13C11 5N Wx dimer. 
The molecular weight recorded by electrospray mass spectrometry for the dimer 
species was 18209 Da, which indicates 927 labelled atoms of the 989 total 
possible atoms available for labelling and so a 94% labelling efficiency for the 
dimer pool. Several minor species were also recorded. The dimer sample was 
known to give poor NIVIR spectra and so generally further analysis any dimer 
sample were never carried out, but stored to be used in future analysis if 
required. 
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3.5. bb'domain 
The recombinantly expressed bb' domain combination was required to test the 
characteristics of various domain combinations and also test the link between 
the monomer and dimer and the presence of the x-region; since it appears that 
all constructs including the x-region were prone to the formation of the dimer 
species. 
3.5.1. Expression and characterisation of the bb' domain 
The bb' domain construct was grown as described in section 2.2.7. Two 400mL 
LB cultures were grown in two 2 Litre flasks. The sample was then applied to 
an Immobilized Metal-Affinity Column as described in section 2.3.1 
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Figure 3-50. bb' domain IMAC purification. Lane 1, low molecular weight marker. Lane 2, 
empty. Lane 3, total protein. Lane 4, soluble protein. Lane 5, flow through. Lane 6, 
imidazole wash. Lane 7, low salt wash. Lane 8, empty. Lane 9, hexa-histidine tagged bb' 
protein elute. 
From Figure 3-50, it is clear that purification step was very effective at removing 
the majority of non-tagged proteins. But the elute still has a protein impurity 
remaining. So the elute was then prepared and further purified on an anion- 
exchange column as described in section 2.3.2. 
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Figure 3-51. Chromatogram of Source 30Q purification of bb'. 
To investigate if the peak in the chromatogram was not overlapped with 
impurities, samples were taken across the peak and run on SDS-PAGE. 
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Figure 3-52.16 % SDS-PAGE of anion-exchange fractions of bb' purification in Figure 
3-51. 
It was clear from Figure 3-52 that all the fractions taken across the peak shown 
in Figure 3-51 are homogenous and pure, with no protein contaminates. The 
same samples were then run on native-PAGE. As shown in Figure 3-53, this 
analysis revealed a very small amount of the higher molecular weight impurity in 
lanes 4 and 5, these fractions were therefore discarded. 
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Higher molecular 
weight species 
Figure 3-53.16% native-PAGE analysis of fraction taken across the anion exchange 
chromatogram in Figure 3-51. 
The remaining fractions (lanes 1-3) were then pooled to produce a 
homogeneous monomer bb' sample. The monomer sample was then 
concentrated and buffer exchanged in to Buffer A. The concentration by 
measurement of absorbance at 280nm was calculated to be 146 mg, 5.8 mM in 
a 300 pL sample. 
The mass spectrum in Figure 3-54 reveals the 25175 Da species matches 
exactly to the predicted mass using the sequence. A number of minor species 
as described earlier are also seen. 
127 
12345 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
24600 
Figure 3-54. Positive ion mass spectrum of bb' monomer sample. 
mg/ml. 
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Figure 3-55. A Far UV CD spectrum for the bb' domain. Using a sample, of 2.5uM, 0.06 
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From the CID spectrum shown in Figure 3-55, it is clear the recombinantly 
expressed bb' domain was folded. Analysis of the spectrum indicated 42% and 
13% helical and beta content, respectively. This suggested some structural 
difference between ERp57 bb' and human PDI bb' domains, since the ERp57 
IbIb' domain construct (21-18L) PDB file is reported to have 33% and 18% helical 
and beta content. 
3.6. b'domain 
The recombinantly expressed b' domain combination was required to test the 
affect of the x-region when compared with the Wx domain construct. 
3.6.1. Expression and characterisation of the b' domain 
The W domain construct was grown as described in section 2.2.7. Since this 
was a test of expression, only a small scale 50 mL LB culture was grown. The 
sample was then applied to an Immobilized Metal-Affinity Column as described 
in section 2.3.1. 
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Figure 3-56. b' domain IMAC purification. Lane 1, total protein. Lane 2, soluble protein. 
Lane 3, flow through. Lane 4, imidazole wash. Lane 5, low salt wash. Lane 6, hexa- 
histidine tagged b' protein elute. Lane 7, low molecular weight marker. 
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From IMAC, it is clear that purification step was very effective at removing the 
majority of protein impurities. But the elute still has a protein high number of 
protein impurities remaining. So the elute was then prepared and further 
purified on an anion-exchange column as described in section 2.3.2, but eluted 
over 50 % of the Buffer B and over a 50 mL volume. 
The chromatogram of the anion-exchange of b' as shown in Figure 3-57 
revealed two peaks. Fractions from this peak were treated and run on a SDS- 
PAGE as described in section 2.2.11. 
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Figure 3-57. Chromatogram of Source 30Q IEX purification of W. 
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Figure 3-58.12% SDS-PAGE of the fractions across the two peaks of the anion-exchange 
purification step. 
Lanes 10 to 15 (Figure 3-58) appear to be a mixture of the b' domain with 
several larger mass impurities. Therefore the fractions were pooled into two 
groups. Pool 1 consisting of the first peak in the anion-exchange step, fraction 
from lanes 4 to 9. Pool 2 consisting of the later peak and fractions in lane 10 to 
15. Native-PAGE analysis on these fractions was unsuccessful as the samples 
appeared heavily smeared (gel not shown), so no further characterisation could 
be done. 
The concentration by measurement of absorbance at 280nm was calculated to 
be 4.88 mg, 340 pM in a 500 pL sample for Pool 1- For Pool 2 the 
concentration was calculated, using the same method, 4.34 mg, 300 pM in a 
400 pL sample. 
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Figure 3-59. Positive ion mass spectrum of b' Pool 1. 
The mass spectrum in Figure 3-59 reveals the major 14360 Da species which 
matches exactly to the predicted mass using the sequence. The spectrum also 
shows several very minor species discussed in other spectra and a degradation 
product with a mass of 12850 Da. 
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Figure 3-60. Positive ion mass spectrum of b' Pool 2. 
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The mass spectrum for b' Pool 2 in Figure 3-60 appears much more complex 
than that for Pool 1. The major species of 14360 Da matches exactly to the 
predicted mass using the sequence. There are many species, mainly of a lower 
molecular weight, which fits with what was observed in SDS-PAGE of the anion- 
exchange purification in Figure 3-58. It therefore appears that the b' was much 
less stable or more prone to proteolysis than the other PIDI constructs 
expressed so far. The mass spectrum does reveal the phosphorylated (+258 
Da) a-N-6-Phosphogluconoylation of the histidine tag at 14618 Da and one of 
the unlabelled peaks was most likely the dephosphorylated modification. 
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Figure 3-61. A Far UV CD spectrum for the b' domain monomer pool. Using a sample, of 
IOuM, 0.14 mg/ml. 
From the CID spectrum shown in Figure 3-55, it is clear the recombinantly 
expressed W domain was not well-folded, there appears to be a reduced 
positive peak at approximately 190nm; larger peak is seen for proteins with a 
helical content. Furthermore, the two negative peaks at approximately 209 and 
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222 nm, typical of proteins with beta strand content are shifted toward a lower 
wavelength. As shown in Figure 2-4, the signal derived from random coils have 
a minima around 200nm, it appears that this is influencing the spectrum, 
resulting in the shifted beta strand signal and a reduced helical signal since the 
random coil signal also has a negative peak around the 190nm range, 
swamping the helical peak. 
Analysis of the spectrum indicated 8% and 41% helical and beta content, 
respectively. The low helical content recorded suggests a poorly folded domain. 
The poor folded state of the individual b' domain observed here by CD could be 
indicative of the intrinsic flexibility or conformational heterogeneity also seen in 
initial NMR experiments discussed in section 5.2, with particular reference to 
Figure 5-1. 
3.7. Full Length PDI 
The recombinantly expressed full length PDI was required to investigate the 
presence of the monomer and dimer species in this construct and to be used in 
subsequent NMR experiments. 
3.7.1. Expression and characterisation of full length PDI 
The full length PDI construct was grown as described in section 2.2.7. Two 
400ml- LB cultures were grown in two 2 Litre flasks. The clarified cell lysate 
was then applied to an Immobilized Metal-Affinity Column as described in 
section 2.3.1. 
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Figure 3-62.16% SDS-PAGE of the IMAC purification of Full length PDI. Lane 1, low 
molecular weight marker. Lane 2, total protein. Lane 3, soluble protein. Lane 4, empty 
lane. Lane 5, flow through. Lane 6, low salt wash. Lane 7, imidazole wash. Lane 8, low 
salt wash. Lane 9, hexa-histidine tagged Full length PDI protein elute. 
A slight difference in the normal protocol here is that, an extra low salt wash 
(lane 6) was inadvertently added after the flow through was collected. But this 
extra step appears to have had no ill-desired effects. From Figure 3-62, it was 
clear that purification step was very effective at removing the majority of protein 
impurities. The elute sample still has a large number of protein impurities 
remaining. So the elute was then prepared and further purified on an anion- 
exchange column as described in section 2.3.2. 
Figure 3-63. Full length PDI Source 30Q purification. 
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The chromatogram of the anion-exchange of PDI shown in Figure 3-63 reveals 
two overlapped peaks. To analyse the two peaks further, fractions from these 
peaks were treated and run on a SDS-PAGE as described in section 2.2.11. 
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Figure 3-64.16% SDS-PAGE of fractions taken across peak of full length PDI Source 30Q 
purification from approximately 100-1 14mL shown in Figure 3-63. 
The fractions across the anion-exchange purification peak run on a 16% SDS- 
PAGE in Figure 3-64 revealed no impurities. So one fraction sample from each 
of the overlapping peaks in Figure 3-63 (from fractions at 1OOmL and 114mL, 
lanes 2 and 8 in Figure 3-64) were then treated and run on a native-PAGE as 
described in section 2.2.12. 
12 
Figure 3-65.16% native-PAGE of Full length PDI. Lane 1- lane 2 fraction in Figure 3-64 
and Lane 2- lane 8 fraction in Figure 3-64. 
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The two samples taken from each peak in Figure 3-63 appear to have no 
impurities as shown in Figure 3-64 and under native conditions in Figure 3-65. 
All the fractions from under the peak in Figure 3-63 were concentrated down 
and buffer exchanged into Buffer A. The concentration by measurement of 
absorbance at 280nm as described in section 2.2.8 was calculated to be 312 
mg, 5.6 mM in a 500 plL sample. 
From the CID spectrum shown in Figure 3-66, it was clear the recombinantly 
expressed Full length PDI was well-folded, since there is a large positive peak 
at approximately 190nm. Furthermore, there are two negative peaks at 
approximately 209 and 222 nm. Analysis of the spectrum indicated 21% and 
37% helical and beta content, respectively. 
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Figure 3-66. A Far UV CD spectrum for the Full length PDI domain. Using a sample of 
5uM, 0.28 mg/ml. 
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3.8. Characterisation of the Pool I and Pool 2 species 
identified during purification 
This section attempts to answer the question of what is the high molecular 
weight species which was fractionated into Pool 2 or dimer pool of most protein 
constructs. The section attempts to analyse the nature and the size of this 
species by using a combination of biophysical tools. Furthermore the section 
begins the preliminary investigation of the relationship of the two species by 
observing the formation of the high molecular weight species during storage. 
3.8.1. Summary of observations during purification 
In Table 4, the observations of protein behaviour in terms of the higher 
molecular weight species or dimer seen during purification and storage are 
reported. The general trend was that two peaks are observed during anion- 
exchange chromatography then generally two peaks can also be observed by 
gel filtration which indicates there are two species observed; the high molecular 
weight species (dimer) and the lower molecular weight species (monomer). The 
exception was Full length PIDI, where two overlapped peaks were observed in 
the anion-exchange chromatography purification, but only a single species was 
observed on SIDS and native-PAGE. 
Note also that the b' domain was a very difficult protein sample to work with, 
prone to aggregation and very unreliable when analysed on PAGE. Although 
two peaks are seen during both purification steps, the identity of the peaks can 
only be inferred by what was seen with other domain constructs. The b' domain 
could not be characterised using native-PAGE as the samples smear heavily in 
the lanes. 
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So to summarise, with the exception of full length PDI and the W domain all 
other domain combinations produce two products, a low and high molecular 
weight species, speculated to be monomer and dimer, from the gel-filtration and 
native-PAGE analysis but as yet unconfirmed since no molecular weight 
analysis has been carried out . 
Table 4. 
PDI domain/ Peaks seen in Peaks seen on Observed Observed Stored 
domain anion-exchange gel filtration LMW species HMW Fractions 
combination chromatograms chromatograms on native- species developed 
PAGE on native- HMW 
(Monomer) PAGE species 
(Dimer) overtime 
(Dimer) 
W 2 2 X 
b 1 N/A X X 
bb' 2 X I/ V 
Full length 2 X X 
PDI 
Wx 2 2 
bb'x 2 2 V 
Table 4. Table summarising observations during purification and storage of various 
domain combinations. LMW - low molecular weight, HMW - high molecular weight, N/A - 
indicating not applicable, /- observed, X- not observed and Indicating observed in 
chromatograms but not observed on gels. 
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3.8.2. Analysis of storage of fractionated samples 
to 
I-Y-j L-Y-j domain bW bb' OOlg FL 
combination 00NN000 
Figure 3-67.16% native-PAGE of various domain combinations. N- New samples (run 
on the gel here within two weeks of production), 0- Old samples, stored at -120C in 
excess of 3 months. 
The final column in Table 4 summarises the observation of Figure 3-67, which 
shows fractionated samples of all domain combinations. Old samples were 
stored frozen (for a minimum of 3 months storage) and new samples were 
produced and analysed within two weeks of their production; samples of each 
were taken and run on native-PAGE. This allowed the analysis of prolonged 
storage, where samples are stored frozen until required. The trend that appears 
is that any domain combination which gives two pools during purification, once 
purified and fractionated, in to the monomer pool will over time produce the high 
molecular weight species or dimer during storage; this was observed with bbl, 
bb'x and Wx (b'x effect of storage not shown, but was carried out by 
Dr. K. Wallis). 
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The interesting exception was full length PDI, which produces two pools during 
anion-exchange purification, so you would expect to observe the higher 
molecular weight species or dimer on native-PAGE analysis, this was not the 
case, but this high molecular weight species was observed after storage as 
seen in Figure 3-67. The full length PDI protein may behave in similar fashion 
as bb' whereby a very small amount of the higher molecular weight species was 
produced but the concentration was too low to observe the species on native- 
PAGE analysis and is observed as it does form over time during storage. 
Unfortunately since no high molecular weight species was observed on native- 
PAGE, gel filtration was never done, but in this case this further analysis using 
gel filtration is expected to identify the existence or not of the high molecular 
weight species in full length PDI expression which is expected to be formed in a 
low quantity. 
The other unclear case was the b' domain, which produces two peaks during 
anion-exchange and gel filtration. Unfortunately the b' domain was prone to 
aggregation and smears when run on native-PAGE, hence the higher molecular 
weight species or dimer one would expect to be produced was never observed 
as highlighted in Table 4, only assumed to exist from the purification 
chromatograms. Interestingly, after storage at -40C over a period in excess of 
three months, the high molecular weight species does not form as reported in 
Figure 3-67. Hence, the two peaks observed during purification may not 
actually result from the high molecular weight species or dimer (see section 
3.6.1, for details of purification). 
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3.8.3. Further analysis of the monomer/dimer species by AUC 
To further analyse the molecular weight of the monomer and dimer species, 
analytical ultra centrifugation was used as described in section 2.4.1. 
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Figure 3-68. Analytical ultra-centrifugation data analysed using SEDFIT and showing 
sedimentation coefficient and molecular weight for bbIx. 
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An unlabelled bbIx monomer fractionated sample was used for the 
sedimentation velocity experiments, which produced the chromatograms as 
shown in Figure 3-68. The monomer species was calculated to be 25 kDa and 
the dimer 51 kDa. The monomer species is known to be 27.7 kDa, so the 
calculation by the sedimentation velocity experiments is a little low. 
3.8.4. Characterisation of the high molecular weight species or 
dimer by SDS and native-PAGE 
Initial thoughts were that the higher molecular species were a dimer of the 
protein constructs, which from native gel analysis was unclear since no markers 
could be used to confirm the molecular weight of the species. As reported in the 
majority of the protein construct expressions, the mass spectrometry analysis in 
every Pool 2 or dimer samples gave the same molecular weight as the Pool 1 or 
monomer samples. In only one case was there any evidence of the dimer by 
mass spectrometry analysis, as shown in Figure 3-40 from the 13C/1 5N bb'x 
dimer pool sample. 
To some degree this was conclusive since no evidence of dimer was seen in 
any monomer pool samples, but the fact that the dimer species was only 
observed in only one of the numerous mass spectrometry samples analysed is 
puzzling. Attempts were made to analyse the masses of species in Pool 2 or 
'dimer' samples by mass spectrometry under native conditions but only species 
with the monomer mass were observed. This strongly suggests that dimers are 
held together by weak non-covalent forces. 
However, since it is known that the b' domain contains buried unpaired Cys 
residues which could, in principle, form intermolecular disulphide bonds, it was 
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thought essential to check directly for the presence of such bonds. This was 
necessary since the native-PAGE analyses reported earlier were carried out in 
non-reducing conditions, whereas SDS-PAGE analyses were conducted in 
reducing conditions (in the presence of 10% beta-mercaptoethanol). 
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Figure 3-69.16% SDS-PAGE of bb'x Pool 2 'dimer' of varying concentrations under 
reduced and no-reduced conditions. 
As a first step, samples of bb'x Pool 2 'dimer' were prepared for SDS-PAGE 
either in standard reducing SIDS sample buffer, or in presence of SIDS but in 
absence of reducing agent. The results are shown in Figure 3-69 where various 
protein loadings of reduced and non-reduced samples are compared. Reduced 
samples show only a single major band at the monomer mass, but non-reduced 
samples also contain a higher mass band corresponding to dimer, whose 
intensity increases with sample loading. This band can be assumed to be a 
disulphide-linked dimer. However, these are heavily overloaded samples; by 
comparing the monomer and dimer bands in the non-reduced track with the 
lowest protein loading it is clear that the dimer was a very small fraction of the 
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bb'x samples (probably <10%). When a comparable sample was analysed by 
gel-filtration the dimer species constitutes roughly half the material. Hence it 
seems likely that the dimer observed by these methods was not disulphide- 
bonded and that the dimer species observed after non-reducing SDS-PAGE in 
Figure 3-69 was an artefact arising from air oxidation to generate inter- 
molecular disulphide formation between denatured species after SIDS-treatment. 
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Figure 3-70.16% SDS-PAGE of carboxymethylated bbIx under reduced and non-reducing 
conditions. Lane 1, low molecular weight marker. Lane 2, empty. Lane 3, bb'x sample 
treated with lodoacetamide and no reducing agent. Lane 4, bb'x treated with 
iodoacetamide and reducing agent. 
To check this interpretation, samples of bb'x containing significant levels of 
dimer were analysed by SDS-PAGE in presence of the thiol-blocking reagent 
iodoacetamide to block artefactual disulphide bond formation or isomerisation. 
Figure 3-70 shows the results of SDS-PAGE analysis of a Pool 2, dimer sample 
of bb'x after sample treatment with iodoacetamide in presence of SIDS and in 
absence (lane 3) or presence (lane 4) of beta-mercaptoethanol. The former 
treatment should retain any pre-existing protein disulphides, whereas the latter 
should break them and alkylate the free thiol groups generated. As is clear from 
Figure 3-70, the dominant species observed in both samples is the bblx 
monomer, confirming that there was no disulphide-linked dimer. Interestingly, 
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lane 3 shows the presence of three higher molecular weight species; one minor 
band is common to both lanes 3 and 4 and is likely to be a non-disulphide- 
bonded contaminant whereas the other two of these are clearly disulphide- 
linked since they are not observed in lane 4. It is possible that these bands are 
oligomers of bb'x, but since lane 4 also contains a number of lower molecular 
weight species not seen in lane 3, it is likely that these bands represent 
disulphide-bonded contarninants. 
Figure 3-71.16% native-PAGE of bb'x with different percentage of P-Mercaptoethanol in 
the loading buffer 
As a final check, samples of bb'x containing significant amounts of dimer were 
analysed by native (non-denatu ring) PAGE but in the presence of increasing 
quantities of the reductant beta-mercaptoethanol. As shown in Figure 3-71 this 
sample showed the presence of roughly equal quantities of monomer and dimer 
species in presence of 10% or 20% mercaptoethanol. These are strongly 
reducing conditions implying that the dimer was not formed as a result of 
covalent disulphide bonds. At extremely high mercaptoethanol concentrations 
(ý50% by volume) the dimer band disappears, but this is likely to be a solvent 
denaturation effect rather than the effect of reduction since it is not observed in 
the lower concentrations which are nevertheless strongly reducing. 
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3.9. Discussion 
As summarised in Table 5 the minimum protein concentration required for NIVIR 
analysis were exceeded in almost all cases with the exception of a15 N/13 Cb Wx 
dimer sample, but as described later, monomer samples were used to collect 
NIVIR data to enable backbone assignments and dimer samples were not used 
for NIVIR analysis. Also apparent from Table 5, the labelling efficiency generally 
exceeded 96%, with the exception Of 15 N/13C/2 H were the lower 2H labelling 
efficiency reduced the overall labelling efficiencies. This summary highlights 
the fact that high levels of isotopic labelling were achieved and the use of 
isotopic labelling reagents in minimal growth medium was adequately optimised 
to produce the high concentration protein samples required for NIVIR analysis. 
Also highlighted by the unlabelled protein samples grown in LB, is the 
exceptional efficiency of the recombinant protein expression technique used in 
the research to allow such high protein yields varying from a respectable 28mg 
to a massive 312mg. 
This chapter details and characterises the expression and purification of the 
various domains and domain combinations to be studied further. It was shown 
that sufficient quantities for analysis can be produced and more importantly a 
multi-step purification protocol was established to ensure a homogenous sample 
can be manufactured, providing the basis for more detailed structural analysis. 
It was clear that the initially named high molecular weight species was indeed a 
dimer. This was conclusively shown by the analytical ultra-centrifugation 
experiment, even though the identified masses were not exactly as those 
recorded by mass spectrometry or predicted from sequence analysis. The data 
from mass spectrometry and gel electrophoresis are all compatible with the 
interpretation that the 'dimer' form of bb'x was a weak non-covalent complex. 
147 
Chapter 3 Preparation and Preliminary Characterisation of PDI Proteins 
The chaperone function analysis was regrettably abandoned as a result of the 
lack of reproducibility. The initial results were interesting, suggesting the 
importance of the b' domain for chaperone activity and the lack of activity by the 
bbIx domain; but no firm conclusions can be drawn due to the ambiguity of the 
data. With a more robust method for analysing chaperone activity, many 
interesting questions could be addressed. 
Table 5: 
Protein Isotopic Amount of NMR Labelling 
labelling protein (mg) sample efficiency 
(mg) 
b Unlabelled 28 N/A N/A 
b 15N 28 18 98.7 
bbIx monomer Unlabelled 99 N/A N/A 
bbIx dimer Unlabelled 10 NIA N/A 
bbIx monomer 
15 N 64 41 97 
bbIx dimer 
15 N 57 41 97 
bbIx monomer 
15 N/13C 179 41 96 
bbIx dimer 15 N/13C 29 41 96 
bbIx monomer 
15 N/13 CýH 60 41 77 
bbIx dimer 15 N/13 CýH 85 41 78 
b'x monomer 
15 N 35 26 97 
b'x dimer 15N 18 26 97 
bIx monomer 
15 N/13C 27 27 94 
b'x dimer 
15N/13C 16 27 94 
bb' Unlabelled 146 N/A N/A 
b' Pool 1 Unlabelled 80 N/A N/A 
bI Pool 2 Unlabelled 64 N/A N/A 
FIL PDI Unlabelled 312 N/A N/A 
Table 6. Summary table of protein yields from 800ml- expression of various domains and 
domain combinations. Unlabelled proteins were expressed In LB 15N and 15N/13C, 
expressed in minimal medium with appropriate labelled reagents. ISNPIC/2 H expressed In 
minimal medium with appropriate labelled reagents and H20 substituted with 96% D20- 
b' yields are estimated from a 50 mL expression, since no large scale expression was 
carried out. NMR sample, refers to amount of protein required for a 1.5mM sample, 
minimum required for NMR experiments. 
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Chapter 4. Preparation of 
2 H/13C/l 5N-labelled bb'x 
4.1. Introduction 
A complete backbone assignment from approaches using TOCSY experiments 
on 15 N/13C labelled bbIx was not possible due to the low resolution of data 
obtained from NIVIR triple resonance experiments. It was hoped the two 
complementary TROSY (Transverse relaxation-optimised spectroscopy) 
experiments will allow completion of the gaps in the bb'x assignments. TROSY 
experiments require a triple-labelled 2 H/1 3C/1 5N sample. The advantage of 
TROSY experiments is that deuteration of a protein causes an increase in 
sensitivity of TROSY experiments in comparison to TOCSY experiments 
(described in detail in section 1.4.4.3). It was therefore hoped that with the aid 
of these two experiments the complete backbone could be assigned. 
The difficulty lies in cell growth and expression of protein in high levels of 
deuterium. While most isotopic substitutions (e. g. 13C for 12 C and 15N for 14 N) 
have minimal effects on the chemistry of the labelled compounds, it is well 
known that 2 H20 (otherwise known as D20) is different in many chemical and 
physical properties from 11-120 (1-120). In earlier Chapters, cell growth was not 
hindered by the presence Of 15 N and/or 1 3C; furthermore the incorporation of 
each isotope appeared to be high. This is not the case for 
2H labelling, cell 
growth is greatly affected by the presence of deuterium. So it is essential that 
cells are adapted to high levels of deuterium, which was unnecessary for 
13C/15 N labelling. This Chapter describes methods used to adapt cells to high 
concentrations of deuterium, maximising expression and level of incorporation 
of triple isotopically labelled protein. Ideally isotopic labelling of between 50- 
70% is required; at this range the decrease in sensitivity from the limited number 
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of protons is offset by the reduction in peak linewidths; as discussed previously 
in section 1.4.6. 
4.2. Adaptation of Cells and Expression of Protein in 
Increasing D20Conditions 
The first stage to produce any 2 H/ 13C/I 5N would be to adapt cells to increasing 
amounts of 2H in the growth medium. As described in section 2.2.10 deuterium 
was supplied by substituting D20 for H20 in the minimal medium. Firstly the 
bbIx transformed Ecoli cells were streaked on LB plates with appropriate 
antibiotics from which a single colony was used to grow a 20 mL overnight 
culture. The cells were then centrifuged at 15900 xg for 10 min at 4 'C. The 
cell pellet was then resuspended in 5 mL minimal medium containing 35% D20. 
The O. D. of the resuspended cells was measured and the appropriate amount 
added to inoculate a larger 40mL 35% D20-containing minimal medium at O. D. 
0.1 and this 40 mL culture was grown overnight. A sample of 600 pL of 
overnight culture was taken, added to 400 pL of 50% glycerol and stored at a 
temperature of -80'C as a glycerol back-up culture; to be used in future. This 
process was repeated as shown in Figure 4-1 until cell growth was seen in the 
maximum amount of D20 present. 
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Figure 4-1. Schematic diagram of adaptation of bbIx E-coli cells to 96% D20- 
The adapted cells were able to grow with large step increases of D20 to 86% 
after which a jump to 96% resulted in no growth. The growth was measured by 
increases in cell optical density at a wavelength of 600nm. Smaller increases in 
D20 were therefore required in the 90%+ range of D20. By this method it was 
possible to produce cells adapted to growth in 96% D20. 
4.2.1. Test expression of adapted cells 
To test if the cells adapted to 96% D20 had retained the ability to produce 
soluble recombinant protein, cells were re-grown using the glycerol stock 
samples, by first streaking on a LB agar plate with appropriate antibiotics; a 
colony was transferred to 96% D20 in minimal medium conditions and samples 
taken over a 24 hour period of induction. 1 mL samples were taken before 
induction 0 hours, 2,4,6,8 and 24 hours after induction. The samples were 
treated as described in Figure 3-6 and run SDS-PAGE. 
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Figure 4-2.16 % SDS-PAGE of bb'x 96% D20 test expression. T= Total protein sample, S 
= Soluble protein sample, t= time of sample taken after induction (Hours), m= low 
molecular weight marker (kDa). 
From Figure 4-2 it appears that a very low, if any, expression of soluble bb'x is 
produced with an optimum time of expression around 6 to 8 hours. The 24 hour 
sample shows a clear reduction of soluble protein, since the band in 24 hour 
soluble lane is less visible than the soluble protein sample taken at 6 and 8 
hours. The total protein expression at 96% D20 reveals a very low level of 
expression when compared to SDS-PAGE of 13C/15 N test expressions in section 
3.3.4. Also, all of the 2H soluble protein bands in Figure 4-2 are very small; 
indicative of a low level of soluble protein expression. It was therefore 
attempted to re-adapt the cells to improve protein yields but both attempts led to 
comparable levels of protein expression as shown in the gel in Figure 4-2 
(readapted cell expression data not shown). An alternative method of possibly 
increasing the protein yield would be to express protein at a lower D20 
concentration; this method is fraught with the risk of also reducing the level of 2H 
incorporation. The 86% D20 adapted cells were grown in a 40 mL minimal 
medium culture containing 86% D20 from the glycerol stock cultures. Again 1 
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mL samples were taken over a 24 hour period of induction and treated as done 
previously and run on SDS-PAGE. 
t=2 t=4 t=6 t=8 t=24 
97 
66 
45 
30 
H bb'x 
20 
14 
TSTS 
Figure 4-3.16 % SDS-PAGE of bb'x 86% D20 test expression. T= Total protein sample, S 
= Soluble protein sample, t= time of sample taken after induction (Hours), m= low 
molecular weight marker (kDa). 
From the expression at 86% D20 conditions it was clear that there was still a 
very low amount (if any) of soluble bb'x, as the band at approximately 27 kDa, 
labelled 2H bb'x in Figure 4-3, is no more visible than in the 96% D20 
expression test in Figure 4-2 and is very faint. Since a 300 pL, 1.5 mM sample 
was required for NMR spectroscopy and expression of these cells would require 
a very large volume culture as with the 96% D20 expression culture. Again, this 
was not desirable as D20 was very expensive and considering the high amount 
of 13C_g lucose and 15 N-ammonium sulphate required the cost would be huge. 
Also this 86% D20 would likely have a low isotope incorporation rate. Clearly an 
alternative method of producing 2H/ 13CI15 N-labelled soluble bb'x is required. 
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4.3. Expression of 2H Labelled Protein Using Adapted 
Cells and a Shock Expression Technique 
As a result of the poor expression by simply inducing cells adapted to high 
deuterium conditions an alternative method is proposed in this section. The 
hypothesis was that high incorporation and yields can be achieved by growing 
the adapted cells in LB initially, then transferring the cells to high deuterium 
minimal medium conditions and inducing immediately; this approach was coined 
'shock expression'. This hypothesis was based on the assumptions that if the 
cells can grow to a large cell mass in 11-120, since the cells are selected for 
growth in high deuterium conditions, the cells should be able to produce 
recombinant protein more efficiently when induced, using the deuterium in the 
growth medium and incorporating it into the recombinant protein molecules. 
This method was expected to be more efficient than that based on simple 
growth and induction, whereby all cellular pathways could be affected by 
deuterium incorporation. 
4.3.1. Test expression using the cells adapted to 86% and 96% 
D20 conditions 
The proposed methodology would be to take 96% D20 adapted cells grown to 
an O. D. of 0.6 in LB and centrifuged at 15900 xg for 10 min at 4 OC. The cells 
would then be resuspended in 96% D20 in minimal medium and immediately 
induced with 1mM IPTG. Samples were taken and treated as described in 
Figure 3-6 over 8 hours. 
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Figure 4-4.16% SDS-PAGE of bb'x 96% D20 shock test expression. T= Total protein 
sample, S= Soluble protein sample, t= time of sample taken after induction (Hours), m 
low molecular weight marker (kDa). 
From the data shown in Figure 4-4 it appears there was induction, since there is 
no band at 30 kDa in the 0 hour soluble protein sample but there is a band in all 
the other time point samples at this molecular weight, hence this band is 
suggestive of labelled soluble bb'x expression. The band is far more visible 
than in Figure 4-2, where the 96% D20 adapted cells were not shock induced. 
Cells adapted to 86% D20 were also tested; they were resuspended in 86% 
D20 to see if a lower D20 would increase yield and determine if there is an 
affect on deuterium incorporation. Again samples were taken and treated as 
described in Figure 3-6 over 8 hours to compare with the 96% D20 shock 
induction results. 
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Figure 4-5.16% SDS-PAGE of bb'x 86% D20 shock test expression. T= Total protein 
sample, S= Soluble protein sample, t= time of sample taken after induction (Hours), m 
low molecular weight marker (kDa). 
It is clear in the 86% D20 shock induction gel shown in Figure 4-5 that the band 
at 30 kDa is the induced recombinant protein, since this band is not visible in 0 
hour soluble protein sample. Furthermore, as expected the amount of induced 
protein is greater in this lower 86% D20 concentration expression than 96%, but 
it is expected that the incorporation would be lower. But in a positive view, 
these expression levels appear more promising in their ability to produce a 
sufficient NIVIR sample than the previous method of adaptation and induction 
attempted. These experiments were repeated to confirm reproducibility, which 
was successful and both sets of experiments produced comparable levels of 
recombinant protein running at the same molecular weight on the gel (gels not 
shown). 
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4.3.2. Production of a mass spectrometry sample to assess 
incorporation efficiency 
To confirm the band around 30 kDa in the preliminary test expression is in fact 
the 2H labelled soluble recombinant bb'x, expression was repeated using the 
shock induction method, the protein product was purified using affinity 
chromatography and a mass spectrometry sample prepared. Both 86% and 
96% adapted cells were used to identify any advantageous effects of using 
lower D20 conditions in relation to yield whilst maintaining high incorporation 
efficiency. 
86% and 96% cells were grown in 40 mL LB, spun down and resuspended in 
86% and 96% D20 conditions in minimal medium, respectively and immediately 
induced as described in section 4.3.1. The cells were induced for 6 hours as 
there appears very little difference in yield between 6 and 8 hour of induction 
shown in the test induction experiments in section 4.3.1. The crude extract was 
then prepared as described in section 2.2.7 and run on an affinity column. 
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Figure 4-6.16% SDS-PAGE of 86% D20 minimal medium expression and IMAC 
purification. Lane 1, low molecular weight marker. Lane 2,0 hour expression total 
protein. Lane 3,0 hour expression soluble protein. Lane 4,6 hour expression total 
protein. Lane 5,6 hour expression soluble protein. Lane 6, flow through. Lane 7, 
imidazole wash. Lane 8, low salt wash. Lane 9, hexa-histidine tagged 2H labelled bb'x 
protein elute. 
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It is apparent from lanes 6 to 9 in Figure 4-6, of the affinity chromatography 
purification of 86% shock induced culture, that the purification of a labelled 
sample was effective, highlighted by the single band in the elute. Since there 
appears to be very few protein impurities, it was possible therefore to 
immediately prepare a sample for mass spectrometry analysis; this was done by 
buffer exchange into 10mM ammonium bicarbonate. The concentration of the 
elute fraction was measured to be 40 pM. 
From the mass spectrometry analysis, the main species has a molecular weight 
of 28177 Da. The unlabelled mass of bb'x is 27477 Da and there are 1910 
hydrogen atoms. So the unlabelled mass of 27477 Da subtracted from the 
labelled mass of 28177 Da gives 700 labelled atoms, therefore (700/1910) x 100 
gives a 36.6% 2H labelling efficiency. 
There are several other proteins species visible in the mass spectrometry 
analysis; a peak at 27476 Da shows a very small amount of completely 
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unlabelled material. There is also peak, at half the intensity of the main peak at 
28042 Da, which is minus 135 Da; it was unknown what this species is. It is 
highly unlikely that this species results from reduced isotope incorporation. 
Several other unknown minor species also exist at 28330,28493 and 28560 Da. 
Perhaps the lower amount of D20 in the expression medium might be the cause 
of the low deuterium incorporation; hence the 96% D20 minimal medium 
expression can be compared to test this hypothesis. 
kDa 
97 
66 
45 
30 
20 
Figure 4-8.16% SDS-PAGE of 96% D20 minimal medium expression IMAC purification. 
Lane 1, low molecular weight marker. Lane 2,0 hour expression total protein. Lane 3,0 
hour expression soluble protein. Lane 4,6 hour expression total protein. Lane 5,6 hour 
expression soluble protein. Lane 6, flow 2 
through. Lane 7, imidazole wash. Lane 8, low 
salt wash. Lane 9, hexa-histidine tagged H labelled bb'x protein elute. 
Again the affinity chromatography purification of 96% shock induced culture, 
was successful in purifying the labelled protein as shown in lanes 6 to 9 in 
Figure 4-8. The eluted protein has a few impurity bands but relatively clean 
enough to allow a mass spectrometry sample to be produced. The eluted 
proteins appear comparable by visually comparing the size of the elute bands in 
86 and 96% D20 conditions. 
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Figure 4-9. Positive ion mass spectrum of 96% D20 shock induced bb'x. 
The major labelled species has a mass of 28283 Da, therefore 28283 - 27477 
gives 806 labelled atoms which is a 42.2% labelling efficiency. This is a 5.6% 
increase from the 86% D20 labelling efficiency of 36.6%. Using the 96% shock 
induction method, the eluted protein was 45 pM, 12.5% increase to that 
produced in the 86% D20 in minimal medium. If these experiments were scaled 
up 20 fold to the typical 800ml- expression then theoretically a 0.8 mM sample 
should be produced; this concentration was too low for a NIVIR sample. Hence it 
was most important to increase the labelling efficiency and some improvement 
of yield. 
4.3.3. Test expression using un-adapted cells and shock 
expression to test the necessity of adaptation 
To determine whether adaptation of cell was required, cells un-adapted to high 
deuterium conditions using the process described in section 4.2 are grown using 
160 
Chapter 4 Preparation of 2 H/13C/15 N-labelled bb'x 
the same methodology as with 86 and 96% adapted cells and the level of 
incorporation measured using mass spectrometry. 
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Figure 4-10.16% SDS-PAGE of the affinity column protein from un-adapted cell shock 
induction in 96% D20. Lane 1,0 hour induction total protein. Lane 2,0 hour induction 
soluble protein. Lane 3,6 hour induction total protein. Lane 4,6 hour induction soluble 
protein. Lane 5, low molecular weight marker. Lane 6, flow through. Lane 7, imidazole 
wash. Lane 8, low salt wash. Lane 9, hexa-histidine tagged protein elute. 
From the gel of unadapted cells shock induced, it was clear the level of 
expression level was lower than for adapted cell if lane 9 of the soluble protein 
after IMAC purification and the corresponding bands in the 86% adapted cells 
Figure 4-6, lane 9 or 96% adapted cells Figure 4-8, lane 9 are compared. This 
was further verified as the calculated concentration of the IMAC elute after the 
affinity column was 27 pM, whereas with the adapted cells of 86% and 96% was 
40 and 45 pM respectively. From the gel, it was clear that there are very few 
protein impurities in the eluted protein fraction; the main species believed to be 
the isotopically labelled recombinant protein appears at a molecular weight of 
approximately 31 KDa. Since the elute was sufficiently purified a sample was 
submitted for mass spectrometry analysis. 
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Figure 4-11. Positive ion mass spectrum of the affinity column eluted protein from un- 
adapted cell shock induction in 96% D20- 
The main species has a mass of 27483 Da which indicates 6 of the 1910 
hydrogen atoms have been labelled, which is a 0.3% labelling efficiency. The 
low efficiency is likely to be a result of the cells not being adapted to high D20 
conditions. Therefore it was imperative that any further work done to improve 
yield and more importantly labelling efficiency must be carried out using the 
adapted cells. The other minor species at 27662 Da is an extra 179 which 
results from the dephosphorylated form of the a-N-6-Phosphogluconoylation of 
the histidine tag. 
4.4. Use of Isotopically Labelled Rich Medium with 
Adapted Cells to Increase Isotope Incorporation Efficiency 
There are a host of isotopically labelled rich media commercially available, but 
the draw back was the high price for large quantities required to produce 
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sufficient amount of protein for NIVIR analysis. So the method proposed was to 
supplement the 2 H/13C/1 5N labelled minimal medium with isotopically labelled 
rich medium. This, in theory, will enable the cells to grow to a higher cell density 
in high deuterium conditions and so, once induced, the culture will express a 
larger amount of highly labelled recombinant protein; hopefully exceeding the 
levels already produced in previous attempts of producing 2 H/1 3C/1 5N labelled 
protein. Initially Celtone 2H >97% rich media (purchased from Spectra Stable 
Isotopes) was used as it was cheaper than 2 H/1 3C/15 N triple-labelled medium, 
but if the test expression using Celtone 2H >97% was successful then further 
expression could be done using Spectra 92 H/13C/1 5N >97% (Spectra Stable 
Isotopes), since deuterium conditions are the key environmental change 
believed to be affecting protein expression which was not affected by 13C/1 5N- 
labelling. 
4.4.1. Test expression using 5% and 10% Celtone 2H rich 
medium 
The 96% adapted cells, were re-grown from the glycerol stock by streaking on 
LB agar plates with appropriate antibiotics. A colony from this plate was used to 
inoculate 40 mL cultures. Two cultures were inoculated, one with 96% D20 
minimal medium and the second with 96% D20 minimal medium supplemented 
with 5% (2 ml-) of Celtone 2H >97% rich medium. Both were grown and O. D. 
measured at 600nm over a 24 hour period. 
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Figure 4-12. Growth curves of cultures grown in 96% D20 minimal medium (black line) 
and D20 96 % minimal medium supplemented with Celtone 2H (red line). 
By comparing the relative cell densities, it was clear that the Celtone 2H medium 
leads to a much higher growth rate and cell density. The Celtone 2H medium 
expression was then induced with IPTG at the 23 hour time point for 6 hours 
and products purified using affinity chromatography. 
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Figure 4-13.5% Celtone 2H 40 mL test expression. Lane 1, low molecular weight marker. 
Lane 2, total protein. Lane 3, soluble protein. Lane 4, flow through. Lane 5, imidazole 
wash. Lane 6, low salt wash. Lane 7, hexa-histidine tagged bb'x protein elute. 
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As shown in Figure 4-13 the purification was efficient at removing the majority of 
proteins, leaving a highly pure elute fraction. Note only 5uL, half the normal 
volume usually loaded into the gels, resulting in a much weaker band (it was 
expected a higher yield would result from this experiment and from fear of over- 
loading a lower volume was analysed by gel electrophoresis). The 
concentration of the protein was then measured to be 126 pM, a three fold 
increase from the 96% shock induced experiment described in section 4.3.2. If 
this experiment was scaled up 20 fold to 800 mL it would result in a 2.5 mM 
sample, which is borderline sufficient to produce a NIVIR sample; if you consider 
20-30% losses during purification and preparation. The sample was then 
prepared for mass spectrometry to measure the level of isotope incorporation. 
The mass spectrometry analysis more importantly reveals a major peak at 
28817 Da, which has 1340 labelled isotope out of a possible 1910 possible 
atoms and so is a 70.2% labelling efficiency. This is a 28% increase from the 
96% shock induction expression in section 4.3.2. It may be possible to increase 
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Figure 4-14. Positive ion mass spectrum of the affinity column eluted protein from 5% 
celtone 2H supplemented medium. 
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protein yield by supplementing with more Celtone rich medium. Therefore the 
next proposed experiment was to repeat the expression with 10% Celtone 2H 
rich medium and the eluted protein concentrations compared. 
The other minor species has a 175 Da larger mass than the major species of 
28817 Da and so is likely to be the dephosphorylated a-N-6- 
Phosphogluconoylation of the histidine tag. A very minor unknown species was 
also seen at 28904 Da. 
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Figure 4-15.10% Celtone 2H 40 mL test expression. Lane 1, low molecular weight marker. 
Lane 2, total protein. Lane 3, soluble protein (spherical shape is an air bubble trapped 
during gel drying procedure). Lane 4, flow through. Lane 5, imidazole wash. Lane 6, low 
salt wash. Lane 7, empty lane. Lane 8, hexa-histidine tagged 
2 H-labelled bb'x protein 
elute. 
The experiment was therefore repeated with 10% Celtone 2H rich medium to 
measure the affect on yield and isotope incorporation. Upon visual comparison 
of the two elute fractions in Figure 4-13 and Figure 4-15, the elute fraction in 
the 10% Celtone is much bigger (even though double the volume was loaded 
here). When the protein concentration was measured, it revealed an increase 
of 37% from 126 pM (5% celtone) to 200pM (10% celtone). Therefore if the 
10% Celtone experiment was scaled up 20 fold to 800 mL then an elute sample 
of 4 mM would produced, which with losses during purification would be 
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sufficient to produce a NIVIR sample. The isotope incorporation was not 
measured by mass spectrometry analysis, but since the incorporation measured 
using 5% Celtone was 70.2%, with 10% Celtone the level of incorporation can 
be expected to be comparable if not higher. 
4.4.2. Test expression using cells adapted to 96% D20 grown in 
Spectra9 rich medium and shock induced 
Experiments using 10% Celtone were sufficient to produce enough protein to 
produce a NIVIR sample. It was now essential to test expression and 
incorporation levels using Spectra9 (purchased from Spectra Stable Isotopes) 
which is a rich medium containing 2 H>97%, 13C >98% and 15 N>98%. Two 
methods of expression were tested; in one, cells adapted to 96% D20 were 
grown to O. D. O. P in 40 mL 96% D20 minimal medium with 13 C and 15N-labelled 
reagents, supplemented with 10% Spectra9 culture, induced and harvested 
after 6 hours. 
In the second, the method coined 'shock induction' was used, where cells 
adapted to 96% D20 were grown in 40 mL 96% D20 minimal medium 
supplemented with 10% Spectra9 rich medium to O. D. 0.6, spun down and re- 
suspended in 40 mL 96% D20 in minimal medium (at O. D. 0.1) with 13 C and 
15N-labelled reagents, grown to O. D. 0.6, induced and harvested after 6 hours 
(note no rich medium in expression culture). The proteins produced by both 
methods were then purified by affinity chromatography. 
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Figure 4-16.10% Spectra9 40 mL simple induction test expression. Lane 1, low 
molecular weight marker. Lane 2, total protein before induction. Lane 3, soluble protein 
before induction. Lane 4, total protein after 6 hour induction. Lane 5, soluble protein 
after 6 hour induction. Lane 6, flow through. Lane 7, imidazole wash. Lane 8, low salt 
wash. Lane 9, hexa-histidine tagged triple labelled bb'x protein elute. 
From Figure 4-16, it is clear that expression levels are much higher than seen 
previously, as the size of the elute band is very large. The concentration of the 
elute fraction was measured to be 0.5mM. Also the purification using affinity 
chromatography was successful at removing the majority of protein impurities 
and so the elute was prepared for mass spectrometry analysis. 
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Figure 4-17. Positive ion mass spectrum of 10% Spectra9 40 mL simple induction test 
expression. 
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From the mass spectrum, the major species has a molecular weight of 30105 
Da and a second peak at half the intensity at 30098 Da. These masses indicate 
2628 and 2621 labelled isotopes out of a possible 3468 2 H/ 13C/15 N atoms, 
hence a total labelling efficiency of 75.8% and 75.6% respectively. This is an 
improvement of 5.6% and 5.4% from the previous expressions using the single 
2H labelled Celtone at a 5% supplemented concentration whereby 70.2% 
labelling efficiency was achieved. Two other minor species can be seen by 
mass spectrometry at 30280 Da which is 175 larger than 30105 Da species and 
produced by the dephosphorylated a-N-6-Phosphogluconoylation of the 
histidine tag. 
The shock induction method was also tested to see if yields and incorporation 
efficiency can be increased. Cells adapted to 96% D20 were grown in a 40 mL 
96% D20 minimal medium supplemented with 10% Spectra9 culture, grown to 
O. D. 0.6, spun down, resuspended in 96% D20, (at O. D. 0.1), grown to O. D. 0.6, 
induced and harvested after 6 hours. 1mL samples were taken and run on 
SDS-PAGE. 
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Figure 4-18.10% Spectra9 40 mL resuspended shock induction test expression. Lane 1, 
low molecular weight marker. Lane 2, empty lane. Lane 3, total protein before induction. 
Lane 4, soluble protein before induction. Lane 5, total protein after 6 hour induction. 
Lane 6, soluble protein after 6 hour induction. Lane 7, flow through. Lane 8, imidazole 
wash. Lane 9, low salt wash. Lane 10, hexa-histidine tagged bb'x protein elute. 
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Again the expression appears to be very successful and large protein band is 
produced as seen in the elute fraction after affinity chromatography purification. 
The concentration was measured to be 0.5 mM, comparable to the Spectra9 
simple induction experiment done previously. The elute was then prepared for 
mass spectrometry analysis. 
The mass of the main species was 30134 Da which indicates 2657 labelled 
isotopes, hence a 76.6% labelling efficiency. This is a mere 0.8% improvement 
on the simple induction method. The other minor species has a mass of 30467 
Da, with 2990 labelled isotopes and so has an 86% labelling efficiency but is 
less than 10% of the intensity of the main species. 
Upon comparison of the two methods tested, simple induction and shock 
induction revealed comparable yields of 0.5 mM which is more than sufficient 
when scaled up to produce a NIVIR sample, since scaling up 20 fold to 800 mL 
should produce a sample of 10 mM more than sufficient for a NIVIR sample. 
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Figure 4-19. Positive ion mass spectrum of 10% Spectra9 40 mL shock induction test 
expression. 
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Also, very similar labelling efficiencies were recorded of 75.8% and 76.6% 
respectively, which is sufficiently high enough to carry out the NIVIR experiments 
required with a2 H/ 13C/1 5N sample. Hence in the interest of efficiency, the 
simple induction is less time intensive, so was preferable. This was the method 
selected to be employed when scaled up to produce a triple labelled NIVIR 
sample. The simple induction experiment was repeated to confirm 
reproducibility which was achieved here; it was found that yields and isotope 
incorporation were comparable (results not shown). 
So to recap, the methodology to produce the 2 H/ 13C/1 5N-labelled NIVIR sample 
would be to grow the cells adapted to growth in 96% D20 conditions in 2x 400 
mL 96% D20 minimal medium supplemented with 10% Spectra9 to O. D. 0.6, 
induce and harvested after 6 hours. 
4.5. Production of a2 H/13C/15N Sample for NIVIR 
Experiments 
This section discusses the method and describes the purification of a2 H/ 13C/1 5N 
labelled sample to be used in future NIVIR experiments to assist in the 
assignment of the bb'x backbone. The previous sections have discussed the 
development of methodology to maximise yield and labelling efficiency. In 
section 4.4.2 a final method was established which enabled the production of a 
sample with approximately 76% overall labelling and a concentration of 0.5mM 
from a 40 mL expression. This method of simple induction using minimal 
medium supplemented with 10 % Spectra9 rich medium was scaled up to 800 
mL to produce sufficient quantities of protein for NIVIR experiments. 
The 96% adapted cells were firstly streaked on a LB agar plate with appropriate 
antibiotics added; a colony was added to a small 50 mL 96% D20 minimal 
medium supplemented with 10% Spectra9 and grown overnight. This small 
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starter culture was used to inoculate a larger 2x 400 mL 96% D20 minimal 
medium supplemented with 10% Spectra9 at O. D. 0.1 and was grown to O. D. 
0.6. The culture was then induced and cells harvested after 6 hours of induction. 
The cells were lysed using the freeze-thaw method and purified using affinity 
chromatography; samples were taken throughout the expression and 
purification and run on SDS-PAGE to follow the purification. 
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Figure 4-20.16% SDS-PAGE 96% D20 supplemented with 10% Spectra9 400 mL 6 hour 
expression. Lane 1, low molecular weight marker. Lane 2, soluble protein before 
induction. Lane 3, total protein after 6 hour induction. Lane 4, soluble protein after 6 
hour induction. Lane 5, flow through. Lane 6, imidazole wash. Lane 7, low salt wash. 
Lane 8, hexa-histidine tagged triple labelled bb'x protein elute. 
From the purification it was clear that a high level of expression was achieved, 
Figure 4-20 shows the purification of 400 mL (half the total expression was 
processed to maximise purification and reduce losses by overloading affinity 
column). Hence this purification was repeated with the other 400 mL expression 
culture (gel not shown; results were comparable). From the SDS-PAGE it was 
clear that purification was successful at removing the vast majority of protein 
impurities with little losses during the wash stages. 
The two elutes were pooled and then diluted 5 fold in buffer A and applied to 
anion-exchange column for further purification using a salt gradient of 0 to 1M 
NaCl to elute the protein. 
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Figure 4-21. Chromatogram of triple labelled bb'x using a Source 30Q column with a 0- 
100 % gradient of 1M NaCl. 
The anion-exchange chromatogram revealed two overlapped peaks, as seen 
with all other bb'x preparations. The two peaks have different maxima; in the 
figure the green line shows the maximum of the first peak which is 
approximately 45 mL and the second later peak at 49 mL. To identify the 
properties of the eluted protein peak, samples from across the peak were run on 
native-PAGE. 
123456789 10 11 12 13 
Figure 4-22.16% Native-PAGE of samples taken across the peak in Figure 4-21. 
The native-PAGE reveals the peak is made up of two species as seen in 
previous preparations of bb'x. Lanes 1 to 6 were pooled into Pool 1 and lanes 
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7 to 13 pooled into Pool 2. Pool 1 and Pool 2 were individually re-applied to the 
anion-exchange column. 
t-igure 4-Z3. Anion-exchange 
chromatograph of Pool 2 
Figure 4-24. Anion-exchange 
chromatograph ot Pool I 
12345678 23 
Figure 4-25.16% native gel of Pool 1 
Figure 4-26.16% native gel of Pool 
2. 
The Pool 1 chromatogram in Figure 4-24 shows a single peak and as 
highlighted with the green line the maximum of the peak is 45 mL which elutes 
at an identical volume to the first peak identified in the initial anion-exchange run 
in Figure 4-21. The native-PAGE of fractions across the peak reveals the major 
species was the lower molecular weight in Figure 4-25, with a very low amount 
of the high molecular weight species contaminant. This contamination is very 
low and so deemed not to affect NMR experiments. These fractions were then 
pooled and buffer exchanged into the NIVIR buffer ready for further experiments. 
The Pool 2 chromatogram in Figure 4-23 was also in agreement with the initial 
anion-exchange chromatogram in Figure 4-21, in that the maxima of the peaks 
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were both eluted around 50 mL; highlighted with the blue line. The native gel of 
the fractions of the peak in Figure 4-26, revealed a mixture of the two species. 
From the native-PAGE, lanes 1 to 3 were mainly the lower molecular weight 
species and so pooled with the Pool 1 fractions for NIVIR analysis. Fractions in 
lanes 4 to 8 were pooled and labelled Pool 2, these fractions were treated 
independently from Pool 1 and buffer exchanged to NIVIR buffer in preparation 
for NIVIR studies. The final concentration of the Pool 1 NIVIR buffer was 2mM 
and 2.8 mM for Pool 2. A small amount from each sample was used to prepare 
a mass spectrometry sample; enabling the measurement of the amount of 
isotope incorporation. 
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Figure 4-27. Positive ion mass spectrum of triple-labelled bb'x Pool 1. 
There are many peaks highlighted by the mass spectrum deconvolution 
software, with a range of masses which are produced by species with different 
levels of deuterium incorporation. The mass spectrum of Pool 1 does reveal the 
major species of 30159 Da, hence from the unlabelled species of 27477 Da, 
2682 atoms were labelled and so an overall labelling efficiency of 77.3% (3468 
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maximum number atoms of Carbon, Nitrogen and Hydrogen available to label). 
To be more accurate the double labelled bb'x sample was labelled with a 95.8% 
labelling efficiency described in section 3.3.4. So assuming the same level of 
efficiency was achieved of 95.8% of 1242 Carbon atoms and 316 Nitrogen 
atoms; then 1493 atoms would be labelled. Therefore, if 2682 atoms in total 
were labelled in Pool 1 then 2682-1493 atoms, would give the number of 
labelled hydrogen atoms of 1189, out of a possible 1910, hence a 62% labelling 
efficiency. This was based on the assumption the same level of Carbon and 
Nitrogen labelling would occur. This can not strictly be assumed since the 
medium was supplemented with Spectrag 2 H/ 13C/1 5N labelled rich medium and 
the level of incorporation may not be comparable to 13C_glucose and 15 N- 
ammonium sulfate labelled minimal medium. But either way, whether the 
labelling of hydrogen be 62% or an overall of 77%, the sample should suffice in 
producing quality NMR data, since as discussed previously any incorporation 
between 50 to 70% will provide a better resolved HSQC and triple resonance 
data set. 
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Figure 4-28. Positive ion mass spectrum of triple-labelled bb'x Pool 2. 
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The Pool 2 sample also reveals many species with varying molecular weights. 
This mass spectrum has a far greater resolution to any other spectra; as a result 
many peaks have been highlighted by the analysis software. The range of 
masses detected, as with the Pool 1 sample, was not deemed a problem, since 
these are relatively minor species. The main species has a molecular weight of 
30180 Da, hence 2703 atoms have been labelled with an overall efficiency of 
77.9%. Using the same assumption as Pool 1, whereby previously bb'x was 
double labelled with an efficiency of 95.8%, the number of hydrogen's labelled 
calculated using this method would be 1210, hence a 63.4% labelling efficiency. 
4.6. Discussion 
When the work described in this section was initiated, there were several 
uncertainties as to the optimum strategy for producing a2 H/15N/13C_Iabelled 
protein sample in sufficient quantity and with a high labelling-efficiency for NMR 
experiments. Following staged adaptation of cells for efficient growth in high 
levels of D20 and subsequent careful control experiments to identify conditions 
for optimum protein expression and labelling, it was ultimately possible to 
develop a protocol suitable for use in this and comparable projects. The results 
of NMR studies on the samples produced in this Chapter were used to collect 
the HNCA and HN(CO)CA TROSY experiments which assisted in the 
assignment of the bb'x domain as described previously in section 6.3.4. 
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Chapter 5. Initial NIVIR Studies on PDI Domain 
Combinations 
5.1. Introduction 
This chapter has two sections, one which describes initial NIVIR studies carried 
out prior to this research project by Dr. R. Williamson (University of Kent) and 
the second describing new preliminary NIVIR studies carried out as part of this 
research project. These studies are used to explain the rationale behind 
attempting to assign the backbone structure of the bb'x domain construct as 
opposed to focussing on the b' domain only, when the W domain is the main 
focus of this research project. The HSQC resolution of several domain 
combinations were compared and were used to validate a suitable methodology 
to obtain the b' backbone assignments. 2D-HSQC experiments serve as a 
quick experimental tool, run over approximately 1 hour, as an indicator of 
sample quality. Well resolved and concise resonances indicate that the protein 
sample was pure, the protein was stable and therefore was likely to give good 
quality data in further 3D NMR experiments required to obtain backbone 
assignments. 
This chapter also describes how understanding the heterogeneity of bb'x and 
b'x preparations enabled progress to be made in structural studies. 
Fractionation of preparations to generate more homogenous samples for NMR 
improved the spectra significantly. It was also found that spectra collected at 
higher temperatures gave further improved spectra and could be used to allow 
full backbone assignments. 
To increase the accuracy/confidence of bb'x assignment, the b domain 
chemical shifts were required and used to compare the bb'x chemical shifts; 
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hence overlapped peaks were assigned with a greater degree of 
accuracy/confidence. As a consequence of the newly identified advantage of 
sample fractionation, it was possible also to assign the backbone of the Wx 
domain; this data, as for the b domain, was used to increase the confidence in 
correct assignment of the bb'x domain. 
5.2. Prior NMR Studies on PDI Domain Combinations 
This section describes initial NIVIR studies carried out prior to this research by Dr. 
R. Williamson (University of Kent). General analysis in this section describing 
the quality of the spectra was done by comparing the peak intensity, resolution 
and broadening. Initial NMR studies carried out by Dr. R. Williamson; involved 
an analysis method of measuring the peak widths (in Hz) of the same 20 peaks 
(where possible) in HSQC spectra of different domain constructs. 
Construct Peak Width (Hz) 
b' >40 
bl + KFWWFS 18.5 
bb' 36.9 
bb'x 24.0 
Wx 26.1 
Table 6. Summary of peak width analysis of different domain combinations. Same peaks 
used for all constructs, except bbI where a selection of peaks from b and b' domains 
were used. The b' is a conservative estimation due to difficult in measurements using 
the poor, peak-broadened spectrum. KFWWFS is a short hexa-peptide ligand. 
5.2.1. b' domain 
The b' domain was the main domain of focus in this research. Unfortunately the 
individual domain gave poor resolution in 2D-HSQC experiments. As shown in 
Figure 5-1 the spectrum was very poorly resolved since the peaks are 
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broadened and many are overlapped. The HSQC gives correlations between 
amide protons ('HN) and amide nitrogen ("N) frequencies in a single amide, so 
each residue except Proline residues will give one peak in the HSQC spectrum. 
The spectrum shows 87 peaks but the b' domain has 108 residues (not 
including the histidine tag or prolines), therefore 21 peaks are missing. The 
poorly resolved HSQC made the analysis of peak-widths difficult and so a 
conservative estimate of >40 Hz was given to the b' domain as reported in 
Table 6. 
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Figure 5-1.1 'N/1H HSQC spectrum of 15N-b' domain (sample and spectrum produced by 
Dr. R. Williamson). 
The poor resolution of 2D-HSQC data could result from the W domain being in 
conformational exchange; speculated to be an essential functional feature 
based on b' domain involvement with substrate binding. In one experiment, the 
spectrum was dramatically improved by the addition of a short hexa-peptide 
ligand (KFWWFS) as highlighted in Table 6, where the average peak-widths of 
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>40Hz decreased to 18.5 Hz; but unfortunately this result has not been possible 
to reproduce. Due to the low resolution of the b' domain, alternative domain 
combinations were studied that could lead to better NIVIR resolution, by 
stabilising the b' domain. 
5.2.2. bb' domain 
The lbb' domain construct was analysed by 2D-HSOC experiments, it was 
hoped that with the addition of the b domain, the b' domain would be stabilised; 
hence an improvement in spectral resolution could be achieved. Unfortunately, 
as seen in Figure 5-2, in the bb' domain spectrum there are still regions of 
overlap and many peaks are broadened; in relation to its increase size, the 
spectrum has improved when compared to the W HSQC but not sufficiently for 
further analysis. The peak-width analysis also supports the visual 2D-HSQC 
observations, since the b' domain gave >40 Hz, the bbI domain combination 
was improved slightly to 36.9 Hz. 
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Figure 5-2. '5N/H HSQC spectrum of '5N-bb' domain (sample and spectrum produced by 
Dr. R. Williamson). 
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5.2.3. bb'x domain 
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Figure 5-3.15N/'H HSOC spectrum of '5N-bb'x domain Pool I (sample and spectrum 
produced by Dr. R. Williamson). 
The bb'x samples in these early experiments were crudely fractionated on the 
basis of the two peaks identified during anion-exchange chromatography 
purification and not using native-PAGE analysis. The 2D-HSQC run on the 
pooled fraction from the early anion exchange peak (Pool 1) as shown in Figure 
5-3, shows that the resolution was again an improvement on the W domain and 
bb' domain construct. The vast majority of the peaks are well resolved and 
concise; there is some peak broadening and some degree of overlap resulting 
from the high number of residue signals given by this larger domain construct. 
The peak-width analysis details the extent of the improvement, whereby this 
bb'x Pool 1 sample gave peak-widths of 24 Hz whereas the peak-widths of the 
b' and bb' domains were much higher (see Table 6). Pool 2 gave very poor 
spectra (data not shown) again consistent with the theory that the late pool 
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(Pool 2) is in a more flexible conformation; indicated by broad/poorly resolved 
resonances. 
As highlighted in Figure 5-3, a double tryptophan resonance was seen. Only a 
single tryptophan residue is present in bb'x domain construct, which is located 
in the x-region. This double signal from the tryptophan residues is suggestive 
that the tryptophan exists in two different environments (discussed further later). 
5.2.4. Wx domain 
The initial experiments carried out prior to this research revealed a poor b'x 
spectrum (as shown below in Figure 5-4). The resonances are very broad and 
there is a large amount of resonance overlap, this is likely to result from the 
conformational heterogeneity of the sample which at that time was an unknown 
characteristic exhibited by the various protein constructs. The peak-width data 
suggested the b'x was slightly worse than the bb'x each giving average peak- 
widths of 26.1 Hz and 24 Hz respectively as shown in Table 6. Important to 
note, is that the sample of b'x used here was not stringently fractionated, so an 
improvement was later found to be possible with fractionated samples as shown 
to be possible with bb'x samples in section 5.3.1. The increased resolution 
achievable by fractionation is highlighted by comparing the spectrum collected 
for an unfractionated sample of b'x shown in Figure 5-4 and a fractionated b'x 
shown in the later Figure 5-7. 
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Figure 5-4. '5N/'H HSQC spectrum of unfractionated "N-b'x domain (sample and 
spectrum produced by Dr. R. Williamson). 
From Table 6 it is clear there is improvement in the spectral quality with the 
addition of the b domain and x-region to domain combinations. This is most 
clearly visible by the decrease in the average peak-widths of bb' (36.9 Hz) and 
bbIx (24.0 Hz). The method of how the x-region was able to stabilise the whole 
domain construct, particularly the W domain, is not known but is speculated to 
be as a result of the x-region binding to the W domain active site and so 
increasing the W domain conformational stability. At this stage the most 
promising domain combination with the potential to enable full backbone 
assignment was the bb'x as it gave the lowest spectral peak-width 
measurements. 
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5.3. Initial NIVIR Data on New PDI Domain Combination 
Samples 
5.3.1. bb'x domain 
A 15N-bb'x sample was produced as described in section 3.3.3, whereby the 
sample was fractionated based on anion-exchange chromatography peaks, gel 
filtration and native-PAGE analysis. As shown in Figure 5-5 of a monomer 
sample of bb'x, the HSQC resolution is much improved from the unfractionated 
bb'x sample used in Figure 5-3. The peaks in the centre of the HSQC are 
better resolved and overall, the peaks are much sharper and less broadened. 
Also in Figure 5-5, the left hand peak of the two Trp side-chain signals is more 
prominent whereas highlighted in Figure 5-3 the two signals are of equal 
magnitude. The more stringent fractionation process has led to a sample where 
the majority of the protein species have the Trp residue in the x-region buried 
(likely to be in a hydrophobic site) and so stabilises this conformer, hence 
producing a well resolved spectrum, as seen with Wx mentioned previously. 
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Figure 5-5.1 5 NPH HSQC spectrum of 15 N-bb'x domain fractionated monomer sample. 
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The fractionated dimer sample gave a very poor HQSC spectrum as shown in 
Figure 5-6, all the resonances are broadened and there is a large amount of 
overlapping. This supports the theory of two conformations, whereby the dimer 
sample is a less structurally stable conformer. Also as highlighted in Figure 5-6, 
the two signals from the Trp side chain have almost disappeared; indicating a 
lack of x-region structural stability. The x-region is likely to be unbound hence 
the Trp residue is not buried in a hydrophobic site as seen with monomer 
sample in Figure 5-5. 
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Figure 5-6. '*"N/'H HSQC spectrum of 15 N-bb'x domain fractionated dimer sample. 
The sample used to collect the spectrum shown in Figure 5-6 was fractionated 
based on mainly on the gel filtration analysis and this pooled sample was 
defined as a dimer sample. If the major species in this sample was a non- 
covalent dimer with a mass of 54954 Da (2 x 27477 Da) then the spectrum 
observed in Figure 5-6 would be radically different. If this was the case then 
very little would be observed, a 55kDa protein sample would have massive peak 
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broadening and with a size of 55kDa very few peaks if any would be observed 
and the spectrum would appear smeared rather than having defined peaks; 
hence the spectrum in Figure 5-6 is not representative of a sample containing 
primarily a dimer species. The spectrum indicates a less structured monomer 
species as opposed to a dimer species. It was therefore hypothesised based 
also on the observations of the x-region tryptophan residue, HSQC spectrum 
and AUC analysis (in Section 3.8) that the dimer fraction was a mixture of a 
small amount of non-covalent dimer species and a monomer species where the 
x-region is unbound to the b' binding site. 
The spectrum of bb'x monomer sample was far superior in quality to all other 
spectra collected for all domain combinations to date. Based on the 2D-HSQC 
results in Figure 5-5 it was surmised that the triple resonance experiments 
required for backbone assignment would also be of a sufficiently high resolution. 
Hence bb'x offered the best route to obtain the backbone assignments of the bI 
domain. The only draw-back of this approach using bbIx is the complexity of 
the HSQC as a result of the larger number of amide signals. The b' domain 
was the main focus of this research; the backbone assignment of Wx offers 
another possible route since it also produces well resolved HSQC data. But 
considering the substrate binding data, bb'x was a much more attractive target, 
since with this larger protein it will be possible to investigate how the b domain 
(a non-catalytic domain) influences substrate binding (which was shown to have 
an affect in binding studies as discussed in the introduction). Also collaborative 
work with Dr. L. Ruddock on obtaining the x-ray crystal structure of the Wx 
domain was underway hence bb'x was focused on to provide additional 
information. Since the b domain had been solved by NMR an opportunity to 
reduce the difficulties in backbone assignment existed, despite the complexity of 
the bbIx HSQC spectrum. This involved firstly assigning the backbone structure 
of the b domain. Although the b domain has been solved, our running 
conditions are different and also there are always slight differences in spectral 
data using different NIVIR machines. 
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Since the Wx spectrum was almost as good in terms of quality, as that collected 
for bb'x, the Wx assignment could be attempted if bbIx assignments were 
found to be difficult and so assist with bb'x assignments in a similar fashion as 
the b domain. 
5.3.2. Wx domain 
The Wx sample now used was fractionated based on gel filtration and native- 
PAGE analysis and gave a much improved HSQC spectrum although some 
peaks are overlapped and broadened, as highlighted in blue in Figure 5-7. This 
spectrum is significantly better than W and bb' spectra, most of the peaks are 
better resolved, indicating the Wx domain is more stable, with the addition of the 
x-region. Interestingly, the Wx domain contains one Trp residue, located in the 
x-region, but as highlighted in red in Figure 5-7, two signals from the Trp side 
chain are visible. This would suggest the x-region is in a slow exchange 
between two (or more) conformations (Nguyen et aL, (Manuscript in 
preparation)), see Appendix 1. 
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Figure 5-7.15 NPH HSQC spectrum of '*5N-b'x domain monomer sample. 
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As seen here in Figure 5-7, the inclusion of the x-region resulted in the 
improvement of the HSQC, speculated to result from x-region binding to the W 
domain binding site. 
5.3.3. b domain 
To aid the assignment of the bb'x, the b domain can be used to assist in 
accurate assignment. The already solved b domain chemical shifts can be used 
to quickly assign the b domain HSQC spectrum produced under our running 
conditions (slight differences in chemical shifts will exist as highlighted in Figure 
5-8). The b domain was fully assigned using Johan Kemmink's PDI b data 
(Kemmink et aL, 1999) which were used to cross reference assignments. 
Furthermore to the 2D HSQC, TOCSY data was collected by Dr. R. Williamson 
then analysed and assigned by Dr. Katrine Wallis. With the full b domain 
backbone assignments, the assignment of bb'x was hoped to be simplified. 
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Figure 5-8.15 NPH HSQC spectrum of '5 N-b domain (red dots - chemical shifts of b 
domain produced in this research, grey dots - chemical shifts for Johan Kemmink's PDI 
b data (accession number 4156). 
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5.4. Discussion 
The b' domain was the main domain of interest, but spectral data was very poor. 
Spectral resolution was improved with the addition of the b domain and further 
improved with the addition of the x-region. This led to the conclusion that the 
bb'x domain offered the best route to obtaining b' assignments. The obvious 
drawbacks were the complexity of the spectra and since the bb'x was 249 
residues (including His tag), this large number of residues would result in peak 
overlap and so make assignment difficult. The advantage would be, if 
assignment of bb'x was possible, novel analysis of the b domain interaction 
with the Wx domain was possible and allow investigation into the role of the b 
domain in substrate binding. 
By comparison of preliminary data it was observed that fractionation also led to 
improved spectral quality. Two species of the bb'x domain combination were 
observed; the difference between species appeared to be linked to the x-region 
environment, indicated by the double tryptophan signal. This phenomena was 
also observed and further analysed in the Wx domain (Nguyen et aL, 
(Manuscript in preparation)), see Appendix 1. The improvement to spectral 
resolution was linked to the observation of a more intense left-hand tryptophan 
signal in the 2D-HSQC by monomer samples. This species was speculated to 
result from a bb'x conformation where the x-region is bound, speculated to be 
to the b' substrate binding site, so stabilising the bI structure and resulting in a 
much improved spectrum. The alternative conformation observed in the dimer 
samples gives a stronger right-hand tryptophan signal, where the x-region is not 
in contact with the W domain binding site, resulting in conformationally un-stable 
species and so gives a very poorly resolved spectrum. Hence a fractionated 
bbIx sample was shown to offer a route with the highest probability of achieving 
full backbone assignment. 
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Chapter 6. NMR Backbone Assignment of bblx 
6.1. Introduction 
This Chapter describes the approach to obtain the backbone resonance 
assignments of bb'x, using a double-labelled (13C/15 N) bb'x sample. This 
sample was expressed and purified as described in section 3.3.4, whereby the 
sample was fractionated based on anion-exchange, gel-filtration and native- 
PAGE analysis; the improvement of resolution in 2D-HSQC experiments is 
described in section 5.3.1. Here this sample was used to generate triple 
resonance data, specifically, HNCACB and CBCA(CO)NH spectra. These data 
sets were used to obtain the sequence specific backbone resonance 
assignments (N, NH, C., Cp), as described in section 1.4.4, from the 
identification of the intra and inter-residue connectivities using the CcpNMR 
Analysis package (Vranken et aL, 2005). 
Also as previously discussed, due to the large size of bb'x, the complexity of the 
data could make assignment difficult. Hence this chapter also describes how 
the b domain HSQC assignments were used to cross-reference the 
assignments on to the bb'x HSQC. It was also found to be necessary to assign 
the Wx backbone and also use these assignments to cross-reference on to the 
bb1x data using the same principle as with the b domain. Later it became 
necessary to produce a2 H/1 3C/15 N bb'x sample which was used to collect 
TROSY data and this provided another data set to aid the assignment. This 
three-way cross reference method allowed full unambiguous assignment of the 
bb'x and Wx with high level of confidence. 
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6.2. First Attempt at bb'x Backbone Assignment and 
Stability Analysis 
Initial 2D-HSQC experiments were carried out at 25 "C. Although the sample 
gave good HSQC spectra, unfortunately this was not true in triple resonance 
experiments and so this section describes how the resolution was increased by 
raising the temperature at which the experiments were run. 
6.2.1. Backbone assignment of bb'x at 25 OC 
A 2D-HSQC experiment was run to test the quality of data using a double- 
labelled (13C/1 5N) bb'x sample, produced as described in section 3.3.4, before 
attempting triple resonance experiments. The assessment of quality was made 
on the basis of the two signals from the Trp indole side chain. As previously 
described a strong left hand peak, appeared stronger in Pool 1 or monomer 
fractions and was associated with high resolution spectra. As highlighted in 
Figure 6-1 of the 1 3C/15 N bb'x sample and as seen previously with 15 N-labelled 
bbIx test spectra in Figure 5-5, the left hand indole resonance is the stronger 
peak. Also all the other resonance peaks are very clear and concise, there 
appears to be very little peak broadening. The overall quality is perhaps a little 
lower as there appears to be some overlap of resonances in the centre of the 
spectrum in comparison with the spectrum collected with the 15 N-labelled bb'x 
test spectra in Figure 5-5. This could result from a slight contamination with 
Pool 2, likely to have occurred during fractionation. But most of the peaks are 
well resolved and clear, therefore it was not deemed at this stage to be a 
serious problem. 
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Figure 6-1. is N/ IH HSOC spectrum of 13C/15N-bb'x domain at 250C. 
The first triple experiment run was the HNCACB, which give the intra and inter- 
residue amide C, and Cp resonances. A quick cursory analysis on this data set 
was carried out to investigate the quality of data obtained. 203 residues were 
identified in the 2D-HSQC and for each HSQC peak, the triple resonance was 
recorded in terms of whether all the data was visible (intra and inter resonances), 
half the data visible (Intra resonances only) or no data visible (No resonances). 
This data is presented in Table 7, from which it is clear that only 54% of quality 
usable data had been collected from this sample. This was far too low, even 
with the assistance of extra data sets; a full assignment would not be possible 
and a method of increasing triple resonance data quality was required. 
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Triple Resonance data Number of resonances Percentage of the 208 
type identified residues identified seen 
N 
Intra and Inter 109 54 
resonances 
Intra resonances only 70 34 
No resonances 24 12 
Table 7.13C/'5N-bb'x domain HNCACB quality assessment. 
6.2.2. Stability experiment at 350C 
One method of improving NIVIR data quality and resolution would be to increase 
the temperature at which data was collected. The increase in temperature 
results in an increase in the molecular tumbling rate; this reduces the spectral 
linewidths and so increases spectral resolution. A 2D-HSQC was collected on 
the same sample that was used in section 6.2.1, to test the protein stability at 
35'C. The HSQC was collected after 4 days at 35 OC, the approximate amount 
of time required to collect the HNCACB data set. The increase in temperature 
appeared not to affect the stability of the protein as shown in Figure 6-2, as the 
peaks were still concise and there was little peak broadened indicating the 
protein was still folded. However, some new peaks have begun to appear 
indicating some degradation of the protein sample and some of the peaks have 
weakened but remain visible. Unfortunately, the two signals from the Trp indole 
side chain now appear with equal intensity, perhaps indicating an equilibrium 
between the two conformers inferred here from the increase of the Pool 2 dimer 
(right hand indole) signal. 
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Figure 6-2. '6 NPH HSQC spectrum of 13C/15N-bb'x domain at 35*C after 4 days. 
6.2.3. Stability experiment at 400C 
The NMR machine running temperature was then the raised to a maximum of 
400C, to determine whether the protein was stable at this temperature. Since 
the protein appears to be stable at 350C and to maximise the improvement to 
resolution it was hoped data could be collected using the maximum temperature 
possible. A 2D-HSQC experiment was run 30 minutes after increasing the 
temperature to 400C as shown in Figure 6-3. Generally the peaks are still 
concise indicating the majority of the protein sample was still folded, some more 
minor peaks have appeared indicating some further degradation, but overall the 
protein was still folded and stable. 
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Figure 6-3.15 NPH HSQC spectrum of 
13C/15 N-bb'x domain at 400C after 30 minutes. 
The protein sample remained at 400C for 22 hours to further measure protein 
stability at 400C as shown in Figure 6-4. Again the majority of the protein 
sample appears to remain in a folded state, since the peaks have not massively 
broadened. Some further degradation has taken place, as previously identified 
minor peaks seen in Figure 6-2 and Figure 6-3 become stronger and more new 
minor peaks appear. To summarise the treatment of this sample, it has been at 
250C for 4 days, 35'C for 4 days and 400C for 1 day. This exceeds the normal 
run time for the collection of HNCACB and CBCA(CO)NH spectra which would 
be 8 days. So most importantly the protein sample appears to remain relatively 
well stable in these conditions and using a new double labelled protein sample it 
appears viable to collect triple resonance data at 400C. 
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Figure 6-4. "5N/H HSQC spectrum of 13C/I 5N-bb'x domain at 40'C after 22 hours. 
6.3. Backbone Assignment using 400C Triple Resonance 
Data 
The initial triple resonance data collected on bb'x at 25'C, showed a lack of 
resolution in the HNCACB, but the thermo-stability analysis of bbIx at a 
temperature of 40'C identified a possible method of improving resolution and so 
enabling backbone assignment. This section begins with a description of how 
the triple resonance data collected on bb'x at 400C was used and how the pre- 
assigned b domain HSQC was used to partially assign the backbone. 
Unfortunately, the dataset collected at 40'C was insufficient to assign the 
backbone completely. Therefore this section goes on to describe how it was 
essential to return to the Wx domain construct to obtain backbone assignments 
of Wx and cross reference these assignments to allow further assignment of 
bb'x. Yet again, full confident assignment was not possible. This section also 
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describes the use of a triple-labelled 2 H/13C/15 N-bb'x sample to collect TROSY 
experimental data to finally complete the backbone assignment of bb'x. 
6.3.1. Initial backbone assignment attempt 
A new sample of double labelled 13C/1 5 N-bb'x was produced as described in 
section 3.3.4 and an initial 2D-HSQC collected at 400C. When comparing the 
HSQC shown in Figure 6-5 with the sample used in section 6.2.3 (Figure 6-4 to 
test the thermo-stability of the protein) this new sample gives much better 
resolved data. The resolution is much improved, unlike the old sample, there is 
no degradation (likely to have been caused by prolonged exposure to high 
temperatures in the previous thermo-stability test and not a direct affect of the 
400C temperature), the peaks are concise with no broadening indicating the 
protein is stable at 400C. More importantly, the left hand resonance of the two 
signals from the Trp indole side chain is the more prominent and so a good 
indicator that the fractionation was effective at separating the two conformers. 
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Figure 6-5.15N/1H HSQC spectrum of a new 13C/1 5N-bb'x domain sample at 400C 
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This sample was then used to obtain triple resonance data, HNCACB and 
CBCA(CO)NH spectra each taking 4 days to collect data. A typical HNCACB 
and CBCA(CO)NH spectrum data set for a residue (Gly151) of bb'x at 400C is 
shown is Figure 6-6. The HNCACB experiment was run first since this 
experiment is inherently less sensitive, which is clear from the weaker signals 
observed in this spectrum. The CBCA(CO)NH was run second and it is also 
clear that this experiment is far more sensitive as the signals in this spectrum 
are far stronger. The two spectra collected on the bb'x sample were used to 
make sequence specific sequential assignments. However, as a result of the 
weak signals in the HNCACB spectrum it was expected that assignment would 
be difficult and might require the use of alternative experiments and data. 
13C 
13C 
ppm 
PPM 
-300 
i-i CP 
-1 
cp i 
900 400 
-41,0 
-4', 
' i Ca 
50,1 
i-i ca 
-550 tj 
i-1 Ca 
fin ýi 1.00 
-fis n IS 0 
1 (1 C, qn 
IH ppm IH ppm 
Figure 6-6. Typical "N plane (115.35 ppm) of CBCA(CO)NH (left) and HNCACB (right) 
spectra for what was later determined to be Gly151 of bb'x at 400C. In the CBCA(CO)NH 
the i-I Ca and CP, positive peaks are shown in green (Ca and CP) and negative peaks 
shown in purple. In the HNCACB show the i and i-1 peaks, where the negative plane 
peaks are shown in red and positive plane peaks shown in black. 
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intra-residue cross peaks linking residues Ala3 to Thr5. The red arrows indicate 
sequential connections. 
Figure 6-7 shows the CBCA(CO)NH and HNCACB spectra of bb'x at 40'C of 
residues Ala3 to Thr5. This figure illustrates the sequential, inter and intra- 
residue connectivities from AIa3 to Thr5. It is possible to assign residues 
sequentially in a forward or reverse direction. So starting with AW, using the 
CBCA(CO)NH and HNCACB firstly the i-1 Ca (approx. 57 13C ppm) and CO 
(approx. 33 13C ppm) signals were identified. From the HNCACB spectrum, this 
residue was easily identified since Alanine is the only residue with a CP shift of 
approximately 20 13C ppm shift. Residues such as Alanine, Serine, Threonine 
residues have distinct Ca and CP shifts, Glycine also has a distinct single Ca 
shift (see Figure 2-5 for standard residue chemical shifts). The i-1 peaks in the 
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CBCA(CO)NH were selected and matched to every HNCACB spectrum to 
identify the residue which is i-1 to Ala3; no signal were matched indicating either 
a redundancy in the data set or the i-1 residue is a proline (proline signals are 
not seen because prolines have no amide proton). 
The i signals of Ala3, Ca (approx. 55 13C ppm) and CP (approx. 19 13C pPM), 
were matched to all CBCA(CO)NH spectra signals. Only an exact match was 
selected and its Ca and CP identified which had very similar shifts to Ala3 and 
so indicates another Alanine residue. The i shifts for Ala4 were then selected 
and again matched to all CBCA(CO)NH spectra signals, until an exact match 
was found as shown in the Thr5 CBCA(CO)NH in Figure 6-7. The i residues of 
Thr5 were then identified and as a result of Threonine having a distinct Ca and 
CP shift, this residue was easily identified as a Threonine amino acid. This 
string of three residues was checked against the full bb'x sequence and there 
was only one site at which Ala-Ala-Thr existed and so these residues were 
assigned with great confidence. Also to further confirm these assignments they 
were compared to the pre-assigned b domain and were found to have identical 
15 N/1H HQSC shifts, so increasing confidence in this assignment. 
Initially all Alanine, Serine, Threonine and Glycine residues which have distinct 
Ca and CP shifts were used as anchor points; used to start chains of 
assignments. Using the method described and cross referencing from the pre- 
assigned b domain, sequence specific assignments were obtained for all 
residues within sequential stretches Ala4 to Leu101. Residues 1 to 101 make 
up the b domain which has already been speculated to be far more stable and 
here almost completely assigned (with the exception two Proline residues) aided 
by the pre-assigned b domain discussed in the next section 6.3.2. This is in 
contrast to the Wx domain region in bb'x, where sequence specific assignments 
were only obtained for sequential stretches from Thr108 to AIa112, AIa145 to 
Ilel 58, and Thr202 to His2l 1; this relates to only 34% of the Wx region in bb'x. 
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Clearly the Wx domain is more conformationally flexible, resulting in low spectral 
resolution and so causing difficulty in sequence-specific assignments. 
6.3.2. b domain cross assignment 
The b domain was fully assigned by Dr. K. Wallis (University of Warwick). This 
data set was used to cross reference the assignments made in b domain on to 
the bb'x HSQC at 400C. This was done to reduce ambiguity when assigning 
bb'x. This cross assignment was done initially by overlaying the bb'x HSQC 
collected at 400C with the b domain spectrrum collected at 250C as shown in 
Figure 6-8. The temperature difference will inherently result in some resonance 
shifts as highlighted in the yellow circle of the expanded HSQC in Figure 6-8, 
but many of the resonances overlaid exactly as highlighted with the green circle 
in the expanded HSQC in Figure 6-8. Since every residue was assigned in the 
b domain HSQC this information was cross referenced and checked if the 
assignments made in the bb'x data set have equivalent 1H and 15C HSQC shifts. 
Once located in the HSQC, the bb'x CBCA(CO)NH and HNCACB were re- 
analysed with lower contour levels to identify the Ca and Cp resonances. This 
method reduces ambiguity and enabled all the b domain residues to be 
assigned in the bb'x data set with the obvious exceptions of Proline. 
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Figure 6-8. "'N/'H HSQC spectrum of 13C/I 5N-bb'x domain at 40'C (black peaks) overlaid 
with 15N-b domain (red peaks). Right HSQC - expanded image of overlaid HSQC 
spectrum (dashed box in the left spectrum). 
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6.3.3. Wx backbone assignment to assist the assignment of the 
bb'x backbone 
Using the 40'C bbx data, only 34% of the Wx domain was assigned. So to 
obtain further assignments, attention was directed at the Wx domain. The 2D- 
HSQC described in section 5.3.2, was produced using a 15 N-labelled Wx sample, 
as described in section 3.4.1. The 2D-HSQC spectral quality was high and so in 
this situation whereby assignment of bb'x has emerged to be difficult, a step 
back to Wx could solve these difficulties. A double-labelled Wx sample was 
produced as described in section 3.4.2 and the 2D-HSQC of this sample was 
comparable in resolution to that obtained in section 5.3.2 with the 15 N-labelled 
bIx. The Wx backbone assignments were made as described in section 6.3.1 
for bb'x using the same CBCA(CO)NH and HNCACB triple resonance 
experimental data collected using the 13C/15 N Wx sample. Using these data 
sets, 82 of the 136 (60%) Wx domain residues were assigned, with the aid of 
the Wx segment assignments made using bb'x in section 6.3.1. Therefore, an 
extra 26% (60% Wx assignments - 34% bIx assignments already made in bbIx 
and described in section 6.3.1) could be cross referenced to the bb'x data set 
and assigned. Hence 60 % of the Wx region in bb'x was assigned using the 
two data set described so far. Still as a result of low resolution in both data sets, 
full unambiguous assignments was proving difficult; an alternative method to 
obtain full backbone assignments was required to complete the remaining 40% 
of incomplete assignments. 
6.3.4. Use of a2 H/ 13 C/15N sample and TROSY experiments to 
complete assignments of bb'x 
A2 H/1 3C/1 5N bbIx sample was produced (as described in Chapter 4) and was 
used to obtain HNCA and HN(CO)CA 3D-data sets-, methodology described in 
section 1.4.4. The advantage of the deuterated sample is that because 
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deuterons have an approximately 6.5 times lower gyromagnetic ratio than that 
of a proton, a large amount of the fluctuating magnetic fields can be removed; 
since fluctuating magnetic fields reduce spectral signals strength. So the 
deuterated sample should provide data with greater resolution. This is 
illustrated in Figure 6-9, whereby the 2D-HSQC has greater resolution, the 
peaks especially in the centre of the spectrum are far more resolved and the 
amount of overlap in this region is greatly reduced when compared with the 2D- 
HSQC collected with the double-labelled bb'x sample shown in Figure 6-5. 
0. 
C 
0 
. 0, -JO 0, %0E 0., 
04.4 CL 
CL 
lb 4. 
000e0 -F0 
Cb 
%&@% 
Z 
4, , 0, e 
IH Chemical Shift (ppm) 
Figure 6-9.15 NPH HSQC spectrum of 'H/"C/'5N-bb'x domain at 400C. 
As expected the HNCA and HN(CO)CA experiments were seen to be far more 
sensitive, with greater resolution as shown in Figure 6-10 in comparison with the 
CBCANH and CBCA(CO)NH data shown in Figure 6-6. These three 
dimensional experiments have a proton axis, a 15 N axis and a 13 C axis. Each 
residue i peak will give a (HN(i), N(i), Ca (i)) and (HNO), N(i), Ca (i-1)) peaks 
while the complementary HN(CO)CA will give only the (HNO), N(i), Ca(i-1)). In a 
similar method as described in section 6.3.1 adjacent residues in the bb'x 
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sequence can be linked using in this case only the Ca peaks and so 
sequentially assigned. 
137 Gly 138 Lys 13 9 Leu 140 Ser 
11C 
M PP 
45 
50 
a 1 4 I 
55 
o 60 
65 
70 
BO an 
IH ppm 
NHCA NHCA NHCA NHCA 
H N(CO)CA H N(CO)CA HN(CO)CA H N(CO)CA 
Figure 6-10. HNCA and HN(CO)CA spectra of bb'x at 400C illustrating the Ca i and i-1 
cross peaks linking residues Gly137 to Ser'140. The red arrows indicate sequential 
connections, red dashed lines indicated inter-spectrum linkages. 
Several residues were initially identified as anchor points since they have 
distinct Ca shifts, such as Glycine, Alanine, Serine and Threonine. As shown in 
Figure 6-10 residue 137 was selected and immediately identified as a Glycine 
residue from the distinct Ca shift of approximately 45ppm (13 C dimension). The 
associated i Ca peak is then identified since it lies directly on the same 1H 
dimension plane in the NHCA spectrum (some ambiguity may exist here, if 
several peaks are visible and so they needed to be checked by scrolling through 
the 15 N plane and identifying which residues were also on the same 15N plane). 
This i peak was then interrogated against all HN(CO)CA peaks until a exact 
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match was found in another residue. This process was repeated until another 
distinct peak was found and in this case, in Figure 6-10, the final spectrum on 
the right is likely to be a Serine or Threonine and from the sequence there is 
only one site where Gly-X-X-Ser/Thr exists and so this stretch can be identified 
as Gly`137 to Ser140. If new stretches of previously un-assigned segments of 
b1x were found, the HSQC assignments were then used to assist in a cross 
assignment in the 400C bb'x data, as carried out with the b domain described in 
section 6.3.2 and Figure 6-8. In a similar method, the 60% of b'x segment of 
bb'x already assigned with the use of b'x was used to cross assign the HNCA 
and HN(CO)CA spectra. The TROSY data and assignment made using this 
data set enabled the completion of the final 40% of the b'x section of bb'x as 
highlighted in Figure 6-11. With the completion of the bb'x, the missing b1x 
assignments could be identified by cross referencing from the bb'x assignments 
to the b1x HSQC as shown in Figure 6-12. The complete chemical shift data for 
bb'x and b'x are recorded in Appendix 2 (note the listed assignments are those 
for bb'x at 250C, cross-referenced as described later in section 7.3.1) and 
Appendix 3, respectively. It was not possible to assign 9 Proline residues since 
Prolines have no amide proton and so give no NIVIR signal. The following 
residues Leu`156, Asn172, Ser'173, Phe'176, Thr`1224 also remained unassigned 
due to lack of spectral resolution obtained from these residues. 
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Figure 6-11. Fully assigned bb'x HSQC at 40'C. Labelled with construct numbers and 
single letter amino acid code. 
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Figure 6-12. Fully assigned Wx HSQC at 250C. Labelled with construct numbers and 
single letter amino acid code. 
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6.4. Discussion 
The bb'x domain construct is 27447 Da and as result of peak broadening 
resulting from the conformational flexibility is approaching the boundary for 
viable NIVIR targets. The 2D-HSQC NIVIR spectrum collected for bb'x was 
observed to be complex and assignment deemed to be demanding. During the 
process of assignment, it became clear that elucidation of the backbone 
assignments would require a combination of NIVIR experimental data. Whereas 
a smaller protein, more stable protein which gave less complex 2D-HSQC NIVIR 
spectrum would typically only require the triple resonance experiment data to 
obtain full backbone assignments. Using the combination of well established 
NIVIR experiments is likely to not be novel and likely to be widely used by NIVIR 
spectrocopists; although is often unreported. This methodology in modern 
biophysical research is likely to become a trend in tackling the more difficult and 
larger protein targets in research. 
As shown below in Figure 6-13, the demanding task of assignment is 
summarised. The process begins by exhausting the triple resonance data 
collected on bb'x, to assign as much as possible with this dataset, iteratively. 
Once this process was exhausted, the second step was to cross reference the b 
domain assignments (assigned by Dr. K. Wallis) on to the bb'x, leading to full 
assignment of the b domain in the bb'x spectrum. To complete the bb'x 
assignments, the bIx was assigned as much as possible and then cross- 
referenced on to bb'x. This method was advantageous for both datasets, as 
redundant data in each set of experiments could be complemented and 
completed in the other; so aid the assignment of each protein (b'x and bb'x). 
The final step to enable completion required TROSY data collected using a 
triple-labelled sample, the preparation of which is discussed in the next chapter. 
This elaborate method was not initially expected, but proved very effective in 
achieving the goal of full backbone assignment of a large and demanding 
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protein molecule. The fruit of this labour is that it allows further analysis of the 
domain construct and paves the way to allow probing dynamic and more 
detailed molecular NIVIR analysis. 
b domain 
assignments 
Cross reference, tentative 
assignments made if resonances 
match 
bb'x 
assignment C, % 
CIO at 400C 
fkl" . N, c", AýD , C', 01' 0 
Wx 
bb'x TROSY 
assignment 
assignment at 400C 
ig 
C 
Cross reference confident 
at 250C 
assignments 
Figure 6-13. Schematic diagram of the assignment method using the different 
experimental NIVIR data collected. 
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Chapter 7. Protein Conformation and Dynamics 
7.1. Introduction 
This chapter describes NIVIR dynamic analysis using the assigned spectrum for 
the bb'x domain. All the preparatory work discussed in previous chapters 
culminating in full assignment of the bb'x domain was vital to allow probing 
dynamic and more detailed molecular NIVIR analysis. 
7.2. Alternate Conformations 
It was previously suggested that the improvement of spectra associated with 
fractionation and the observation of the double tryptophan indole peaks that x- 
region was in two conformations. In the first conformation the x-region was 
hypothesised to be bound to the b' substrate binding site, observed in the 
monomer fractions. Whilst the second conformer existed in a state where the x- 
region was unbound. Evidence of the two conformers was observed during the 
assignment and clear once full assignments had been achieved. Whereby the 
resonances resulting from the x-region in the 2D-HSQC were significantly 
stronger and better resolved than any other peaks in the HSQC, as shown in 
Figure 7-1. The residues from the x-region such as Glu226, Trp231, Met223 
(construct numbers; mature PIDI numbers are Glu342, Trp347, Met339) appear 
much stronger with many more contours than any other peaks observed in the 
spectrum. This would infer the x-region was in a much more stable/rigid 
conformation. 
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Figure 7-1. Zoomed in image of bb'x HSQC at 400C. 
The species observed during the preparation and characterisation of the bb'x 
protein samples were defined in Figure 3-22, based on observation made during 
the purification and fractionation. With these new observations from the NMR 
data, these definitions of species require redefining, as shown in Figure 7-2. 
The Pool 1 monomer fractions, were initially defined as containing a monomer 
species, but in light of the NIVIR data, this species must be redefined as sample 
containing predominately a 'capped monomer' species where the x-region is 
speculated to be bound to the b' substrate binding site. Whilst the Pool 2 dimer 
sample, initially defined as containing primarily a dimer species, but must be 
redefined as sample containing some of the dimer species and an 'un-capped 
monomer' species where the x-region is not bound to the b'domain. It was still 
unclear as to the proportions of the dimer and uncapped monomer species 
which exist in the Pool 2 dimer samples. 
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Figure 7-2. Diagram showing the redefinition of species observed through various 
stages of characterisation and analysis. 
7.3. Chemical Shift Analysis 
One type of molecular analysis involves using the chemical shift data which can 
be employed to investigate the effect of temperature change on specific 
residues in the bb'x domain construct. Another involves comparative analysis 
of spectra of different domain constructs to define inter-domain 
interactions/interfaces. An assigned HSQC spectrum, for example the bb'x 
construct, can be compared to another assigned HSQC, such as that of the b 
domain, and any perturbations of the b domain resonances in bb'x recorded. 
These perturbations that arise would highlight the residues involved in direct 
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interactions or long distance structural changes arising from addition of adjacent 
domains. Assuming that the perturbations result from direct contact, this would 
imply a direct interface region between the domains. The perturbations can 
then be mapped to structure or to a sequence and using this approach it is 
possible to build a contact map of the full PDI molecule which is of great value 
since the large size of PIDI renders it unsuitable for NIVIR structural 
determination. 
The chemical shift data can also be used to predict secondary structure using 
the TALOS program. The program uses a combination of five types of chemical 
shift (Ca, CP, C', HN and Ha) for any number of residues; four of which have 
been experimentally determined in this study and inputted into the program (Ca, 
CP, HN and Ha). The program uses sequential groups of three amino acids of 
the input sequence which is interrogated against the database. If a triplet of 
residues in a structurally determined protein is found with similar chemical shifts 
to the target sequence then the psi and phi angles could be predicted accurately. 
7.3.1. bb'x chemical shifts associated with temperature 
During the process of optimising NIVIR spectral resolution by increasing the 
temperature at which data was collected (described in Chapter 6), HSQC 
spectra were collected at 25,35 and 40"C. This provided an opportunity to 
investigate how the increase in temperature affected residues determined by 
chemical shift. It was determined that assignment of the bb'x domain could be 
possible using data collected at 400C and assignments were made using the 
HSQC and triple resonance data collected at 400C. Once the assignment was 
complete, it was possible to cross-assign simply by overlaying the spectra as 
shown in Figure 7-3, transferring the assignments from the 400C HSQC to the 
350C data and then finally to the 250C data. The majority of peaks had 
sufficiently similar chemical shifts at each temperature to allow unambiguous 
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cross-assignment; occasionally overlapping did hinder assignment but upon 
close analysis all peaks were assigned. 
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Figure 7-3.15N/'H HSQC overlaid spectrum of a 13C/15 N-bb'x domain sample at 400C 
(green), 350C (red) and 250C (blue). 
The chemical shifts from the 40'C assignments were compared to those 
transferred to 350C and are presented below in Figure 7-4. 
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Figure 7-4. Chemical shift difference of residues assigned in the 350C from the 400C 
spectrum. --- )3 Standard deviation, ( --- )4 Standard deviations. 
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From Figure 7-4 it is clear there are a range of Ashifts which occur as a result of 
the decrease in temperature, the most significant are those which shift with a 
difference greater than 4 standard deviations. Three of these residues are 
situated at the extremities of the protein molecule, Thr`122 at the N-terminal of 
the molecule in the b domain and Ile334, Leu343 at the C-terminal in the x- 
region. Large Ashifts here would be expected since there would be a greater 
degree of flexibility. The two interesting residues highlighted from this analysis 
are Asp280, Met307 which are both situated in the W domain and so do not lie 
at the extremities of the protein. 
The same type of analysis was done for spectrum collected at 25'C, whereby 
assignments in the 35'C HSQC were cross-assigned to the 25'C spectrum; the 
shifts are shown in Figure 7-5. 
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Figure 7-5. Chemical shift difference of residues assigned in the 250C from the 350C 
spectrum. --- )3 Standard deviation, ( --- )4 Standard deviations. 
The same residues Ile334, Leu343 and Thrl22 from the construct's extremities 
again produced the highest shifts in excess of 4 standard deviations, along with 
Asp280, Met307 as identified from the 35'C shifts. This supports the hypothesis 
by Dr. L. Ruddock, whose research also alluded to the importance of the L343 
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residue, which featured in the research to structurally determine the Wx domain 
(see Appendix 1). Other residues with shifts in excess of 4 standard deviations 
were Lys335 and Ala120. Also an interesting residue with a shift above 3 
standard deviations is Glu342. This data suggests as expected, that the regions 
at the extremities of the protein are the most flexible but also two residues in the 
b' domain are also very flexible, these are Asp280, Met307. Also apparent from 
Figure 7-5 is that again there are a higher number of large shifts in the Wx 
region than the b domain. The average shifts for the Wx region is 0.078ppm, 
whereas the b domain averages 0.066ppm. 
Alternatively the reverse analysis is also possible, whereby residues which are 
structurally important will have no or very low perturbations. The following 
residues feature in both temperature change experiments in having the very low 
perturbations TWO, Glu286, Thr318, lle274 and lle221 which surprisingly all 
reside in the bI domain. Since the b' domain is known to be structural flexible, 
these residues could be functionally important. 
7.3.2. Chemical shift mapping 
Another chemical shift analysis method involves measuring shift differences 
between spectra from different domains described in section 1.4.8. The 
difference of individual residues of bb'x and the two smaller domain constructs 
b'x, b were determined using 15N/1H HSQC data obtained for each domain 
construct under identical conditions. The fully assigned bb'x HSQC is 
compared to the assigned b domain HSQC and any perturbations would infer 
the domain interface between the b domain and b'x. The perturbations 
observed between the spectra would result from the influence of the adjacent 
domain and since the b domain has been structurally determined, the interface 
residues can be mapped on to the structure. 
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Figure 7-6. Chemical shift perturbation identified in the b domain by comparison of the b 
domain HSQC and the bb'x HSQC. ( --- )I Standard deviation, ( --- )2 Standard deviations. 
From the chemical shift analysis shown in Figure 7-6, the residues with greater 
than 2 standard deviations were Glu194, Phe'192, ArgI196, Gly195 and Asn215. 
Those with greater than 1 standard deviation were 2171-eu, Asp`193, Ala139, 
Lys`190, Glu202, Ala120, Lys191 and Gln216. From the graph in Figure 7-6, it is 
clear that the perturbation arise in distinct areas; the clearest area is that around 
residue Asn197. The ends of the domain would inherently be more flexible and 
reveal high perturbations; hence the area of interest is that around residue 139. 
These perturbations reveal far more information when plotted onto the b domain 
structure as shown in Figure 7-7. 
1800 
Figure 7-7. Two viewpoints of the space-fill b domain structure. Perturbations >1 
standard deviation highlighted in red. 
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From the Figure 7-7 it is clear that the perturbations observed in the NMR 
spectral chemical shift analysis are mainly concentrated to one discreet patch 
and on one particular side of the b domain structure. This therefore implies that 
this region could be in direct contact with the Wx domain. 
The same analysis can be carried out using the assigned b'x HSQC and that of 
bb'x. In a similar fashion the possible Wx interface region to the b domain 
could be inferred. The b'x perturbations when in the bb'x domain are shown in 
Figure 7-8. 
Figure 7-8. Chemical shift perturbation identified in the Wx domain by comparison of the 
Wx domain HSQC and the bb'x HSQC. 1 Standard deviation, 2 Standard 
deviations. 
The perturbations were much greater in the b'x domain (note the difference in 
scale between Figure 7-6 and Figure 7-8), inferring greater structural flexibility. 
Again the perturbations are focused to distinct regions, as expected 
perturbations are observed near the start of the domain construct. Interestingly 
no large perturbations are seen at the very end of the domain, but seen a little 
further into the x-region such as Leu338 and Met339. Apart from Met307, the 
remaining large shifts >1 S. D. are grouped (Thr279, Leu285, Glu286 and Ile284). 
Again this data is most informative when mapped on to a structure, since no 
human PDI b'x structure has been determined a model was produced using the 
Geno3D (available at http: //-qeno3d-pbil. ibcp. fr) (Combet et al., 2002) which 
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used the Erp57 bb' as a template structure (see section 2.6.1. for more details). 
This Wx model was used to map the perturbations as shown in Figure 7-9. 
Figure 7-9. Two viewpoints of the space-fill Wx domain structural model with 
perturbations >1 standard deviation highlighted in red. 
The perturbations >1 standard deviation mapped on to the Wx structural model 
reveal the perturbations at the direct residue contacts between the b domain 
and b'x domain, highlighted in Figure 7-9. Expected perturbations on the 
flexible and unbound x-region are also highlighted. Importantly residues Thr279, 
Leu285, Glu286 and Ile284 are grouped to a distinct region and this is expected 
to be the interface between the domains. Residue Met307 is also perturbed and 
is also situated on the surface, highlighted in red, at the bottom of the left-hand 
image in Figure 7-9. At this stage it was unclear if this an internal structural 
change induced by the addition of the b domain or forms part of the interface 
between the domains. 
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7.3.3. Secondary structure prediction: TALOS 
The Ca, CP, HN and Ha chemical shift data for each residue using the 400C 
bbIx can be inputted to the TALOS program, which predicts the phi and psi 
angles, relates the information to the next and previous residue to make 
predictions on the central residue. The TALOS predictions are shown in Figure 
7-10, firstly focusing on residues from 119 - 217 (b domain). Some of the 
secondary structure elements are slightly shifted but the program had correctly 
identified all the secondary structure elements in the correct order 
Ojai NaAaA4044. Therefore the secondary structure boundary predictions for 
the Wx region are unlikely to be accurate, including the predicted a-helical 
structure predicted for the x-region. But the overall order is likely to be correct, 
which is predicted to be the same as the b domain and the thioredoxin-fold, 
PlaAaAaAP44 structure. 
The low accuracy for the TALOS program results from the fact that 40 residues 
were inputted lacking the Ca and CP chemical shifts; 10 residues were prolines 
for which the Ca and CP could not be recorded. The missing Ca and CP 
chemical shifts resulted from poor spectral resolution where no shifts could be 
recorded. 
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Figure 7-10. Diagram showing the numbered bb'x sequence, with the TALOS predictions 
and actual b domain secondary structure. B-strands in red, A-helices in yellow, ends of 
domains highlighted in grey. X-region helical secondary structure denoted by M. 
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7.4. Hydrogen/Deuterium Exchange 
This section describes results collected using hydrogen/deuterium (H/D) 
exchange experiments on the b and bb'x domain constructs. Samples 
remained in high deuterium conditions for 21 hours and spectra were collected 
at various time points from 5 minutes to 21 hours. The general approach to 
analysis of this kind of data involves fitting a single exponential decay to residue 
peaks over the time period. Unfortunately the experiment which was run at 
250C did not give good data and rates were not informative, although a basic 
analysis is possible by identifying which residues are slow and fast exchanging. 
The problem of poor data could be resolved by repeating the experiments at 
400C, which should improve spectral resolution. 
7.4.1. b domain H/D exchange 
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Figure 7-11. HSQC spectrum of the b domain H/D exchange after 5 minutes. Blue peaks 
show the HSQC collected for the b domain at 25"C prior to deuterium exposure. Overlaid 
purple peaks show the HSQC resonances of the b domain after 5 minutes of exposure to 
deuterium. 
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As highlighted in Figure 7-11, only 52 peaks (44%) remain after 5 minutes of 
being dissolved in D20 (listed in Appendix 4). The fast-exchanging 56% of 
residues are likely to be the solvent exposed residues and regions of structural 
flexibility. Also noticeable from the spectra is that some of the peaks have 
shifted slightly, which is likely to result from slight structural changes possibly 
resulting the freeze-drying process or from deuterium exchange. 
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Figure 7-12. HSQC spectrum of the b domain H/D exchange after 21 hours. Blue peaks 
show the HSQC collected for the b domain at 250C prior to exposure of deuterium. 
Overlaid red peaks show the HSQC resonances of the b domain after 21 hours of 
exposure to deuterium. 
After 21 hours of exposure to deuterium, only 22 peaks remained (listed in 
Appendix 4). These residues are likely to be the most buried residues in the 
structure or residues situated in stable secondary structure elements and so the 
least solvent-exposed regions. 
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Figure 7-13. The b domain ribbon diagram with the slow-exchanging 22 residues 
highlighted in red. 
Since the b domain structure has been solved, it is possible to map the 22 slow- 
exchanging residues as shown in Figure 7-13. This also serves as self test tool 
to ensure the experiment is functioning correctly before moving on to the more 
complex bb'x domain. It is clear from Figure 7-13 that the majority of slow- 
exchanging residues are located at the centre of the molecule, in the least 
solvent exposed regions. Also highlighted are a number of other residues which 
as predicted, are located amidst secondary structure elements. 
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7.4.2. bb'x H/D exchange 
Since the b domain H/D exchange experiment was successful at identifying the 
core, slow-exchanging residues, the bb'x domain construct was also analysed. 
Again a HSQC spectrum was run before and after 5 minutes of being dissolved 
in D20, as shown in Figure 7-14.91 residues (39%) remained after the short 5 
minute exposure to D20 (listed in Appendix 4); hence 142 residues (61%) were 
fast-exchanging. 
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Figure 7-14. HSQC spectrum of the bb'x domain H/D exchange after 5 minutes. Grey 
peaks show the HSQC collected for the b domain at 25*C prior to deuterium exposure. 
Overlaid purple peaks show the HSQC resonances of the bb'x domain after 5 minutes of 
exposure to deuterium. 
A HSQC was then re-run after a delay of 21 hours to identify the slow- 
exchanging residues which are likely to lie at the centre of the protein molecule 
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and the least solvent exposed regions. As highlighted in Figure 7-15, very few 
residues remained unexchanged; totalling 34 residues (listed in Appendix 4). 
Upon comparison of the slow-exchanging b domain residues in both H/D 
exchange experiments of b and bb'x domains, the same residues were 
identified. This also validates the confidence in the experimental data. Also of 
the 34 slow-exchanging residues in the bb'x experiment, only 12 residues arise 
in the Wx region of the construct and none in the x-region. This suggests the 
Wx and particularly the x-region is more exposed as a result of structural 
fluctuation, which supports the HSQC data described in an earlier chapter 
suggesting that Wx region is more conformationally flexible. 
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Figure 7-15. HSQC spectrum of the bb'x domain H/D exchange after 21 hours. Grey 
peaks show the HSQC collected for the b domain at 25C prior to deuterium exposure. 
Overlaid red peaks show the HSQC resonances of the b domain after 21 hours of 
exposure to deuterium. 
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7.5. Dynamic Analysis using Relaxation Experiments 
This section describes more detailed studies involving the collection and 
analysis of NIVIR relaxation dynamic (Ti and T2) and Het NOE (heteronuclear 
nuclear overhauser effect) data which not only reveals dynamic information 
about the whole construct but also structural information on individual domains 
and residues. 
7.5.1. Heteronuclear-NOE 
As described in section 2.5.3.9, HSQCs were collected with 1H saturation on 
- shown in Figure 7-16. and off, 
L LG 0* 0 
0 
00 te 
op (0 a8i 
-Fe ýe 
m0;. .40 
ce g 61 0 
LO 5 log .5 90 a5 &0 -, 0 65 4 
1H Chemical Shift (ppm) 
Figure 7-16.2D-HSQC collected at 400C of 15N-bb'x with 1H saturation on and off. 'H 
saturation off is shown in red peaks, 1H saturation on is shown in red peaks for positive 
peaks and yellow for negative peaks. 
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As shown in Figure 7-16, with 1H saturation on, many negative are also shown, 
while the off peaks are weak and broadened, reflecting a slightly poor quality of 
data collected. Unfortunately due to time constraints, a repeat of the experiment 
at a lower temperature, which could improve data quality, could not be carried 
out. But it was deemed the data quality was sufficient to carry out meaningful 
analysis. 
The NOEs were calculated for each peak by comparing peak heights for 
where I is the peak height with 1H saturation off and lo is the peak height with 1H 
saturation on. This data is presented in Figure 7-17, which reveals the majority 
residues have NOE values below >-0.5, indicating slow internal motion. 
However a number of residues which have <-0.5 NOE values have faster 
internal motion and were found to lie in loop regions when mapped on to the b 
domain structure and therefore it was assumed that residues with <-0.5 NOE 
values in the W domain are also likely to be situated in loop regions. Also very 
noticeable was the very low NOE values recorded from the x-region, indicating 
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a very high degree of rapid motion, which may be a feature of the region or 
possibly resulting from termini flexibility, which is unlikely as the low values 
extend throughout the final 20 residues. This motion occurs in a longer region 
than expected for only termini flexibility which normally only extends for a few 
residues into the protein at terminal ends; an example of this is highlighted by 
Mackay and colleagues (MacKay et aL, 1996). 
It is difficult to distinguish different internal motions between the two domains as 
a result of low spectral quality; since the average NOE value for the b, domain 
was -0.22 and -0.29 for the b' domain. Although the experiment does detect the 
sub-nanosecond motion observed for the x-region which gave an average of - 
1.44 NOE value. More accurate comparative analysis is hoped to be achieved 
in the next section using the more sensitive T, and T2 experiments. 
7.5.2. T, and T2 relaxation data 
A series of T, HSQC experiments were run with relaxation delays of 128,256, 
385,512,641,769 and 897 milliseconds as described in section 2.5.3.8. The 
peak volume values were exported from each HSQC collected; note in the NOE 
experiment peak height values were used and here peak volumes. Both can be 
used to analyse both sets of experiments, with the choice dependent on the 
quality of the data. 
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Figure 7-18. Typical T, decay for 5 residues using peak volume against T, time delays. 
The peak volumes for each residue can be plotted against the T, delay and the 
T, decay rate calculated for each residue from the three-parameter nonlinear fits 
of the experimental data to l(T)=I. j IAJ exp(-T/Ti), where , 
1, ) and I- are the 
cross-peak volumes at zero- and infinite-time, respectively. T2 values were 
likewise obtained from the three-parameters fits to the equation 1(, U)=I. +[ 1-+101 
exp(-T/T2) as described by Mackay and colleagues (MacKay et al., 1996). The 
T, and T2 rates are regularly expressed as lrF, (Rj) and 1/T2 (R2). 
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The R, rates presented in Figure 7-19 indicate the Wx domain has a much 
higher internal motion on a nanosecond timescale highlighted by the higher R, 
rates. The average R, rate was 1.2 s-1 for the b domain, 2.0 s-1 for the b' 
domain and 1.9 s-1 for the x-region. The Tj/R2 experiment clearly highlights the 
different nanosecond motional dynamics of the b' domain compared to the b 
domain, which was unseen in the HetNOE experiment. 
Similar analysis can be carried out using the T2 rates, and as shown in Figure 
7-20, can also be plotted in terms of R2 rates. T2 and R2 rates measure protein 
motion on a milli to microsecond timescale. The average R2 rate was 13.4 s-1 
for the b domain, 11.5 s-1 for the W domain and 5.8 s-1 for the x-region. This 
does not highlight any distinct differences between the b and b' domain at these 
timescales; but supports the results seen in the R, analysis where motion is 
observed, and must be on the faster nano-picosecond timescale. The very low 
x-region R2 average can be explained since only the very terminal residues 
indicate a different timescale of motion which is likely to be attributable to termini 
flexibility and so give the very low R2 rates. But not all the x-region residues 
have very low R2 values hence the low R2 average is biased by the termini 
flexibility. 
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7.5.3. T, and T2 rates to determine isotropy or anisotropy 
Using the model-free formalism (Lipari and Szabo, 1981; Lipari and Szabo, 
1982) contours can be calculated with spectral density functions to represent 
fixed values for the order parameter S2 with varying correlation times -cm. These 
theoretical contours are shown in Figure 7-21 and are calculated based on an 
internal correlation time Te of 50 picoseconds. If T, and T2 rates are recorded 
above the theoretical S2 value of 1 then the protein is predicted to be spherical 
and isotropic, whereas any rates recorded below S2 value of 1 are likely to be 
anisotropic. From Figure 7-21 it is clear that the majority of b'x residues fall 
below the S2=1 contour and so indicating that this domain is anisotropic. Whilst 
the majority of the b domain residues lie above the S2=1 contour and so is likely 
to isotropic. As a result of the anisotropic nature of the b'x domain, use of the 
Lipari and Szabo Model-free approach to interpret protein dynamics and 
determine dynamic parameters was not possible. 
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Figure 7-21. Plot of experimental T, against T2 rates. The yellow, green and blue contour 
lines represent theoretical 1,0.8 and 0.6 S2 rates, respectively. 
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7.6. Discussion 
The chemical shift analysis not only allowed the transfer of assignment to the 
HSQC spectrum collected at 250C, at which temperature backbone assignment 
was impossible, the assignment allowed more probing dynamic and detailed 
molecular NIVIR analysis. Since 250C is the standard NIVIR experiment running 
temperature the ability to assign a HSQC spectrum at this temperature was vital. 
Analysis of chemical shifts was very informative, firstly by analysing chemical 
shifts over the temperature changes of 400C to 250C revealed a number 
interesting residues likely to be structurally significant in allowing protein 
flexibility. Secondly, by mapping chemical shifts between spectra from different 
domain constructs. This led to very convincing evidence of a contact site on the 
b domain which interacts with the Wx domain. The data also suggested that the 
interaction of the bIx domain with the b domain causes long-range internal 
structural changes. Also, current on-going work carried out by Dr. L. Byrne 
(University of Kent) involves further analysis of the bb'x domain dynamics using 
residual dipolar coupling (RDC) experiments. These experiments provide 
information about the length and orientation of internuclear vectors and so will 
aid in the understanding of the domain-domain orientations. 
Hydrogen/deuterium data analysis was limited as a result of poor spectral 
quality, likely to result from the freeze-drying process. Due to time constraints 
repeating this experiment was not possible to test this hypothesis or to attempt 
to improve resolution by increasing the temperature at which spectra would be 
collected. The basic analysis carried out on the b domain did highlight key 
slow-exchanging residues, which when mapped on to the structure appeared to 
be core buried residues and so with a high degree of confidence a number of 
core residues are also reported for the bb'x domain. 
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The T, and T2 relaxation experiments highlighted a distinct difference between 
backbone motions of the b and Wx domains. Unfortunately, since the Wx 
domain was identified to be anisotropic, quantification of backbone motion using 
the model-free formalism was not possible. Understanding the complex nature 
of backbone motion for the Wx domain will require further NIVIR dynamic 
analysis, possibly using the 'extended model-free' approach (Clore et aL, 1990), 
designed for intradomain dynamics comprising of fast and slow motions. 
Alternatively, more recently a method of modelling interdomain dynamics was 
proposed by describing the dynamics as an interconversion between two 
distinct states (Ryabov and Fushman, 2006). 
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Chapter 8. Discussion 
8.1. Introduction 
in previous work on PDI, scientific attention had been focused primarily on the a 
and a' domains which were shown to contain the active site C-X-X-C consensus 
sequences; involved in disulphide bond catalysis. Attention later turned to the b 
and bl domain since it was shown that these were required for the complex 
isomerisation reactions (Darby et aL, 1998). It was also found that the b'a'c 
construct was the minimum PDI domain combination that allowed isomerisation 
and the addition of the b domain to this construct increased the activity further. 
This interest led to the structural determination of the b domain in 1999 by the 
Kemmink group, but attempts to crystallise or obtain high resolution NIVIR data 
on the W domain were unsuccessful. Hence it was not until 2006, two years 
into this research project, that the first b' domain structure had been determined; 
highlighting the intransigent nature of the W domain in structural analysis. At 
that time, the structures of the three other human PDI domains, a, b and a' had 
been determined (Kemmink et aL, 1996; Kemmink et aL, 1999; Tochio et aL, to 
be published) as had other a and a' domains from a host of different species. 
The importance of the W domain was established when experimental data 
suggested a principal substrate binding site lay in this domain and proved the 
functional significance of the b' domain in PDI function (KIappa et aL, 1998). 
Hence this study set out initially with an ambitious goal of full structural 
determination of the b' domain which was later limited to obtaining backbone 
assignments for a b' domain containing construct. The procedure to make 
assignments was made difficult by poor NIVIR data resolution and an elaborate 
method using a range of NIVIR experimental data was required to achieve the 
goal. The assignments were used to analyse structure and backbone dynamics. 
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8.2. Expression and Characterisation of PDI Proteins 
A detailed protocol, involving sample fractionation, was established in this 
research to allow the preparation of homogenous protein samples. This 
provided the basis to obtain quality NMR data, improving upon prior 
preparations of samples. Fractionation was based on the observation of two 
species during the purification steps, which was initially speculated and later 
characterised to result from a monomer and dimer species. The dimer species 
was shown to be a non-covalent dimer, but upon NMR analysis this pool was 
later defined to also contain the open form of the bb'x molecule and the 
monomer defined as a closed form; whereby the open and close refers to the 
positioning of the x-region. Generally the 'monomer' sample was shown by 
native-PAGE to be a homogenous sample. The 'dimer' sample appeared to be 
less homogenous; this was also shown in NMR experiments whereby spectra 
appeared to show a poorly resolved monomer species. This sample was 
defined as the open form of the bb'x species, evidence of this open and close 
form was further analysed in the Wx domain (Nguyen et aL, (Manuscript in 
preparation)), see Appendix 1. Unfortunately a sample of the dimer pool was 
not analysed by AUC during this study as attention was focused on the 
monomer species; this would be an important experiment for future work to 
quantify the amount of non-covalent dimer produced. The dimer pool also 
requires further characterisation to see if the dimer and open forms of bb'x 
domain can be separated. 
Expression particularly of the bb'x domain was optimised to reduce the amount 
of 13C_glucose used in the minimal expression medium, whilst maintaining the 
high levels of protein yields required for NIVIR analysis. It was also shown by 
mass spectrometry analysis that high levels of isotopic labelling could be 
achieved using 15 N and 13C labelled reagents in minimal growth medium. The 
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most important protocol established in this research defines a procedure to 
prod UCe 2 H, 15N, 13 C-labelled proteins, we foresee no reason why this protocol 
could not be used for other PDI domain combinations and it is likely that any 
future work on large PDI domain combinations will require triple-labelling to 
overcome the low spectral resolution from analysis of large protein constructs. 
8.3. NMR Approach to Obtain b' Backbone Assignments 
Chapter 4 describes prior NMR analysis carried out by Dr. R. Williamson and 
initial NMR analysis using samples produced early on in this study. The 
spectral analysis carried out in Chapter 4 was used to devise an appropriate 
approach to enable backbone assignment of the b' domain. Since the bI 
domain was the main domain of focus, collecting NMR spectra on this domain 
would be the easiest and most obvious starting point. Unfortunately the bI 
domain gave very poor NMR data, as measured using average peak width 
analysis, described in section 5.2; believed to result from conformational 
exchange which is likely to be an intrinsic feature linked to function in terms of 
substrate binding. 
Improvement to spectra was observed with the addition of domains, as seen 
with the addition of the b domain in the bb' domain construct. A more marked 
improvement was seen with addition of the x-region in the bb'x domain 
construct. This was believed to be caused by the x-region binding to the b' 
domain, stabilising this domain and so resulting in an improved spectrum. This 
hypothesis was supported once full assignments were obtained; the x-region 
peaks in the HSQC were much stronger than any other peaks by a substantial 
amount. This implies the x-region is indeed held in stable conformation but no 
NMR experimental data obtained here defines the site of the binding, which is 
still speculated to be the W binding site since the peak resolution of this domain 
were improved. Future work would entail titrating a ligand into a bb'x sample 
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and recording perturbations to HSQC spectrum which would highlight specific 
residues involved in substrate binding. Presently there is no known or well 
established substrate molecule; all reported work on substrate binding has been 
carried out using short hydrophobic peptides with the exception of BPTL A 
possible approach could be to synthesise the x-region and use this short 
peptide as substrate molecule; since the NMR experiments reported here 
shown the x-region binding in the bb'x PDI domain combination. 
It is important to note that here it is suggested that the x-region is bound to the 
b' domain and later, paradoxically, the relaxation experiments suggested the x- 
region had flexibility. This can be explained by the fact that the HSQC is 
influenced more by the stable x-region conformation, which results in stronger 
HSQC peaks; the weaker extra peaks believed to result from the unbound x- 
region were observed but were so weak and poorly resolved as a result of their 
motion that they were impossible to assign. Conversely the relaxation 
experiments are influenced more by the unbound x-region, the bound form 
would influence to a certain degree but not enough to suppress rates to a 
negligible level. 
From the observed improvement to the bb'x spectrum, it was logical to target 
the bIx domain which would reduce assignment complexity and it was hoped 
that the x-region would again stabilise the W domain to give a well resolved 
HSQC spectrum. Unfortunately, the HSQC spectrum was not initially radically 
improved as seen with the bb'x spectrum, this may be caused by the fact the 
Wx sample was unfractionated; whereas the bb'x was fractionated based on 
anion exchange chromatography. 
A major breakthrough was the protocol designed in this research to fractionate 
the samples into two pools. As described in section 5.3, the monomer 
fractionated pool again further improved the HSQC resolution; to such a degree 
that it was hoped assignments could be made. A key feature observed in the 
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HSQC spectrum, was the double tryptophan signal resulting from the single 
tryptophan residue situated in the x-region. Although this signal was observed 
and noted in early NIVIR spectra collected by Dr. R. Williamson, only in this 
study using the fractionated samples could a link be made as to the origin of this 
signal. The left-hand indole side chain peak was clearly linked to the monomer 
pool fractions, hence indicating and supporting the hypothesis of the x-region 
binding to the b' domain, since this fraction resulted in a highly resolved HSQC 
spectrum; indicative of a high stable molecule. Whereas a stronger right-hand 
indole side chain peak, gave very poorly resolved HSQC indicating a 
conformationally flexible molecule, likely to result from an unbound x-region. 
The important outcome resulting from the stringent fractionation was that the 
HSQC resolution was now sufficiently high enough that backbone assignment 
could be possible. 
The effect and nature of the x-region is intriguing; in work carried out by Dr. K. 
Wallis and Dr. L. Ruddock, this behaviour has been characterised in the b'x 
domain construct and work based on this feature has enabled the structural 
determination of a b'x mutant which has the x-region constantly fixed in the 
bound state with the bI domain (Nguyen et al., (Manuscript in preparation)), see 
Appendix 1. Ongoing work carried out by the Freedman, Ruddock and 
Williamson groups focuses on defining the importance of the x-region features 
in the full length human PDI molecule. 
The most important and relatable structural information was the recent 
publication of the human bbI domain NIVIR chemical shifts assignments 
(Denisov et aL, 2006) two years into this study and at a time when the chemical 
shift assignments reported here were almost complete. The chemical 
assignments are from human PDI residues 135-357, this construct has an extra 
5 residues on the N-terminus which are not found in the human PDI sequence. 
But more importantly, the construct has only the first 7 residues of the widely 
accepted x-region (Freedman et aL, 1998) and lacks the final 12 residues of the 
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x-region. This is significant as the x-region appears to have a unique 
involvement in the domain construct and may affect the biological relevance of 
this domain construct. Hence dynamic and structural analysis on an untrimmed 
x-region in the bb'x domain as described in this study is likely to yield more 
relevant data. 
Assignment of the bb'x was not a simple task as first expected, even though the 
bbIx HSQC was highly resolved, the triple resonance experiments lacked the 
similar high resolution. As discussed in section 6.4, an elaborate method 
requiring three data sets (b domain, assigned by Dr. K. Wallis, bx assignments 
and bb'x TROSY data) was used to enable full backbone assignments of the 
bbIx domain. Spectra were also required to be collected at 40OC; this higher 
temperature increased the molecular tumbling rate and so resulted in improved 
spectra quality, assignments of spectra at 400C which could then be mapped 
back to the 25(C HSQC. Assignment was a labour intensive procedure, 
requiring many iterations of assignments in each data set to ensure no mis- 
assignments were made. This task was carried out by myself and Dr. L. Byrne, 
whereby assignments were made independently and then cross-checked, to 
again minimise mis-assignments. The main difficulties were peak overlap and 
the low resolution of the triple-resonance data, caused primarily by the size of 
the protein. The bbIx domain is 27477 Da, which is not too large for NMR 
analysis but due to the protein's conformational flexibility resulting in peak 
broadening and overlap, the protein bordered on the limits of NMR analysis 
feasibility. NIVIR protein analysis is plagued by this size limitation and spectral 
complexity issues; although using a number of NMR experimental data sets is 
not novel, it is expected that for the larger and more demanding proteins of 
biological importance such elaborate approaches will be required. 
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8.4. Protein Conformation and Dynamics 
Backbone assignments are the first step in detailed analysis, and if a 
demanding protein molecule is analysed, as described here, a usually mundane 
and simple task as backbone assignment can become a complex problem 
requiring ingenuity and lateral thinking. The product of the immense effort to 
obtain NMR assignments for bb'x and Wx was that they pave the way for more 
detailed structural and dynamic analysis. 
At the onset of this study no full length PDI structure was available, but again 
two years into this study the first full length PDI structure from Saccharomyces 
cerevisiae was published (Tian et aL, 2006). But still no full length human PDI 
structure has been reported to date. NMR structural determination of any full 
length PDI protein was impossible due to the large size of the PDI molecule 
(55kDa). Hence the long term strategy devised at the onset of this project by 
the three groups involved would be to collect NIVIR assignments for small 
domain constructs and use these in a similar fashion as used in this study to 
define interfaces between domains. Strong evidence of the residues involved in 
the interface between the b and Wx domain were found. So by using additional 
NIVIR data, primarily residual dipolar coupling experiments to define domain 
orientation, a full length PDI domain map could be produced; overcoming the 
size limitations to define the full length PDI structure. This remains a target for 
the groups and is an area of future work to be done. 
The basic analysis using the hydrogen/deuterium exchange experiments 
revealed important core buried residues in the b and bb'x domains. 
Unfortunately the data quality was poor and exchange rates were not accurate. 
A repeat of this experiment is required, run at a higher temperature which could 
overcome the problems of poor data quality. 
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The T, and T2 relaxation experiments were very enlightening, highlighting the 
significantly different motions in the bb'x domain. These experiments 
highlighted the high degree of flexibility and motion of the x-region. The 
relaxation data therefore suggests that the x-region is bound, but can open and 
close; hence has flexibility. The observed improvement to HSQC spectra 
results from the fact that when the protein molecules are in an open state the 
signals are very weak as a result of movement, whereas the closed state would 
give stronger signals and drown out the weaker open state resonances. 
Unfortunately, since the Wx domain in the bb'x domain construct was identified 
to be anisotropic, quantification of the backbone motion using the model-free 
formalism was not possible. Understanding the complex nature of backbone 
motion for the Wx domain will require further NIVIR dynamic analysis, possibly 
using the 'extended model-free' approach (Clore et aL, 1990) or modelling the 
interdomain dynamics as an interconversion between two distinct states 
(Ryabov and Fushman, 2006). Current ongoing work includes collecting 
residual dipolar coupling (RDC) experimental data which will further define 
interdomain orientations. The dynamic analysis carried out to date is in its 
infancy and is likely to further quantify the differences in motions observed in 
this study. This analysis relies on the backbone assignments, which was the 
most significant achievement described in this study. The backbone 
assignments provide the springboard to allow more highly detailed structural 
and dynamic analysis, which is hoped to lead to a greater understanding of the 
W domain substrate binding function and synergic relationship with the b 
domain. 
All the dynamic and structural data collected during this project reveals the W 
and b domains have intrinsically different backbone motions. The dynamic 
analysis of the b domain revealed faster motion than the W domain. This is 
hypothesised to be related the protein function, where the slower motion in the 
bI domain could be related to the substrate binding function. Where the b' 
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domain could be interpreted as breathing and feeling it surrounding space for a 
substrate molecule. Future experiments involving titration of a substrate could 
reveal differences in backbone motion upbn substrate binding. As discussed in 
section 1.3.5, there are distinct differences between human and the recently 
published yeast PDI structure. The results here and proposed future analysis 
allows a more versatile and definitive method to analyse the affect of substrate 
binding on backbone motion which is expected to greatly differ from the Yeast 
PDL 
Furthermore since a full length PDI structure has eluded research groups, 
defining interfaces between domains as described in this research used in 
conjunction with the proposed future RDC analysis could allow us to build a 
model of the full length PDI protein. The interface analysis defined specific 
residues whilst the RDC would define domain orientations, which is at the 
present time the most likely method to determine the full PDI domain 
configuration. This future work would prove an invaluable model which can be 
used to determine how the multi-domain organisation works in synergy during 
protein function. 
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Protein disulphide-isomerase (PDI) is a 
key protein folding catalyst in the 
endoplasmic reticulum and the b' domain 
of human PDI is essential for non-covalent 
binding of incompletely folded substrates. 
No high resolution crystal or NIVIR 
structure of the b' domain of human PDI 
has been determined. We have now shown 
by fluorescence and NIVIR that 
recombinant human PDI b'x (comprising 
the b' domain and the subsequent x linker 
region) can assume at least two different 
conformations in solution. We have 
resolved two conformers and shown that 
one is a monomer in which the unique Trp 
in the x region is immobilized in a 
hydrophobic environment, whereas the 
other is mainly a dimer in which the Trp is 
dynamic and exposed to the aqueous 
environment. We have screened mutants 
in the b'x region to identify mutations 
which favour one of these conformers and 
have isolated and characterised examples 
of both types. We have crystallised one 
variant ( 1272A mutation), identified as 
stabilizing the monomeric species, and 
determined its crystal structure to a 
resolution of 2.2 A. This confirms that the 
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bl domain has the typical thloredoxin fold 
and that the x region can interact with the 
bl domain to bury the unique Trp by 
dcapping' a hydrophobic site on the bl 
domain. The position and orientation of 
the x linker sequence In this structure is 
different from that In yeast Pdilp and we 
infer that the x region of PDI can adopt 
alternative conformations during the 
functional cycle of PDI action. 
The protein disulphide-isomerases 
(PDls 1) are a family of proteins initially 
defined by their ability to assist the formation 
of native disulphide bonds in secretory and 
cell-surface proteins during their biosynthesis, 
but now characterised structurally by the 
presence of one or more thioredoxin-fold (trx) 
domains, and by their location within the 
lumen of the endoplasmic reticulum. The 
human PIDI family is large (> 17 members) 
and the structures and specific roles of the 
multiple family members have not yet been 
defined (1); the best-characterised is PDI 
itself, the archetype protein folding catalyst. 
PDI from a number of mammalian species 
has been studied for many years (2) and its 
properties as a catalyst of disulphide- 
interchange and associated protein folding 
are well-understood (3-7). 
When mammalian PIDI was first cloned 
and sequenced, it was immediately 
recognised that it comprised multiple 
homologous domains (8) and subsequently 
the overall domain organization was defined 
as a-b-b'-x-a'-c, where a and a' are trx 
domains containing the active site dithiol 
sequence -WCGHC-, b and b' have the trx 
conformation but lack the active-site motif, x 
is a linker region and c is a C-terminal acidic 
tail (9-12). This domain organization was 
finally confirmed by the x-ray structural 
analysis of full-length yeast Pdilp (13-14). 
While the a and a' domains of human PDI can 
catalyse simple thiol: disulphide interchange 
reactions, the presence of the bI domain is 
essential for catalysis of protein disulphide 
isomerizations and for non-covalent ligand 
binding (15-16); the domains operate 
synergistically in linking catalytic and 
chaperone activities in protein folding (10). 
The b' domains of human PDI family 
members show greater sequence diversity 
than do the b, a and a' domains, and studies 
with hybrid and chimaeric species indicate 
that the specificities of PDls for ligands and 
partner proteins are primarily defined by their 
b' domains; this has been confirmed in 
studies on the pancreas-specific isoform PDlp 
(17), on the PDI homologue ERp57, which 
interacts specifically with the lectins calnexin 
and calreticulin (18-21), and on the newly- 
described species ERp27 (22) which 
comprises only b and b'-like domains. These 
results make it of particular interest to study - 
in molecular detail - the b' domains of PDls 
and their interactions with ligands. 
Frustratingly, the b' domain of human PDI is 
the only domain for which the structure has 
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not been solved and for several members of 
the family (e. g. PDlp, ERp27), the b' domains 
do not give good yields of well-folded soluble 
protein when expressed as recombinant 
constructs in Ecoli. 
We previously reported the expression 
and characterization of the b' and Wx domain 
fragments of human PDI (12). In this paper 
we report further characterization of the 
recombinant Wx fragment and show that it 
exists in two distinct conformations which 
differ in tertiary structure -- specifically in the 
environment of the unique Trp residue in the x 
region -- and in tendency to dimerize. In 
addition, we describe mutants of Wx which 
exclusively adopt one or other of these 
alternative conformations and we report the 
crystal structure of one of these mutants. The 
properties of the two conformers, and of the 
interconversion between them, may throw 
light on the dynamic interactions between the 
b, and x regions in full-length PDL 
Furthermore, they may explain some of the 
difficulties in characterizing the molecular 
properties of PDI and its sub-fragments and in 
understanding the ability of PDI to interact 
with folding substrates. 
EXPERIMENTAL PROCEDURES 
Mutagenesis, expression and purification. The 
plasmid containing the gene encoding the 
human PDI b'x domain fragment is a 
derivative of pET23b (Novagen). The resulting 
protein is expressed with an N-terminal His 
tag MHHHHHHM and encodes residues K213 
to P351 of mature PDL Mutagenesis, 
transformation, expression and initial 
purification were done as described 
previously (12). 
To subfractionate the Wx conformers, 
the eluate from initial purification on chelating 
Sepharose was dialysed overnight against 20 
mM phosphate buffer, pH 7.3 and applied to a 
10 ml Source30Q ion exchange column. The 
protein was eluted from the ion exchange 
column with a linear gradient from 0-250 mM 
NaCl over 100 ml. Fractions (2 ml) were 
pooled based on reducing native-PAGE and 
SDS-PAGE gels. Pools were concentrated 
using Vivaspin 20 columns with a molecular 
weight cut-off of 5000 Da. To obtain 
preparations enriched in monomeric and 
dimeric species, pools were applied to a 
Superdex 75 column equilibrated with 20 mM 
sodium phosphate, 150 mM NaCl pH 7.1. 
Purification on a micro-scale from 5- 
10ml of bacterial culture for fluorescence 
screening of mutants was done using Ni-NTA 
spin columns (Qiagen) according to the 
protocol recommended by the manufacturer. 
Spectroscopy. Fluorescence spectra were 
measured on a Photon Technology 
International fluorometer or on a Perkin/Eimer 
LS50 fluorometer. CID spectra were measured 
on a Jasco J-815 or J-715 CID spectrometer. 
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Analytical gel-filtration. Analytical gel-filtration 
was carried out on a Superdex 75 10/300 
column (GE Healthcare) in 20 mM phosphate, 
150 mM NaCl, pH 7.1. The markers used 
were horse heart cytochrome c (1.64 nm), 
bovine carbonic anhydrase (2.39 nm), bovine 
serum albumin (3.52 nm), yeast alcohol 
dehydrogenase (3.72 nm) and sweet potato 
a-amylase (4.15 nm); the values in brackets 
1 
are the Stokes radii. [-Iog(K, )]2was plotted 
against the Stokes radii of the marker proteins, 
where K,, is the partition coefficient 
determined as (V. - Vo)/(Vt - VO), where V. is 
the elution volume, Vt the total column volume 
and VO the void volume. This graph was then 
used to determine the Stokes radii. 
Analytical ultracentrifugation. Analytical 
ultracentrifugation experiments and data 
analyses were as described in Girija et al (23). 
The protein samples were dialysed overnight 
into 20 mM phosphate, 150 mM NaCl, pH 7.1. 
The partial specific volume of 0.746 cm 3/g 
(based on the amino acid composition of the 
recombinant Wx fragment) was used in the 
calculation of molecular weight from 
sedimentation velocity data. 
NMR spectroscopy. Cells were grown in 
minimal medium to allow isotopic labeling 
using Jg/I 15 N ammonium sulphate as sole 
nitrogen source and labelled protein was 
expressed and purified as above. Samples for 
NIVIR analysis were concentrated to between 
0.36mM and 1mM in 20mM phosphate buffer 
(pH 6.5) containing 150mM NaCl by 
centrifugation on Vivaspin columns with a RD 
cut-off and then D20 added to a final 
concentration of 10% (v/v). '5N/'H HSQC 
spectra were collected as described in Alanen 
et al (22). 
Crystallization. To prepare selenium-labelled 
protein, a fresh colony of Ecoli B834(DE3) 
carrying plasmid pAKL73 encoding for human 
PDI Wx 1272A was inoculated into 200 ml of 
sterile M9 minimal media with an additional 
0.5 mM L-methionine at 370C, 200 rpm for 20 
hours. The bacteria were collected by 
centifugation and washed twice with 200 ml of 
sterile water. The bacteria were then 
resuspended in M9 media with an additional 
0.5 mM of selenonium-methionine to an OD600 
of 0.3 and grown at 370C, 200 rpm to an 
OD600 of 0.7 and then induced with 1 mM of 
IPTG at 250C, 200rpm, for 12 hours. The 
bacteria were then harvested by centifugation, 
resuspended in 1/10 volume 20 mM 
phosphate pH 7.3, DNAase added to final 
concentration of 1 ltg/l and lysozyme to final 
concentration of 1 mg/ml and then frozen. The 
protein was purified as for non-labelled 
protein. 10 mg of purified Se-labeled protein 
was obtained from I litre of culture. 
Crystals of the SeMet derivative were 
obtained after one week by the hanging-drop, 
vapour diffusion equilibration method (24) 
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using 2gl of protein solution (10mg/ml) and 
2ýtl well solution (0.2 M NaCl, 2.95 M 
ammonium sulfate, 0.1 M Tris-HCI buffer pH 
9.5) at 22"C. Crystals of unlabelled protein 
were obtained by the same method at pH 7.5, 
8.5 and 9.5. Crystals were harvested from 
drops, put into paraffin oil for a few seconds 
and then frozen in liquid nitrogen. X-ray data 
were collected at cryogenic temperature (100 
K). 
Data collection, structure determination and 
refinement Multiwavelength anomalous 
dispersion (MAD) data were collected for the 
Se-Met crystal on CCD detector at beamline 
BW7A (DESY, Hamburg, Germany). The X- 
ray data from native crystals at pH7.5,8.5 and 
9.5 were collected at X12 (DESY, Hamburg, 
Germany). Images were processed using the 
XDS program package (25-26). Using the 
Auto-RickShaw protocol (27), the MAD- 
dataset resulted in the initial model that was 
completed with COOT (28). Subsequently the 
structure of the native datasets were refined 
using REFMAC5 (29) with the translation 
libration screw JLS) description of the 
anisotropic rigid body motion (30). The data 
collection statistics and refinement statistics of 
the pH 8.5 structure are given in table 1. The 
model includes 49 waters and one sulphate 
ion. 
RESULTS 
Preparations of recombinant human PD1 Wx 
contain at least two conformers. The domain 
boundaries of human PDI were defined in 
previous work (11-12); the constructs studied 
here correspond to the complete b' domain 
and subsequent x region with a short N- 
terminal tag. The b' domain of human PDI 
contains no Trp residues, but there is a single 
Trp residue located in the x region (W347). 
Despite only having a single tryptophan, 
preparations of unfractionated recombinant 
b'x gave a fluorescence emission spectrum 
with two maxima at c. 334 nm and 355 nm 
(Fig 1a). Furthermore, in HSQC spectra of 
1,5N-labelled human PDI b'x (Fig 1b) there 
were two peaks for the characteristic Trp 
indole sidechain resonance (shown boxed). 
There was, however, no indication of 
heterogeneity by mass spectrometry (data not 
shown). We have previously shown that b'x 
preparations give a CD spectrum consistent 
with substantial cc-helix and P-sheet content 
and a single denaturation transition curve with 
a midpoint of 2.32M guanicline hydrochloride 
(12), both suggesting that the preparations do 
not contain any significant proportion of 
denatured protein. These results therefore 
indicated the possibility of conformational 
heterogeneity in the b'x preparations. 
Analysis by fluoresence spectroscopy and CD 
indicated that the ratio between these 
conformers could be altered by the applied 
salt concentration and that in dilute conditions 
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at room temperature this salt-induced change 
in structure was reversible (data not shown). 
To better study the alternative 
conformers we attempted to resolve them by 
ion-exchange chromatography (Fig 2a). 
Fractions corresponding to distinct elution 
peaks were pooled and analysed. 
Electrospray MS of the pools showed that 
they each comprised a single protein species 
which had the identical mass of 17282 Da 
(expected 17283 Da); SDS-PAGE also 
indicated a single homogeneous species of 
c. 17 kDa (see also Fig 4a, below). The pools 
were stored under various conditions in 150 
mM NaCl, 20 mM phosphate buffer pH 7.3 
and then re-analysed by ion-exchange 
chromatography. As shown in Figure 2b, the 
pool of early-eluting material was converted to 
a mixture of 'early' and 'late' eluting material 
after being stored frozen and then thawed, 
whereas similar material stored at 4"C 
showed much less conversion; the pool of 
'late' eluting material was not affected 
significantly by storage (Fig 2c). 
Spectroscopic analysis of the 'early' 
and 'late' pools confirmed that they differed in 
conformation. Both forms gave CID spectra 
characteristic of globular proteins with defined 
secondary structure, although the spectra 
were clearly different in detail (Fig 3a). The 
forms also differed markedly in fluorescence 
emission spectra (not shown); the 'early' pool 
showed a single broad emission peak with a 
maximum at 332 nm, characteristic of a Trp 
residue in a hydrophobic environment, while 
the 'late' pool showed a very broad maximum 
over the range 340-350nm, the latter being 
characteristic of a Trp residue in an exposed 
aqueous environment, plus a distinct peak 
with a maximum at 304nm, indicating 
inefficient energy transfer from Tyr residues in 
the protein to the single Trp. To confirm that 
neither pool represented a denatured form of 
the protein, pools of 'early' and 'late' fractions 
were titrated with guanidine hydrochloride to 
assess their respective stabilities to 
denaturation. Both species showed some 
changes in fluorescence at low concentrations 
of denaturant (< 0.5M) followed by a plateau 
in the concentration range 0.5-1.5 M and then 
a pronounced denaturation transition over the 
concentration range 1.5-2.5M with the 
emission maximum of the denatured protein 
being 350nm for both pools; the mid-points of 
these transitions were indistinguishable (Fig 
3b). HSQC spectra of the two pools showed 
marked differences in peak resolution and 
dispersion; the 'early' pool (Fig 3c) gave a 
well resolved spectrum consistent with a 
folded protein of the expected molecular size, 
whereas the spectrum for the 'late' pool (Fig 
3d) was much broader with fewer peaks 
discernible. This type of spectrum suggests a 
protein in conformation exchange with the 
possibility of some oligomer formation. The 
spectrum of the 'late' pool contains many 
peaks of the 'early' form of the protein 
showing that the sample is not pure. The 
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peaks from the 'late' form do not appear so 
obviously in the 'early' pool sample as they 
are much broader and therefore more difficult 
to see. The indole Trp crosspeak was 
predominantly in the downfield form in the 
'early' pool sample (suggesting that this peak 
is from the indole sidechain experiencing a 
hydrophobic environment) and in the upfield 
form in the'late' pool (suggesting this peak is 
from the indole in a more aqueous 
environment). It is interesting that the 'late' 
pool peak is sharper than that in the 'early' 
sample suggesting that the Trp residue in this 
material was in a region of polypeptide that 
was tumbling faster, and that its chemical shift 
matches that expected for a random coil (31). 
Based on these results, we infer that 
the Wx fragment can exist in at least two 
alternative structured conformations. In one 
conformation (which we term the 'capped' 
form), the Trp residue in the x linker is buried 
in a hydrophobic environment sufficiently 
close to the Tyr residues of the W domain for 
efficient Forster resonance energy transfer, 
whereas in the other conformation (which we 
term the 'uncapped' form) the Trp residue is 
fully exposed to solvent, remote from the Tyr 
residues of the W domain, and showing 
dynamic behaviour indicative of being in a 
flexible region of polypeptide. Our results 
show that the 'capped' form predominates in 
early fractions from the ion-exchange column 
while the 'uncapped' form predominates in 
'late' fractions. 
The 'capped'form of PD1 Wx is a monomer in 
solution but the 'uncapped' form has a strong 
tendency to form dimers. The marked 
differences in properties of the 'early' and 
'late' fractions of wild-type PDI Wx, as seen 
by NMR (Fig 3c, d), led us to examine the 
oligomer status of the two pools. Analysis of 
ion-exchange fractions by SDS-PAGE 
showed no differences across the ion- 
exchange peaks but native polyacrylamide gel 
electrophoresis showed that later elution 
fractions showed both monomer and dimer 
bands, whereas the earlier fractions showed 
only a monomer band (Fig 4a). Analytical gel- 
filtration was carried out on 'early' and 'late' 
pools (Fig 4b) and showed clearly that both 
pools contained a mixture of two species 
differing in size, but that material of lower 
Stokes radius predominated in the 'early' pool 
and material of higher Stokes radius 
predominated in the 'late' pool. Based on 
markers, the Stokes radii for the two species 
were calculated as 2.12 nm and 2.68 nm 
respectively. The early pool sample was also 
studied by sedimentation velocity 
ultracentrifugation (not shown) and the data 
analysed using the experimental Stokes radii 
from the gel-filtration experiments. This 
confirmed the presence of two distinct species; 
a major species of mass 16.3 kDa, 
(corresponding to a monomer) and a minor 
contaminating species of mass 34.7 kDa 
(corresponding to a dimer). 
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Screening mutations that trap a single 
confonnation of PD1 Wk. Since neither the 
'early' nor 'late' pools of wild-type Wx 
represent homogenous preparations of 
'capped' or'uncapped' conformer, we decided 
to screen mutants in the Wx construct which 
might alter the conformer distribution and 
perhaps allow a single species to be 
characterised in detail. Since the fluorescence 
spectrum gave an easily-diagnosable read- 
out of the proportions of the 'capped' and 
'uncapped' forms, this was chosen for the 
screen. In total 75 mutants of Wx were 
screened, a significant proportion of which 
were generated previously (12). These 
mutants were purified on a micro-scale and 
their fluorescence spectra recorded in the 
elution buffer immediately after purification. 
Many of the mutants - like the wild type 
protein - showed a mixed fluorescence 
spectrum with peaks c. 334nm and 355nm. 
However, some mutants showed a significant 
shift in fluorescence spectrum towards a 
single 355nm peak while others showed a 
significant shift towards a single 334nm peak 
(Fig 5a, b). Since the concentrations of the 
proteins obtained from the micro-scale 
purification varied by about three-fold, the 
parameter chosen to cross-compare spectra 
was the ratio of the average fluorescence at 
331-337nm to the average fluorescence at 
352-358nm. This ratio in elution buffer was 
1.03 for the wild type protein and varied from 
0.76 to 1.29 for the mutant proteins (Fig 5c). 
Many of the mutations which resulted in a 
significant shift in the fluorescence ratio were 
either located around the substrate binding 
site as defined previously (12) or were located 
in x. 
Two red-shifted and two blue-shifted 
mutants were chosen for purification to 
homogeneity on the milligram scale. 
Fluorescence analysis of these mutant 
proteins confirmed the results obtained from 
the micro-scale purification (data not shown). 
The CID spectra were characteristic of 
globular proteins with defined secondary 
structure, although the spectra were clearly 
different in detail from each other and from 
the unfractionated wild-type protein (data not 
shown). The mutant proteins were generated 
in 15N-labelled form and HSQC spectra of the 
blue-shifted 1272A (Fig 5d) and D346A/D348A 
mutants (not shown) were very similar in 
terms of line widths and peak numbers to that 
of the 'capped' wild-type species (Fig 3c). In 
contrast, the HSQC spectra of the red-shifted 
L343A (Fig 5e) and K349A mutants (not 
shown) revealed that both purified proteins 
showed the poorly defined broad peaks 
characteristic of the 'uncapped' conformer of 
the wild-type protein. The proportion of 
6 uncapped' and 'capped' forms, as judged by 
the two crosspeaks from the Trp indole HN, 
showed that the two red-shifted mutants were 
entirely in the 'uncapped' form, whereas all 
blue-shifted mutants had substantially less of 
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the 'uncapped' form than the unfractionated 
wild-type sample (Fig 1b); the amount of 
'uncapped' form in the blue-shifted mutants 
decreased in the order D346A/D348A > 1272A 
> the triple mutant 1272A/D346A/D348A, with 
the triple mutant containing essentially none 
of this conformer (not shown). These results 
suggest that the blue-shift mutations act to 
stabilise the 'capped' form relative to the 
'uncapped' form and that the effect of the 
blue-shift mutations was additive. 
Ctystallography of mutant PD1 Wk. Despite 
numerous attempts, we have been unable to 
obtain crystals from wild4ype PDI b' or b'x, a 
situation we tentatively assigned to the mixed 
conformers present. To test this hypothesis, 
we tried to crystallize the 1272A and 
D346A/D348A mutants of human PDI Wx 
which had appeared by NIVIR to be 
predominantly in a single conformation. Both 
mutants gave crystals, but despite extensive 
optimization we were unable to improve the 
crystallization of the D346A/D348A mutant to 
obtain crystals which diffracted well. In 
contrast, we obtained crystals of the 1272A 
mutant which diffracted well using 3 different 
conditions. Excluding the high B-factor loop 
which contains E304, E305 and E306 the 
crystals obtained under the three conditions 
gave structures whose backbone traces were 
effectively super-imposable. We chose to 
refine the structure Of the pH 8.5 crystal, since 
the diffraction pattern was slightly better than 
that obtained at pH 7.5 and since it is closer 
to physiological pH than the crystal obtained 
at pH 9.5. This structure has been refined at 
2.2A resolution (table 1). There is one 
monomer per asymmetric unit. The final 
model contains 2 cis-peptide bonds (C295- 
P296 and E304-E305). Altogether seventeen 
residues were not observed in the electron 
density map, these being the three C-terminal 
residues and fourteen N-terminal residues, 
including the eight residues of the His-tag. 
Therefore the ordered part of the Wx domain 
extends from L219 to D348. 
The crystal structure of the b' domain 
of the 1272A Wx construct (Fig 6a, b) 
unsurprisingly exhibits a PDI-type trx fold 
(BaGaGaIll1a) with part of x (residues P336- 
L338) forming an additional P-strand to the 
mixed P-sheet core of the trx fold and the rest 
of x looping round to remain juxtaposed to bI 
with residues E345-D348 forming a short C- 
terminal helix. 
The b' domain of PDI binds peptides 
and non-native proteins via predominantly 
hydrophobic interactions (16,17) and hence a 
hydrophobic surface or solvent exposed 
hydrophobic pocket might be expected on W. 
Surface charge density maps (Fig 6c, d) of bI 
reveal a hydrophobic pocket on one face of 
the domain which is capped by the x region. 
Specifically, the side-chain of M339 (the first 
residue after the P-strand in the x region) 
binds in a hydrophobic pocket comprising the 
sidechains of F287, F288,1301, M307 and the 
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alkyl chain of K309. The side-chains of L343 
and W347 (further along the x region) also 
make hydrophobic interactions with the bl 
domain and interact with the side-chains of 
F223, A228, P229, F232,1284, F287, F288, 
L303, M307 in a broad site immediately 
adjacent to the binding pocket of M339. The 
residues F223,1284, F287 and F288 interact 
most closely with the side-chain of W347, and 
the site of mutation (A272) is located behind 
F223 which forms the bottom of this 
interaction pocket. The indole HN of W347 
makes polar interactions with the side-chain 
carboxyl of E225 which also forms a salt 
bridge with the guanidino group of R283 on 
the top rim of the site (Fig 6d). It is noteworthy 
that the residues M339, L343 and W347 in 
the x region, and those forming the 
hydrophobic patches on the W domain with 
which they interact, are well conserved in PIDI 
sequences of metazoan animal species. 
This hydrophobic location of the side- 
chain of W347 is consistent with the single 
peaked blue-shifted fluorescence spectrum of 
this mutant. Structure analysis by ICIVI 
(Molsoft L. L. C., La Jolla, CA) shows a 
vacancy in the structure with a size of 50 A3 
adjacent to the A272 side chain. This is 
consistent with the difference in volume 
between the side chain of the isoleucine 
found in the wild-type protein at this position 
and the alanine found in the mutant, 
suggesting that the structure obtained for the 
mutant is valid for that of the wild-type protein, 
or at least for the 'capped' conformer of it. 
This conclusion is strengthened by 
comparison of the HSQC data for the 1272A 
mutant (Fig 5e) and for the wt 'capped' 
conformer (Fig 3c) which revealed that c. 80% 
of backbone amide cross-peaks were 
unperturbed by the residue substitution. 
DISCUSSION 
A high resolution structure of the Wx region of 
human PDL The biological significance of 
mammalian PDI in the folding of disulphide- 
bonded secretory proteins has been clear for 
many years (2) and throughout that time pure 
protein has been abundantly available, either 
from mammalian tissues or recombinant 
sources (32-33). No high-resolution structure 
of a full-length PDI from a multicellular 
organism has been achieved to date, despite 
the fact that many groups have attempted to 
determine the structure of PDls by x-ray 
crystallography. This may reflect inter-domain 
flexibility or the existence of regions within the 
full-length molecule that can adopt alternative 
conformations. The structures of individual a, 
b and a' domains of human PDI have been 
determined by NMR, but it is interesting that 
no structure has been achieved by this 
approach for the b' domain or the 
combination of b' domain and adjacent x 
linker region. The difficulty in previous studies 
of the b' domain or bIx combination could 
have arisen from poor definition of the domain 
273 
boundary, but it is possible that this domain 
does show some intrinsic flexibility or 
conformational heterogeneity. 
We have now conducted NIVIR studies 
on recombinant preparations corresponding to 
the b', b'x, bb' and bblx domain 
combinations and have completed backbone 
assignments of both b'x and bbx (manuscript 
in preparation). In the current paper we have 
analysed recombinant human b'x in detail - 
using a wide range of techniques for structural 
study in solution - and identified the 
existence of at least two conformational states 
which clearly differ in the structural 
relationship between the x region (specifically 
W347) and the b' domain. Wild-type b'x 
preparations can be sub-fractionated to 
generate samples which comprise mainly a 
monomeric species in which the environment 
of W347 can be characterised by 
fluorescence and NMR as being hydrophobic 
and immobilized; other sub-fractions comprise 
mainly a dimeric species in which the W347 
residue is mobile and experiences an 
aqueous environment. Samples containing 
mainly these two alternative conformations 
are stable for periods of weeks in solution. We 
have not fully investigated the conditions 
under which they form or interconvert, but 
they are clearly both present at an early stage 
in our preparations. 
In order to overcome the complexities 
introduced by the existence of these states, 
we sought to generate mutants which might 
preferentially stabilize one state and eliminate 
the conformational heterogeneity. Using 
fluorescence screening we were able to 
identify mutants which preferentially adopted 
one or other conformation and we have 
crystallized and determined the structure of 
the 1272A mutant of b'x, which we inferred to 
be entirely in the 'capped' conformation. In 
accordance with our inference from solution 
studies on the wild4ype b'x, the x region is 
intimately associated with the bl domain in the 
crystal structure of b'x 1272A, and the indole 
side-chain of W347 is buried in a hydrophobic 
pocket. Most of the strong 'red-shift' mutants 
involve mutations in residues directly involved 
in the contact between x and b'. While many 
of the'blue-shift' mutants are also in residues 
involved in this contact, others - including 
1272A and all of the mutations previously 
identified to inhibit substrate binding (12) - 
are not contact residues and we infer that 
these act indirectly by stabilizing the 
conformer in which the hydrophobic pocket is 
'capped' by x relative to the 'uncapped' 
conformer. 
Comparison with W and x conformations in 
other PDI family structures. In Fig 7a we show 
a structure-based sequence alignment of the 
human PIDI Wx region with the corresponding 
region of yeast Pdilp, based on the structure 
of 1272A Wx solved here and on the full- 
length structure of Pdilp (13). This shows that, 
overall, the two b' domains adopt very similar 
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conformations with the exception of the region 
of Pdilp (residues 330-344 in mature Pdilp 
numbering) which forms a loop and a short 
additional helix. In human PDI b'x, this region 
comprises simply a short loop linking P5 
directly to a4. A superposition of the 
backbone atoms (N, Ccc, C) for the core P- 
strands (42 residues) of yeast and human b'x 
using the alignment in Fig 7a gave an RIVISID 
of 0.6A, this value increased to 1.5A when 
both P-strands and helices were included (102 
residues). Comparison using DALI (34) of 
human b'x to all structures in the protein 
databank other than yeast Pdilp found 
closest similarity to the trx domains in (i) the 
b' domain of PIDI from the thermophilic fungus 
Humicola insolens (2djk), (ii) Drosophila Wind 
chaperone (lonn and 2cOe), (iii) thioredoxin-2 
from Anabaena (1thx), (iv) the C73S mutant 
of human thioredoxin (lerv) (v) domain 2 of 
rabbit skeletal calsequestrin (1a8y), (vi) the b' 
domain of human bb' fragment from Erp57 
(2h8l) and (vii) the b domain of human PIDI 
(I bjx). 
However there is a major difference 
between the human and yeast PDI structures 
in the orientation of the x region, which in the 
Pdilp structure does not cap the hydrophobic 
surface of b' as is observed for human PIDI 
b1x (Fig 7b). Were human PDI bx to adopt 
such an arrangement as found in yeast Pdi 1 p, 
W347 in the x region would be solvent 
exposed and highly mobile, consistent with 
the fluorescence and NIVIR data for the 
'uncapped' conformer of the wild-type human 
b'x protein. We infer that the structure of the 
'uncapped' conformer of isolated wild-type 
human b'x has some similarities to that 
observed in the crystal structure of yeast 
Pdilp and that the identified 'red-shifting' 
mutations act by stabilising this structure in 
isolated human b'x. However, the 'uncapped' 
species of wild-type PDI b'x shows a strong 
tendency to dimerize and its NMR spectrum 
also indicates that it undergoes 
conformational exchange. We infer that in this 
state, the b' region shows some disorder and 
two b' domains interact (possibly via their 
ligand binding sites) leaving the x regions 
freely mobile and exposed to the aqueous 
medium. 
In analyzing their structure of yeast 
Pdilp, Tian et al (13) drew attention to a 
'highly hydrophobic pocket' on the surface of 
the b' domain (Fig 7b) which - together with 
hydrophobic patches at homologous positions 
on the surfaces of the a, b and a' domains - 
forms a continuous hydrophobic surface. We 
had previously proposed that the bl domain 
provided the principal binding site on PDI for 
peptides and unfolded proteins, based on 
studies on human PDI domains and domain 
combinations, (12,16). Functional studies on 
yeast Pdilp mutants by Tian et al. (13) 
confirm that this conclusion is also valid for 
the yeast enzyme. In Fig 7a, the residues 
which contribute side-chains to the 'highly 
hydrophobic pocket' identified by Tian et al. 
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(13) are highlighted and the corresponding 
residues in the structurally-aligned human 
sequence are also highlighted. Also in Fig 7a, 
we identify the residues of the b' domain of 
human Wx which form hydrophobic contacts 
with the sidechains of L343 and W347 of the 
x-linker. It is clear that the x-linker is retained 
in close contact with the bl domain by binding 
in the centre of a wider hydrophobic surface 
which corresponds to the hydrophobic pocket 
identified by Tian et al (13) in the yeast Pdi 1p 
structure and which has been identified as the 
putative ligand binding site (Fig 7b). 
Functional significance of novel structural 
interaction between W domain and x linker. 
This work has i) demonstrated that there is an 
intrinsic conformational heterogeneity in 
isolated human PD1 Wx between conformers 
which differ in the structural relationship 
between the bl domain and the x region, ii) 
determined the structure of a mutant Wx 
showing an interaction between parts of the x 
region and sites on the W domain, and iii) 
confirmed that, in this structure, x is 
interacting with a hydrophobic site 
homologous to that postulated as the ligand 
binding site in the structure of full-length yeast 
Pdi 1 p. Hence it appears that the x region can 
adopt alternative conformations and can 
potentially exchange between the 'capped' 
conformation, in which it occludes a site on 
the W domain, and an 'uncapped' 
conformation which reveals this site. It is, of 
course, conceivable that these phenomena 
are artefacts of working with isolated domain 
constructs rather than with full-length PIDI, but 
there are grounds for considering that the x 
region does cycle on and off the principal 
substrate binding site in full-length PDI and 
that this is significant as part of the function of 
the enzyme in facilitating protein folding. The 
existence of such alternative conformations 
for the x region in full-length PIDI would 
provide an explanation for why the structure 
of full-length mammalian PDI has been so 
resistant to determination by x-ray 
crystallography. It is significant that the 
structure of yeast Pdi 1p was generated from a 
slowly-developing crystal form in which one 
molecule of the protein occupies the putative 
ligand binding site of a second, symmetry- 
related molecule (13); this may have the 
effect of trapping the protein in the 'ligand- 
bound' form and inhibiting conformational 
exchange. This suggests that the yeast 
structure represents a conformation in which 
a protein ligand is bound, displacing the x- 
linker, whereas the human Wx structure 
represents an alternative ligand-free state and 
that both these conformations may be 
relevant to the functional cycle of the enzyme. 
It is well-known that in the functional cycle of 
GroEUES, the hydrophobic binding site in the 
apical domain of GroEL that binds unfolded 
protein substrates alternates between being 
available for binding such ligands and being 
occluded by interaction with part of the GroES 
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cap (35); the interconversion between such 
states involves relative re-orientations of the 
domains of the chaperonin molecule. Such re- 
orientations between domains (and especially 
of the x linker relative to its neighbouring 
domains) may be a critical feature of the 
functional cycle of PDI and the process of 
such re-orientations in preparations of full- 
length PDI may generate the conformational 
heterogeneity which has frustrated previous 
structural studies 
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FIGURE LEGENDS 
Figure 1. Spectroscopic properties of human PDI bIx 
(a) Representative relative fluorescence emission spectra, excitation at 280nm and 
(b) 15N/'H HSQC NIVIR spectra for unfractionated purified wt protein. The dashed 
box in (b) surrounds the two Trp indole cross-peaks. 
Figure 2. Resolution of conformers of Wx by ion-exchanqe chromato-qraphv. 
(a) Samples purified by [MAC were further resolved by ion-exchange 
chromatography as described in Methods; the solid line represents absorbance at 
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280 nm and the dotted line shows the conductivity. Fractions were pooled as 
indicated by the horizontal bars. (b and c) Re-chromatography of stored fractions; 
each pool was split in two and stored for a week; half was stored in the refrigerator 
(solid line) and half in freezer (dashed line). (b) Re-chromatography of pool 1 after 
storage, (c) Re-chromatography of pool 2 after storage. 
Figure 3. Characterization of subfractionated bIx pool samples. 
(a) CD spectra of 'early' (solid line) and 'late' (dashed line) pooled samples. Data 
are from an average of 8 scans with 1OpM protein in 20mM sodium phosphate 
buffer, pH 7.3. (b) Denaturation of Wx by guanidine hydrochloride (GdmCI). 'Early' 
pool Wx is shown by the closed circles, 'late' pool Wx by the open circles. 
Fluorescence measurements were collected from 2ptM protein in 20mM sodium 
phosphate buffer containing 150mM NaCl, pH 7.1. Samples were excited at 280nm 
and the data shown are a ratio of the average fluorescence between 330-334nm 
and 348-352nm (the \,,, values for the fluorescence peaks of the 'early' pool in OM 
and 3.5M GdmCl respectively). (c) 15N/1H HSQC NIVIR spectra for the 'early' pool 
and (d) the 'late' pool of Wx. 
Figure 4. Size analysis of Wx samples from ion-exchange chromatography. 
(a) Ion exchange chromatograrn (solid line, UV absorbance; dotted line, 
conductivity). The upper insert panel shows reducing SDS-PAGE analysis of 
fractions across the major peak as indicated by the horizontal bar, the lower insert 
panel shows native-PAGE analysis of the same column fractions. (b) Analytical gel- 
filtration of Wx pools from ion-exchange chromatography. The dashed line shows 
pool 1 material (fractions I to 4) and the solid line shows pool 2 material (fractions 
6-10). 
Figure 5. Screening of Wx mutants to identify mutations stabilisin-q-a single 
conformer 
Representative relative fluorescence emission spectra, excitation at 280nm, of 
micro-scale preparations of (a) 1272A and (b) L343A mutants of human PDI bIx. (c) 
Shifts in fluorescence ratios (331-337nm/352-358nm) for all 75 mutants of human 
PDI b'x relative to the wild type protein (wild type fluorescence ratio = 1.03). The 
data shows the mean from at least 2 independent measurements. (d) 15NPH HSQC 
NIVIR spectra of 1272A and (e) L343A mutants. 
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Figure 6. Crystal structure of bIx 1272A 
(a) Ribbon diagram showing the trx fold of Wx with the x region coloured in *green. 
(b) Surface charge density for the W domain in the same orientation as (a) with the 
x region shown in ribbon format. Blue = positive charge; red = negative charge; 
white = neutral charge. (c) Ribbon diagram with the x region in the front of the 
molecule. The side-chains of M339 (magenta), L343 (green) and W347 (green) are 
shown as sticks. (d) Surface charge density map for the W domain in the same 
orientation as (c). This figure was produced using MOLMOL (36). 
Figure 7. Structural comparison of human and yeast Wx domains 
(a) Structure-based alignment of the human and yeast Wx sequences. A cyan 
background denotes residues identified as part of the hydrophobic binding site in 
the yeast structure (13) and the corresponding residues in the human protein. Two 
further residues (17287 and M307) appear to contribute to the human hydrophobic 
site (shown underlined in red) whereas two residues (N281 and R299) appear to fall 
outside the site (shown underlined in black). Residues in the human sequence 
coloured red comprise the binding site for W347 and L343 as judged from the bIx 
structure (at least one side-chain to side-chain atom distance within 5A). The x 
region for both sequences is shown on a grey background with the hydrophobic 
residues in x important for interaction with b' shown in green and magenta. The 
residue numbering is for the mature protein in both cases and the secondary 
structure assignments (as defined in the pdb header for yeast (2b5e) and using the 
Kabsch and Sander algorithm as implemented in MOLMOL (36) for human) are 
shown above or below the sequence as appropriate. (b and c) Surface 
representation of the hydrophobic binding sites as defined in the sequence 
alignment above (those residues highlighted in cyan and underlined in red) for yeast 
and human Wx respectively. The side-chains of the hydrophobic sites are shown in 
white whilst the backbone and all other W residues are coloured blue. The x regions 
are shown in ribbon format and the side-chains of L343 and W347 in the human 
structure are shown in green and M339 in magenta. The two views are in the same 
orientation (achieved by superposition of the core P-sheet) corresponding to that in 
Fig 6c and 6d. This figure was generated using MOLMOL (36). 
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Table 1. Statistics for the model of the crystal structure of the non-labelled human 
PDI bIx domain 1272A mutant grown at pH 8.5. The values in parentheses are for 
the highest resolution shell. 
Data collection statistics 
Space group P3(1)21 
Unit cell parameters. 
a, b, c (A) 57.37,57.37,68.31 
Temperature (K) 100 
Wavelength (A) 0.89997 
Resolution (A) 50-2.2 
Rmerge (Yo) 5.5(29.3) 
Completeness (016) 99.3(99.6) 
1161 17.84(5.0) 
Unique reflections 6879(849) 
Redundancy 4.3(4.4) 
Mosaicity (9 0.17 
B-factor from Wilson plot (A) 41 
Refinement statistics 
Resolution (A) 50-2.2 
Total number of reflections 6877 
Working set: number of reflections 6533 
Rf,, to, (%) 19.4 
Test set: number of reflections 344 
Rfr,,,, (%) 25.5 
Protein atoms (A, B, C, D) 1063 
Water atoms 49 
S04 2- atoms 5 
Geometry statistics 
Rmsd (bond distance) (A) 0.012 
Rmsd (bond angle) (0) 1.4 
Rmsd B 
Main chain bonded atoms (A) 0.8 
Side chain bonded atoms (A 2) 1.8 
Main chain angle (9) 1.3 
Side chain angle (A) 2.8 
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Average B 
Main chain atoms (A) 36.4 
Side chain atoms (A) 37.7 
Water molecules (9) 39.5 
Sulfate atoms (A 
2) 80.7 
Ramachandran plot 
Most favored region 94 
Additionally allowed regions 6 
Generously allowed regions 0 
Disallowed regions (%) 0 
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APPENDIX 2- CHEMICAL SHIFT DATA FOR BB'X AT 
250C. 
The chemical shift data (in ppm) is presented below for amide nitrogen (15 N), 
amide proton (11-1) and the Ca and Cp (13C), un-assigned shifts highlighted 
with - and unapplicable shifts with N/A. 
Residue construct Mature PIDI 'HN 15N 
13 Ca 13cp 
Number number 
Ala 1 119 8.4 123.9 55.8 20 
Ala 2 120 7.5 117.8 50.9 20.9 
Thr 3 121 8.6 119.1 70.5 62 
Thr 4 122 8.7 124.9 68.6 64 
Leu 5 123 8.9 126.4 49.8 41.6 
Pro 6 124 - - - - 
Asp 7 125 7.1 112 52.4 42.1 
Gly 8 126 9 106.5 47.2 N/A 
Ala 9 127 8 125.1 47.3 17.4 
Ala 10 128 8.2 121.7 50.7 18.2 
Ala 11 129 7.6 120.5 53.8 18.5 
Glu 12 130 8.4 117 55.3 30.1 
Ser 13 131 7.9 112.7 61.2 62.8 
Leu 14 132 7.4 122.9 58.4 41.4 
Val 15 133 7.9 119.3 58.6 31.5 
Glu 16 134 8.1 115 57.9 29.4 
Ser 17 135 7.5 112.5 64 57.6 
Ser 18 136 7 115.5 57.2 65.2 
Glu 19 137 8.6 124.4 59.7 30.4 
Val 20 138 7.3 113.5 60.6 35.8 
Ala 21 139 9.1 126.9 51.5 22.8 
Val 22 140 7.9 120.1 60.5 34.3 
Ile 23 141 9 124.4 60.5 34.3 
Gly 24 142 8.6 115.7 44.5 N/A 
Phe 25 143 8.4 127.9 43.1 36.5 
Phe 26 144 8.1 116.9 55.6 43.1 
Lys 27 145 9.4 124.6 55.6 31.7 
Asp 28 146 8.8 117.1 51.8 31.6 
Val 29 147 8.5 121.1 63.8 30.4 
Glu 30 148 8.2 117.1 55.2 29.3 
Ser 31 149 7.5 115.9 58.1 65.3 
Asp 32 150 8.8 121.3 58.2 40.1 
Ser 33 151 8.4 113.9 57.9 62.5 
Ala 34 152 6.9 125.3 54.5 18.6 
Lys 35 153 8 115.9 60.1 31.8 
Gln 36 154 7.8 118.9 56.3 28.5 
Phe 37 155 7.7 119.9 57.4 39.2 
Leu 38 156 - - Gln 39 157 7.6 117.7 58.6 28.5 
Ala 40 158 7.6 123.6 55.2 17.2 
Ala 41 159 7.2 118 53.1 17.6 
Glu 42 160 6.9 112.7 57.4 30.1 
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Ala 43 161 7.2 119.7 52.7 20.3 
Ile 44 162 7 118.9 59.8 39.4 
Asp 45 163 8.3 122.9 54.5 42.2 
Asp 46 164 8.5 115.7 54.7 40.3 
Ile 47 165 7.1 118.9 57.6 42 
Pro 48 166 - - - - 
Phe 49 167 8.6 120.2 42.1 32.5 
Gly 50 168 9.4 109.4 43.4 N/A 
Ile 51 169 8.9 120.7 58.4 43.2 
Thr 52 170 8.6 121.2 72.2 60.2 
Ser 53 171 8.6 119.8 56.4 66 
Asn 54 172 - - - - 
Ser 55 173 - - - - 
Asp 56 174 8.6 122.6 57.4 40.1 
Val 57 175 8 122.2 56.8 30.8 
Phe 58 176 - - - - 
Ser 59 177 8 112 61.4 62.7 
Lys 60 178 7.6 124 58.8 32.6 
Tyr 61 179 7 113.7 57.9 37.8 
Gin 62 180 7.8 113.5 57.3 30 
Leu 63 181 8 120.4 54.2 40.4 
Asp 64 182 8.5 120.3 53.2 41.8 
Lys 65 183 7.7 117.2 54.2 34.1 
Asp 66 184 7.7 116.9 54.4 41.4 
Gly 67 185 8.6 107.2 45.6 N/A 
Val 68 186 8.4 117.8 61.1 35.3 
Val 69 187 8.9 126.8 61.3 35.9 
Leu 70 188 8.6 127.3 54.3 32 
Phe 71 189 9.5 126.5 56.9 42.3 
Lys 72 190 8.4 116 53.5 34.6 
Lys 73 191 7.9 121.3 56 32 
Phe 74 192 6.6 113.4 54.4 40.4 
Asp 75 193 8.8 117.6 56.2 40.4 
Glu 76 194 10.1 123.6 58.3 28.7 
Gly 77 195 7.7 108.9 46 N/A 
Arg 78 196 7.2 121 54.9 32.6 
Asn 79 197 9.2 121.6 53.5 43.8 
Asn 80 198 9 123.2 52.3 43.9 
Phe 81 199 8.3 124.8 58.9 39.1 
Glu 82 200 7.3 128.5 54.9 32 
Gly 83 201 6.9 108.4 43.4 N/A 
Glu 84 202 8.3 120.5 55.7 30 
Val 85 203 9 126.4 64.2 30 
Thr 86 204 7.2 117.7 58 72.8 
Lys 87 205 9.3 124.1 60.7 32.2 
Glu 88 206 9 116.6 60.9 28.7 
Asn 89 207 7.9 118.1 55.3 37.5 
Leu 90 208 8.5 121.5 58.2 42.2 
Leu 91 209 8.4 120 58.9 40.7 
Asp 92 210 7.6 118.7 57.4 41.2 
Phe 93 211 7.9 120.8 60.3 39.6 
IleN 94 212 8.7 121.2 65.4 38.1 
Lys 95 213 8.2 117.9 59.3 31.9 
His 96 214 7.8 113.9 58.4 28.9 
Asn 97 215 7.3 114.2 54.5 41 
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GIn 98 216 7.6 115 57.5 28.7 
Leu 99 217 7.4 119.5 51.9 42.1 
Pro 100 218 - - - - Leu 101 219 9.3 123.1 58 42.6 
Val 102 220 7.6 109.9 59.5 34.7 
Ile 103 221 8.6 124.6 60.4 41.4 
Glu 104 222 8.3 127.8 54.6 29.9 
Phe 105 223 8.6 129 59.2 40.2 
Thr 106 224 - - - - 
Glu 107 225 8.9 120.2 59.2 29.1 
Gln 108 226 7.9 114.6 58.1 28.8 
Thr 109 227 7.4 108.8 61.9 69.5 
Ala 110 228 7.6 125.5 56.7 16.1 
Pro ill 229 - - - - 
Lys 112 230 7.2 115.5 56.7 32.3 
Ile 113 231 7.6 118.9 60.9 38.7 
Phe 114 232 7.9 115.4 59.3 38.4 
Gly 115 233 7.6 106.7 45.2 N/A 
Gly 116 234 7.3 108 44.6 N/A 
Glu 117 235 8.4 117.5 57.9 30.6 
Ile 118 236 7.8 119.6 62.1 37.5 
Lys 119 237 8.5 125.4 55.5 33.2 
Thr 120 238 6.8 115.9 62.3 70 
His 121 239 8.8 125.7 53.6 35.2 
Ile 122 240 9.2 122.6 58.8 35.4 
Leu 123 241 9 128.6 53.8 43.7 
Leu 124 242 8.6 123.3 52.9 41.8 
Phe 125 243 9.1 127.5 56.9 39.9 
Leu 126 244 8.9 126.8 50.8 44.5 
Pro 127 245 - - - - 
Lys 128 246 8.2 123.7 58.9 32.4 
Ser 129 247 7.6 108.2 58.5 63.9 
Val 130 248 7.4 122.2 62.1 32.8 
Ser 131 249 8.3 120.2 59.7 63 
Asp 132 250 8.9 122.2 54.1 39.1 
Tyr 133 251 7.6 120.5 63 39.5 
Asp 134 252 8.6 115.3 57.4 40.4 
Gly 135 253 7.8 110.1 46.7 N/A 
Lys 136 254 8 123.1 59.9 33.3 
Leu 137 255 8 120 57.6 40.7 
Ser 138 256 8.3 114.6 57.4 62.3 
Asn 139 257 8 121.7 56.7 38.8 
Phe 140 258 7.7 121.7 61.4 40.6 
Lys 141 259 8.4 117.6 61.4 32.6 
Thr 142 260 8.2 116 59.6 66.8 
Ala 143 261 7.5 123.7 54 18.8 
Ala 144 262 7.3 119.6 53.7 19.7 
Glu 145 263 7 114.4 58.9 30.1 
Ser 146 264 7.4 111.9 60.7 63.6 
Phe 147 265 7.2 115.8 57.5 41.3 
Lys 148 266 7.2 123.8 58.6 31.9 
Gly 149 267 9.6 115.3 45.4 N/A 
Lys 150 268 8.3 118.7 57.1 35.6 
Ile 151 269 7.8 116.6 60.5 43.2 
Leu 152 270 8.3 129.6 54.7 43.3 
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Phe 153 271 9.2 129.8 56.6 39.2 
Ile 154 272 9.1 123.9 59 42.1 
Phe 155 273 8.9 123.1 54.6 42.4 
Ile 156 274 8.7 122 59.9 42.9 
Asp 157 275 8.4 123.9 60.6 40.1 
Ser 158 276 7.5 124 60.3 64.9 
Asp 159 277 8.4 119.6 55.7 45 
His 160 278 7.2 121.3 58.4 31.5 
Thr 161 279 8 121.8 62 68.9 
Asp 162 280 10.7 124.3 56.7 40.1 
Asn 163 281 7.9 115 52.7 38.4 
Gln 164 282 7.6 121 59.3 28.1 
Arg 165 283 8.4 117.9 59.4 29.1 
Ile 166 284 7.7 119.6 61 40.7 
Leu 167 285 8.3 119.3 57.5 40.5 
Glu 168 286 7.2 119.1 59.2 29.8 
Phe 169 287 8.1 121.8 60.7 39 
Phe 170 288 7.5 113 59.6 39.8 
Gly 171 289 8 110.7 46.7 N/A 
Leu 172 290 7.7 121 54 45.9 
Lys 173 291 8.1 119.1 53.9 34.3 
Lys 174 292 9 124 53.9 32.1 
Glu 175 293 9.4 116.6 58.7 28.1 
Glu 176 294 7.6 118.1 55.8 30.5 
Cys 177 295 7 117.6 58.3 27.3 
Pro 178 296 - - - - 
Ala 179 297 8.4 123.1 51.4 23.4 
Val 180 298 8.6 118.1 59.2 35.4 
Arg 181 299 8.9 123.1 53.2 35.5 
Leu 182 300 8.7 125.1 52.8 47.4 
Ile 183 301 9.5 121.8 58.6 42.7 
Thr 184 302 8.7 114 59.2 70.8 
Leu 185 303 8.6 125.2 54.4 42.6 
Glu 186 304 7.5 123.3 56.3 29.9 
Glu 187 305 8.5 122.2 59.3 29.3 
Glu 188 306 7.9 116.3 59.3 29.1 
Met 189 307 8.8 123.8 56 33.8 
Thr 190 308 8.4 121.7 67.5 62.3 
Lys 191 309 8.6 123.4 55 36.3 
Tyr 192 310 9.5 119.6 
Lys 193 311 9.2 122.4 52.6 34.8 
Pro 194 312 - - - - Glu 195 313 8.9 119.5 57.5 31.5 
Ser 196 314 7.5 111.7 56.4 65.4 
Glu 197 315 8.7 122.9 65.4 29.3 
Glu 198 316 8.2 121.2 57.4 31.2 
Leu 199 317 8.6 125.4 53.1 41.3 
Thr 200 318 6.8 108.3 59.5 70.5 
Ala 201 319 9.2 125.3 56.1 18.1 
Glu 202 320 9.3 118.2 60.3 29 
Arg 203 321 7.6 119.5 58 30.1 
Ile 204 322 8.5 121.8 65.4 30 
Thr 205 323 8.6 116.9 68.2 60.5 
Glu 206 324 8 121.7 59.8 30.5 
Phe 207 325 7.9 119.9 59.3 38.7 
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Cys 208 326 7.7 115.9 29.9 27.7 
His 209 327 8.6 118 60.1 30.2 
Arg 210 328 8.7 118.9 59.9 30.2 
Phe 211 329 8.3 120.6 60.2 37.3 
Leu 212 330 8.2 123.6 57.4 41.5 
Glu 213 331 7.7 116.3 56.3 30.6 
Gly 214 332 7.7 108.5 46.5 N/A 
Lys 215 333 8 116.6 56.1 33.8 
lie 216 334 7.8 118.5 59.1 38.5 
Lys 217 335 8.6 128 54.5 32.4 
Pro 218 336 - - - - 
His 219 337 8.4 120.4 57.3 29.9 
Leu 220 338 7.8 118.7 53.3 41.1 
Met 221 339 7.7 120.4 55.8 33 
Ser 222 340 8.1 116.3 58.4 63.4 
Gln 223 341 8.2 121.4 55.6 30.4 
Glu 224 342 7.9 120.6 57.9 30.7 
Leu 225 343 8 125.1 55.1 42.8 
Pro 226 344 - - - - 
Glu 227 345 8.3 121.3 58 29.9 
Asp 228 346 8.2 119.2 54.1 40.4 
Trp 229 347 7.8 120.6 53.8 29.1 
Asp 230 348 8 120.8 53.6 39.8 
Lys 231 349 7.5 120.3 55.8 40.6 
Gln 232 350 8.1 122.9 53.4 28.8 
Pro 233 351 - - - - 
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APPENDIX 3- CHEMICAL SHIFT DATA FOR BX AT 
250C. 
The chemical shift data (in ppm) is presented below for amide nitrogen (15 N), 
amide proton (11-1) and the Ca and Cp (13C), un-assigned shifts highlighted 
with - and unapplicable shifts with N/A. 
Residue construct Mature PDI 'HN 15N 13ca 13cp 
Number number 
Lys 1 213 6.9 112.2 53.5 38.8 
His 2 214 8.3 120.1 55.9 29.4 
Asn 3 215 7.6 116.9 53.2 41.8 
Gin 4 216 7.9 120.5 55.8 33.2 
Leu 5 217 8.5 124.0 53.1 28.8 
Pro 6 218 - - - - 
Leu 7 219 8.2 120.5 42.9 32.2 
Val 8 220 7.4 111.6 59.9 33.9 
lie 9 221 8.7 125.4 59.8 41.7 
Glu 10 222 8.4 127.6 54.7 29.9 
Phe 11 223 8.7 129.4 59.3 40.7 
Thr 12 224 7.1 118.2 59.1 73.2 
Glu 13 225 9.1 120.6 59.6 29.1 
Gin 14 226 7.9 114.5 58.3 28.8 
Thr 15 227 7.5 109.0 61.8 69.6 
Ala 16 228 7.6 125.4 56.8 15.9 
Pro 17 229 - - - - 
Lys 18 230 7.2 115.5 57.6 32.3 
Ile 19 231 7.6 119.5 64.3 38.5 
Phe 20 232 7.9 115.2 59.7 38.4 
Gly 21 233 7.7 106.8 45.3 N/A 
Gly 22 234 7.4 107.8 44.8 N/A 
Glu 23 235 8.5 117.3 58.2 30.6 
Ile 24 236 7.8 119.6 61.8 37.8 
Lys 25 237 8.6 125.5 55.4 33.0 
Thr 26 238 6.8 116.0 62.1 69.8 
His 27 239 8.9 125.9 54.1 - 
lie 28 240 9.3 122.5 58.9 40.2 
Leu 29 241 9.1 129.0 53.6 43.4 
Leu 30 242 8.7 123.3 53.0 41.5 
Phe 31 243 9.2 128.1 57.0 39.0 
Leu 32 244 9.1 127.2 50.8 44.4 
Pro 33 245 - - - - 
Lys 34 246 8.3 124.1 58.9 32.2 
Ser 35 247 7.6 108.2 58.4 63.7 
Val 36 248 7.5 123.0 62.2 32.5 
Ser 37 249 8.5 120.9 59.5 62.8 
Asp 38 250 9.1 122.9 54.2 39.4 
Tyr 39 251 7.6 120.2 63.1 39.4 
Asp 40 252 8.7 115.0 57.4 40.6 
Gly 41 253 7.8 110.2 47.1 N/A 
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Lys 42 254 8.0 123.3 60.0 33.2 
Leu 43 255 8.2 119.8 57.5 40.4 
Ser 44 256 8.4 114.7 57.6 62.6 
Asn 45 257 8.0 121.9 56.3 38.7 
Phe 46 258 7.7 122.0 56.4 40.4 
Lys 47 259 8.5 117.2 59.8 32.5 
Thr 48 260 8.3 116.6 66.5 68.7 
Ala 49 261 7.7 124.6 55.0 18.7 
Ala 50 262 7.3 119.1 53.9 19.9 
Glu 51 263 7.0 113.8 58.8 30.0 
Ser 52 264 7.5 112.0 60.8 63.5 
Phe 53 265 7.2 115.9 57.1 41.3 
Lys 54 266 7.4 123.4 58.9 31.8 
Gly 55 267 9.6 115.1 45.6 N/A 
Lys 56 268 8.4 118.9 57.3 35.7 
Ile 57 269 7.9 116.4 60.4 43.3 
Leu 58 270 8.4 130.6 54.6 43.1 
Phe 59 271 9.3 130.4 56.5 39.1 
Ile 60 272 9.1 123.7 59.0 42.2 
Phe 61 273 8.9 122.2 54.7 42.5 
Ile 62 274 8.8 121.1 59.9 42.8 
Asp 63 275 8.5 123.5 60.0 52.6 
Ser 64 276 7.5 123.9 60.5 64.7 
Asp 65 277 8.3 119.0 55.7 41.5 
His 66 278 7.3 121.5 58.4 31.9 
Thr 67 279 8.9 127.6 65.8 69.0 
Asp 68 280 11.2 125.2 56.8 39.9 
Asn 69 281 8.0 115.3 52.7 38.6 
Gln 70 282 7.6 120.2 59.5 28.5 
Arg 71 283 7.7 118.2 55.9 30.4 
Ile 72 284 8.1 120.9 64.2 37.2 
Leu 73 285 7.5 122.4 60.6 41.2 
Glu 74 286 8.0 117.4 59.3 29.4 
Phe 75 287 8.4 122.4 58.3 29.5 
Phe 76 288 7.6 112.8 60.0 39.6 
Gly 77 289 8.0 110.9 46.7 N/A 
Leu 78 290 7.8 121.2 53.5 46.0 
Lys 79 291 8.2 119.2 53.0 34.3 
Lys 80 292 9.1 124.5 61.1 32.3 
Glu 81 293 9.5 116.5 58.7 28.2 
Glu 82 294 7.7 117.8 53.2 30.7 
Cys 83 295 7.1 117.8 58.4 27.6 
Pro 84 296 - - - - 
Ala 85 297 8.4 123.2 51.7 23.4 
Val 86 298 8.7 118.2 59.4 35.3 
Arg 87 299 9.0 123.3 53.1 35.5 
Leu 88 300 8.8 125.7 54.4 47.0 
Ile 89 301 9.7 122.1 58.3 42.9 
Thr 90 302 8.9 113.7 59.0 71.0 
Leu 91 303 8.7 124.8 54.5 42.5 
Glu 92 304 7.6 123.5 56.5 29.8 
Glu 93 305 8.6 122.6 59.4 29.1 
Glu 94 306 8.0 116.1 54.7 31.6 
Met 95 307 9.1 125.2 56.5 34.2 
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Thr 96 308 8.4 121.3 62.1 70.8 
Lys 97 309 8.8 123.6 54.4 36.3 
Tyr 98 310 9.6 120.0 57.6 41.4 
Lys 99 311 9.3 122.6 52.7 34.9 
Pro 100 312 - - - - Glu 101 313 9.1 119.5 57.6 30.4 
Ser 102 314 7.6 112.1 56.5 65.4 
Glu 103 315 8.8 122.6 56.2 29.3 
Glu 104 316 8.0 120.8 57.8 31.2 
Leu 105 317 8.7 125.2 53.1 41.3 
Thr 106 318 6.8 107.9 59.5 70.5 
Ala 107 319 9.4 125.6 55.9 17.8 
Glu 108 320 9.4 118.4 60.4 29.2 
Arg 109 321 7.7 119.9 57.9 29.8 
lie 110 322 8.6 122.1 65.4 38.3 
Thr ill 323 8.6 117.0 67.7 68.8 
Glu 112 324 8.1 121.7 60.0 30.5 
Phe 113 325 8.0 119.9 59.5 38.8 
Cys 114 326 7.7 116.0 64.3 27.7 
His 115 327 8.6 118.1 60.5 30.2 
Arg 116 328 8.8 119.3 60.1 30.4 
Phe 117 329 8.4 121.1 59.5 37.8 
Leu 118 330 8.2 124.8 57.5 41.4 
Glu 119 331 7.7 116.5 56.1 30.6 
Gly 120 332 7.8 108.6 46.5 N/A' 
Lys 121 333 8.0 116.6 56.3 33.8 
Ile 122 334 8.0 119.4 58.7 38.2 
Lys 123 335 8.9 129.3 54.7 32.7 
Pro 124 336 - - - - 
His 125 337 8.5 120.2 55.2 31.4 
Leu 126 338 8.4 126.0 55.5 42.2 
Met 127 339 8.3 120.8 56.4 32.6 
Ser 128 340 8.3 116.5 63.3 58.4 
GIn 129 341 8.0 120.3 55.2 31.1 
Glu 130 342 8.3 120.9 55.5 29.7 
Leu 131 343 8.3 125.0 53.0 41.7 
Pro 132 344 - - - - Glu 133 345 8.6 120.7 57.2 30.1 
Asp 134 346 8.3 119.2 54.1 40.4 
Trp 135 347 7.8 120.8 58.0 29.2 
Asp 136 348 8.1 120.7 53.9 40.2 
Lys 137 349 7.6 120.6 56.1 33.0 
GIn 138 350 8.2 123.3 53.5 28.9 
Pro 139 351 - - - - Val 140 352 8.4 122.2 63.4 33.0 
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APPENDIX 4- H/D EXCHANGE EXPERIMENTAL 
DATA 
b domain residues after 5 minutes in H/D exchange experiment. 
residue construct Mature PDI 
Number number 
Thr 3 121 
Leu 5 123 
Asp 7 125 
Ala 10 128 
Ala 11 129 
Glu 12 130 
Ser 13 131 
Glu 16 134 
Ala 21 139 
Val 22 140 
Ile 23 141 
Gly 24 142 
Phe 25 143 
Phe 26 144 
Lys 27 145 
Glu 30 148 
Ser 31 149 
Ala 34 152 
Lys 35 153 
Gin 36 154 
Phe 37 155 
Leu 38 156 
Gin 39 157 
Ala 40 158 
Ala 41 159 
Glu 42 160 
Ala 43 161 
Ile 44 162 
Ile 47 165 
Phe 49 167 
Gly 50 168 
Ile 51 169 
Thr 52 170 
Asp 56 174 
Phe 58 176 
Lys 60 178 
Tyr 61 179 
Gin 62 180 
Leu 63 181 
Gly 67 185 Val 68 186 
Val 69 187 Leu 70 188 
Phe 71 189 
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Glu 82 200 
Thr 86 204 
Asn 89 207 
Leu 91 209 
Asp 92 210 
Phe 93 211 
Lys 95 213 
Asn 97 215 
b domain residues after 21 hours in H/D exchange experiment. 
residue construct Mature PDI 
Number number 
Leu 5 123 
lie 23 141 
Gly 24 142 
Phe 25 143 
Phe 26 144 
Lys 35 153 
Phe 37 155 
Leu 38 156 
Gln 39 157 
Ala 40 158 
Ala 41 159 
Glu 42 160 
Gly 50 168 
Ile 51 169 
Thr 52 170 
Phe 58 176 
Gly 67 185 
Val 68 186 
Leu 70 188 
Phe 71 189 
Asn 89 207 
Leu 91 209 
bb'x domain residues after 5 minutes in H/D exchange experiment. 
residue construct Mature PDI 
Number number 
Leu 5 123 
Asp 7 125 
Glu 12 130 
Ser 13 131 
Leu 14 132 
Val 15 133 
Glu 16 134 
Ser 17 135 
Glu 19 137 
Val 20 138 
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Ala 21 139 
Ile 23 141 
Gly 24 142 
Phe 25 143 
Phe 26 144 
Glu 30 148 
Ser 31 149 
Ala 34 152 
Lys 35 153 
Gin 36 154 
Gin 39 157 
Ala 41 159 
Glu 42 160 
Ile 44 162 
Phe 49 167 
Gly 50 168 
Ile 51 169 
Thr 52 170 
Asn 54 172 
Lys 60 178 
Tyr 61 179 
Gin 62 180 
Gly 67 185 
Val 68 186 
Val 69 187 
Phe 71 189 
Lys 72 190 
Phe 81 199 
Glu 82 200 
Thr 86 204 
Leu 90 208 
Leu 91 209 
Asp 92 210 
Phe 93 211 
IleN 94 212 
Lys 95 213 
Val 102 220 
Phe 105 223 
Lys 112 230 
Ile 113 231 
Ile 122 240 
Leu 123 241 
Leu 124 242 
Phe 125 243 
Leu 126 244 
Lys 128 246 
Phe 140 258 
Thr 142 260 
Ala 143 261 
Ala 144 262 
Phe 147 265 
Ile 151 269 
Leu 152 270 
Ile 154 272 
Phe 155 273 
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lie 156 274 
Ser 158 276 
Thr 161 279 
Ile 166 284 
Leu 167 285 
Leu 172 290 
Glu 176 294 
Cys 177 295 
Ala 179 297 
Val 180 298 
Arg 181 299 
lie 183 301 
Glu 197 315 
Thr 200 318 
lie 204 322 
Thr 205 323 
Phe 207 325 
Cys 208 326 
Arg 210 328 
Glu 213 331 
Lys 215 333 
Glu 227 345 
Asp 228 346 
Trp 229 347 
Asp 230 348 
Lys 231 349 
bb'x domain residues after 21 hours in H/D exchange experiment. 
residue construct Mature PDI 
Number number 
Leu 5 123 
Val 15 133 
Ala 21 139 
Ile 23 141 
Gly 24 142 
Phe 25 143 
Phe 26 144 
Gln 39 157 
Ala 43 161 
Gly 50 168 
Ile 51 169 
Thr 52 170 
Lys 60 178 
Gly 67 185 
Phe 71 189 
Glu 82 200 
Leu 91 209 
HeN 94 212 
Ile 122 240 
Leu 123 241 
Leu 124 242 
Phe 125 243 
Leu 126 244 
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Ala 143 261 
Ala 144 262 
Ile 151 269 
Ile 154 272 
Phe 155 273 
Ile 156 274 
Ile 166 284 
Leu 167 285 
Arg 181 299 
Phe 207 325 
Lys 217 335 
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APPENDIX 5- NUCLEOTIDE AND PROTEIN 
SEQUENCES 
b domain: 
ATGCATCACCATCACCACCATNTGGNTGCCACCACCCTGCCTGACGGC 
GCAGCTGCAGAGTCCTTGGTGGAGTCCAGCGAGGTGGCTGTCATCGG 
CTTCTTCAAGGACGTGGAGTCGGACTCTGCCAAGCAGTTTTTGCAGGC 
AGCAGAGGCCATCGATGACATACCATTTGGGATCACTTCCAACAGTGAC 
GTGTTCTCCAAATACCAGCTCGACAAAGATGGGGTTGTCCTCTTTAAGA 
AGTTTGATGAAGGNCGGAACAACTTTGAAGGGGAGGTCACCAAGGAGA 
ACCTGNTGGACTTTATCAAACACAACCAGCTGCCCCTTGTCATCGAGTT 
CACCGAGCAGACAGCC 
MHHHHHH MAATTLPDGAAAESLVESSEVAVI GFFKD 
VESDSAKQ FLQAAEAI DDI PFG ITS NSDVFS KYQ LDK 
DGVVLFKKFDEG RN N FEGEVTKENLLDF I KH NQ LPL 
VIEFTEQTA 
b'x: 
ATGCATCACCATCACCACCATATGAAACACAACCAGCTGCCCCTTGTCA 
TTGAGTTCACCGAGCAGACAGCCCCGAAGATTTTTGGAGGTGAAATCAA 
GACTCACATCCTGCTGTTCTTGCCCAAGAGTGTGTCTGACTATGACGGC 
AAACTGAGCAACTTCAAAACAGCAGCCGAGAGCTTCAAGGGCAAGATC 
CTGTTCATCTTCATCGACAGCGACCACACCGACAACCAGCGCATCCTC 
GAGTTCTTTGGCCTGAAGAAGGAAGAGTGCCCGGCCGTGCGCCTCATC 
ACCCTGGAGGAGGAGATGACCAAGTACAAGCCCGAATCGGAGGAGCT 
GACGGCAGAGAGGATCACAGAGTTCTGCCACCGCTTCCTGGAGGGCAA 
AATCAAGCCCCACCTGATGAGCCAGGAGCTGCCGGAGGACTGGGACA 
AGCAGCCT 
MHHHHHHM KH NQ LP LVI EFTEQTAPK1 FGG EI KTH 1L 
LF LPKSVS DYDG KLSN F KTAAES F KG KI LFIFI DSDH 
TDN Q RI LEFFG LKKE ECPAVRLITLEEEMTKYKP ES E 
ELTAERITE F CH RF LEG KI KP H LMSQELPEDWDKQP 
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b': 
ATGCATCACCATCACCACCATATGAAACACAACCAGCTGCCCCTTGTCA 
TTGAGTTCACCGAGCAGACAGCCCCGAAGATTTTTGGAGGTGAAATCAA 
GACTCACATCCTGCTGTTCTTGCCCAAGAGTGTGTCTGACTATGACGGC 
AAACTGAGCAACTTCAAAACAGCAGCCGAGAGCTTCAAGGGCAAGATC 
CTGTTCATCTTCATCGACAGCGACCACACCGACAACCAGCGCATCCTC 
GAGTTCTTTGGCCTGAAGAAGGAAGAGTGCCCGGCCGTGCGCCTCATC 
ACCCTGGAGGAGGAGATGACCAAGTACAAGCCCGAATCGGAGGAGCT 
GACGGCAGAGAGGATCACAGAGTTCTGCCACCGCTTCCTGGAGGGC 
MHHHHHHM KH NQ LPLVI EFTEQTAPKI FGG EI KTH 1L 
LFLPKSVSDYDG KLSN F KTAAES F KG KI LFI FI DSDH 
TD NQ RI LE F FG LKKE EC PAVRLITLE EEMTKYKP ES E 
ELTAERITEFCHRFLEG 
bb': 
ATGCATCACCATCACCACCATATGGCTGCCACCACCCTGCCTGACGGC 
GCAGCTGCAGAGTCCTTGGTGGAGTCCAGCGAGGTGGCTGTCATCGG 
CTTCTTCAAGGACGTGGAGTCGGACTCTGCCAAGCAGTTTTTGCAGGC 
AGCAGAGGCCATCGATGACATACCATTTGGGATCACTTCCAACAGTGAC 
GTGTTCTCCAAATACCAGCTCGACAAAGATGGGGTTGTCCTCTTTAAGA 
AGTTTGATGAAGGCCGGAACAACTTTGAAGGGGAGGTCACCAAGGAGA 
ACCTGCTGGACTTTATCAAACACAACCAGCTGCCCCTTGTCATTGAGTT 
CACCGAGCAGACAGCCCCGAAGATTTTTGGAGGTGAAATCAAGACTCA 
CATCCTGCTGTTCTTGCCCAAGAGTGTGTCTGACTATGACGGCAAACTG 
AGCAACTTCAAAACAGCAGCCGAGAGCTTCAAGGGCAAGATCCTGTTC 
ATCTTCATCGACAGCGACCACACCGACAACCAGCGCATCCTGGAGTTC 
TTTGGCCTGAAGAAGGAAGAGTGCCCGGCCGTGCGCCTCATCACCCTG 
GAGGAGGAGATGACCAAGTACAAGCCCGAATCGGAGGAGCTGACGGC 
AGAGAGGATCACAGAGTTCTGCCACCGCTTCCTGGAGGGC 
HHHHHH MAATTLPDGAAAESLVESSEVAVI G FFKD 
VES DSAKQ FLQAAEA I DD I PFG ITS NS DVFS KYQ LDK 
DGVVL F KKFD EG RN NF EG EVTKE N LLD F1 KH NQ LPL 
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VI EFTEQTAPKI FGG EI KTH I LLFLPKSVSDYDG KLSN 
F KTAAES F KG KI LFI FI DSDHTDNQ Rl LE F FG LKKEEC 
PAVRLITLE E EMTKYKP ES EE LTAE RITE FC HR FLEG 
bb'x: 
ATGCATCACCACCACCACCATATGGCTGCCACCACCCTGCCTGACGGC 
GCAGCTGCAGAGTCCTTGGTGGAGTCCAGCGAGGTGGCTGTCATCGG 
CTTCTTCAAGGACGTGGAGTCGGACTCTGCCAAGCAGTTTTTGCAGGC 
AGCAGAGGCCATCGATGACATACCATTTGGGATCACTTCCAACAGTGAC 
GTGTTCTCCAAATACCAGCTCGACAAAGATGGGGTTGTCCTCTTTAAGA 
AGTTTGATGAAGGCCGGAACAACTTTGAAGGGGAGGTCACCAAGGAGA 
ACCTGCTGGACTTTATCAAACACAACCAGCTGCCCCTTGTCATTGAGTT 
CACCGAGCAGACAGCCCCNAAGATTTTTGGAGGTGAAATCAAGACTCA 
CATCCTGNTGTTCTTGCCCAAGAGTGTGTCTGACTATGACGGCAAACTG 
AGCAACTTCAAAACAGCAGCCGAGAGCTTCAAGGGCAAGATCCTGTTC 
ATCTTCATCGACAGCGACCACACCGACAACCAGCGCATCCTGGAGTTC 
TTTGGCCTGAAGAAGGAAGAGTGCCCGGCCGTGCGCCTCATCACCCTG 
GAGGAGGAGATGACCAAGTACAAGCCCGAATCGGAGGAGCTGACGGC 
AGAGAGGATCACAGAGTTCTGCCACCGCTTCCTGGAGGGCAAAATCAA 
GCCCCACCTGATGAGCCAGGAGCTGCCGGAGGACTGGGACAAGCAGC 
CT 
MHH PH HH MAATTLP DGAAAESLVESS EVAVI G FFKD 
VESDSAKQ FLQAAEAI DDI PFG ITS NS DVFSKYQ LDK 
DGVVLFKKF DEG RN N FEG EVTKE N LLD FI KH NQ LP L 
VI EFTEQTAP KI FGGE I KTH I LLFLPKSVSDYDG KLSN 
FKTAAES FKG KI LF IF I DSDHTDNQR I LEFFGLKKEEC 
PAVR LIT LEE EMTKYKP ES EE LTAE RI TE FC HRF LEG 
KIKPHLMSQELPEDWDKQP 
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Full length PDI: 
ATGCATCACCATCACCACCATATGGACGCCCCCGAGGAGGAGGACCAC 
GTCCTGGTGCTGAGGAAAAGCAACTTCGCGGAGGCGCTGGCGGCCCA 
CAAGTACCTGCTGGTGGAGTTCTATGCCCCTTGGTGTGGCCACTGCAA 
GGCTCTGGCCCCTGAGTATGCCAAAGCCGCTGGGAAGCTGAAGGCAG 
AAGGTTCCGAGATCAGGTTGGCCAAGGTGGACGCCACGGAGGAGTCT 
GACCTGGCCCAGCAGTACGGCGTGCGCGGCTATCCCACCATCAAGTTC 
TTCAGGAATGGAGACACGGCTTCCCCCAAGGAATATACAGCTGGCAGA 
NAGGCTGATGACATCGTGAACTGGCTGAAGAAGCGCACGGGCCCGGC 
TGCCACCACCCTGCCTGACGGCGCAGCTGCAGAGTCCTTGGTGGAGTC 
CAGCGAGGTGGCTGTCATCGGCTTCTTCAAGGACGTGGAGTCGGACTC 
TGCCAAGCAGTTTTTGCAGGCAGCAGAGGCCATCGATGACATACCATTT 
GGGATCACTTCCAACAGTGACGTGTTCTCCAAATACCAGCTCGACAAAG 
ATGGGGTTGTCCTCTTTAAGAAGTTTGATGAAGGCCGGAACAACTTTGA 
AGGGGAGGTCACCAAGGAGAACCTGCTGGACTTTATCAAACACAACCA 
GCTGCCCCTTGTCATTGAGTTCACCGAGCAGACAGCCCCGAAGATTTTT 
GGAGGTGAAATCAAGACTCACATCCTGCTGTTCTTGCCCAAGAGTGTGT 
CTGACTATGACGGCAAACTGAGCAACTTCAAAACAGCAGCCGAGAGCT 
TCNAGGGCAAGATCCTGTTCATCTTCATCGACAGCGACCACCCCGACA 
ACCAGCGCATCCTCGAGTTTTTTNGCCTGAAGAANGAAGAGTGCCCGG 
CCGTGCGCCTCATCACCCTGGAGGAGGAGATGACCAAGTACAAGCCCG 
AATCGGAGGAGCTGACGGCAGAGAGGATCACAGAGTTCTGCCACCGCT 
TCCTGGAGGGCAAAATCAAGCCCCACCTGATGAGCCAGGAGCTGCCG 
GAGGACTGGGACAAGCAGCCTGTCAAGGTGCTTGTTGGGAAGAACTTT 
GAAGACGTGGCTTTTGATGAGAAAAAAAACGTCTTTGTGGAGTTCTATG 
CCCCATGGTGTGGTCACTGCAAACAGTTGGCTCCCATTTGGGATAAACT 
GGGAGAGACGTACAAGGACCATGAGAACATCGTCATCGCCAAGATGGA 
CTCGACTGCCAACGAGGTGGAGGCCGTCAAAGTGCACAGCTTCCCCAC 
ACTCAAGTTCTTTCCTGCCAGTGCCGACAGGACGGTCATCGATTACAAC 
GGGGAACGCACGCTGGATGGTTTTAAGAAATTCCTGGAGAGCGGTGGC 
CAGGATGGGGCAGGGGATGATGACGATCTCGAGGACCTGGAAGAAGC 
AGAGGAGCCAGACATGGAGGAAGACGATGATCAGAAAGCTGTGAAAGA 
TGAACTG 
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MHHHHHHM DAPEEEDHVLVLRKS N FAEALAAH KYLL 
VE FYAPWCG HC KA LA P EYAKAAG KLKAEGS EI R LA K 
VDATEESDLAQQYGVRGYPTI KFF RNG DTASP KEYT 
AG R EAD D IVNWLKKRTG PAATTLP DGAAAES LVE SS 
EVAVI GFF KDVES DSAKQ F LQAAEAI DD1P FG ITS NS 
DVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLL 
DFI KH NQLPLVI EFTEQTAPKI F GG EI KTH 1 LLFLPKS 
VS DYDG KLSN F KTAAES F KG KI LF1F1 DS DHPDNQR1 
LE F FG LKKE EC PAVR LITLE E EMTKYKP ES E ELTAER 
ITE FC HRF LEG KI KP H LM SQ ELP EDWID KQ PVKVLVG 
KN FE DVA FD EKKNVFVEFYAPWCG H CKQ LA P IWD KL 
GETYKDH EN IVIAKMDSTAN EVEAVKVH SF PTLKFFP 
ASADRTVI DYN GERTLDG F KKFLESGGQ D GAG DDD 
DLEDLEEAEEPDMEEDDDQKAVKDEL 
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